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The respiratory tract is the primary site of exposure to inhaled substances. A 
growing need exists for high throughput in vitro models of the respiratory 
epithelium, which can provide rapid, reliable safety and effective screening in 
preclinical drug development applications. Normal human bronchial epithelial 
(NHBE) cells were cultured at an air-liquid interface in order to produce an in vitro 
model of the respiratory epithelium for toxicological testing.
Extensive biochemical and morphological characterisation during construct 
development revealed that the NHBE model formed a pseudo-stratified, fully- 
differentiated culture of muco-ciliary phenotype. Histochemical and 
immunohistochemical techniques allowed the identification of basal, Clara, goblet 
and ciliated cells. Developmental characterisation revealed a toxicological dosing 
window of 7 days, where the model was deemed to be fully-established.
Fully-developed NHBE cultures were then exposed to classical pulmonary 
toxicants (CPT); Lipopolysaccharide, cadmium chloride, paraquat, Amiodarone 
and cigarette smoke. Conventional toxicology techniques (culture viability, trans- 
epithelial electrical resistance [TEER] and morphology) were utilised to monitor 
the NHBE response to each CPT. The NHBE model responded with both general 
and toxicant-specific defence/irritancy mechanisms, observed to take place in the 
human bronchial epithelium and as such, reflective of in vivo toxicity.
The in vitro model was finally challenged with candidate respiratory drugs 
(AstraZeneca [AZ]) to test the utility of the cell system as a drug pre-screening 
tool. Blind-exposure of AZ compounds were characterised (physicochemical/ 
biochemically/morphologically) in the in vitro model and compared to AZ in vivo 
(rat) parallel exposure, focusing on irritancy end-points. A comparison of in vitro to 
in vivo exposures resulted in a 76.9 -  85% correlation of irritancy responses.
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1.1 In tr o d u c tio n
The respiratory tract is the primary site of exposure to airborne compounds, 
resulting in a growing need for high throughput in vitro models of this region. This 
project involved the investigation of normal human bronchial epithelial (NHBE) 
cells as a viable in vitro model to study injury, repair and disease mechanisms by 
providing a controlled system for the study of toxicological consequences in vitro, 
which may be predictive of in vivo toxicity.
1.2 T he  H u m a n  R esp ir a to r y  S y s t e m
1.2.1 G e n e r a l  O v e r v ie w
The term ‘respiration’ is used to describe two different but related processes: 1) 
cellular respiration; and 2) mechanical respiration. Survival and energy production 
in most tissues of the body require a supply of oxygen, with subsequent removal 
of carbon dioxide; this is known as cellular respiration. Mechanical respiration or 
ventilation is the mechanical process involved in drawing air into and expelling 
waste gases out of the lungs. In multicellular organisms two types of respiration 
exist; internal and external. Internal respiration is concerned with the exchange of 
oxygen and carbon dioxide between the blood (transported via haemoglobin) and 
the cells in the body (Shier et a!., 2004). Cellular respiration is a part of internal 
respiration, involving the generation of energy (ATP) from glucose; carbon dioxide 
is produced as a by-product of this process (Lodish et al., 2001). External 
respiration is the process of exchanging oxygen and carbon dioxide between the 
atmosphere and the blood, via the lungs (Fox, 2004).
Inhalation exposes the lung to a variety of substances, including, inert, non- 
pathological and xenobiotic particles, pathogenic organisms and toxic/inert gases. 
The ability to remove these particles without causing unnecessary inflammation, 
which could result in permanent damage, is essential (Berne et al., 2004). 
Deposition of such inhaled materials throughout the respiratory tract is mainly 
dependent on size (diameter) (West, 2003). Particles greater than 20pm in
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diameter will not be inhaled beyond the conducting airways and those with 
diameters less than 0.05jjm can behave as gases and can therefore, be exhaled 
before deposition. Particles with diameters between these two size fractions (i.e. 
0.05 -  20pm) will by-pass the conducting airways and deposit (initially) in the 
pulmonary region (Brody, 1984). However, many factors influence particle 
deposition, including, density, shape, solubility and charge of the particle, along 
with tidal volume (volume of inspired/expired air during normal respiration) and 
nasal versus mouth breathing (Stuart, 1984).
Numerous protective mechanisms within the lung enable removal of foreign 
debris. These protective mechanisms (Section 1.4) involve the innate/adaptive 
immune responses, muco-ciliary clearance system and barrier functions (Berne et 
al., 2004). Impairment of these defence and/or repair mechanisms causes either 
transient or permanent damage, sometimes irreparably, resulting in permanent 
tissue remodelling with severe adverse effects (Wong and Shanley, 2001).
1.2.2 S t r u c t u r e  and Function o f  th e  R e s p ira to ry  System
The respiratory tract can be divided into the upper, lower and distal respiratory 
tracts (Figure 1.1). The upper respiratory tract includes the nose, nasal passages, 
paranasal sinuses and pharynx. The trachea, bronchi and bronchioles form the 
lower respiratory tract, with the respiratory bronchioles and alveoli being the 
principle structures of the distal tract (Shier et al., 2004).
The two zones of the respiratory system are the conducting and the respiratory 
zones. The conducting zone includes all anatomical structures that the air passes 
(i.e. conducts) en-route to the respiratory zone, it contains no alveoli and can not 
participate in gaseous exchange and as such, is known as the anatomical dead 
space (Levitzky, 2003). The respiratory epithelium lines the conducting zone and 
functions to warm, humidify, filter and clean inspired air, as well as forming the 
protective barrier (Berne et al., 2004). The respiratory zone is the region 
participates in gas exchange; between the alveoli and pulmonary capillaries. 
Respiratory bronchioles, alveolar ducts and the alveoli constitute the respiratory 
zone, or the so-called pulmonary region (Gardner, 2006; Levitzky, 2003).
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Nasal Cavity
Pharynx
Upper Respiratory Tract
Lower Respirato Trachea
Primary Bronchiole
Distal |
Respiratory Trac
Respiratory Bronchiole 
and Alveolar Unit
Figure 1.1 Image of the respiratory system, indicating separation between upper, lower and distal 
respiratory tracts (Adapted from Stevens and Lowe, 2005).
Functionally, the human respiratory system can be divided into three main 
regions: 1) the extrathoracic region; nose/mouth and larynx; 2) the 
tracheobronchial region; trachea, bronchi and bronchioles; and 3) the pulmonary 
region; respiratory bronchioles and all alveolar regions involved with gas 
exchange (Gardner, 2006). An overview of key structural and functional aspects 
of the human respiratory system is presented in Table 1.1.
Anatomically, the lungs consist of five lobes, with the right lung consisting of three 
and the left of two lobes. Initially, the trachea divides into the left and right primary 
bronchi, supplying the left and right lungs, respectively. The primary bronchus 
branches into the secondary or lobar bronchi which supply each of the five lobes. 
The bronchi continue to divide until they become bronchioles, which lack the 
cartilaginous aspect found in the bronchi and trachea. Numerous divisions of the 
bronchioles occur until they become the terminal bronchioles, denoting the end of 
the conducting zone. Subsequent divisions of the terminal bronchioles results in 
the formation of respiratory bronchioles, marking the beginning of the respiratory 
zone. Further divisions of the respiratory bronchioles create the alveolar ducts, 
which eventually terminate in alveolar sacs (Flasleton and Curry, 2006).
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Table 1.1 Table showing an overview of the human respiratory tract (Drawn by Z. Prytherch, Cardiff University, 2007)
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Generally the lining of the airways from the nasal cavity to the terminal 
bronchioles consists of ciliated, goblet and basal cells (Section 1.3.1). However, 
gradual changes in populations of cell types occur as the airways move from 
conducting to respiratory, e.g. the replacement of goblet with Clara cells (Section 
1.3.1.4), which begins in the bronchioles. The pseudo-stratified columnar 
epithelium eventually presents as a simple, cuboidal, non-ciliated epithelium, with 
the alveoli consisting of Type I and II pnuemocytes (Fox, 2004; Hasleton and 
Curry, 1996).
1.3 C e lls  o f  th e  R esp ir a to r y  L in in g
1.3.1 P r in c ip a l B ro n c h ia l E p ith e lia l C e l ls
In larger airways the conducting zone is lined with a pseudo-stratified epithelium 
containing ciliated cells, mucus-secreting goblet cells and along the basement 
membrane, a layer of basal cells. Intermediate or transitionary cells are located 
above the basal cells, but do not reach the apical region as the ciliated and goblet 
cells do. These are undifferentiated cells of the respiratory epithelium, undergoing 
differentiation into specific cell types, followed by migration to their correct 
location. Further down the respiratory tract, in the bronchioles, the goblet cells 
become less frequent and become gradually replaced by another type of cell, the 
Clara cell. (Breeze and Wheeldon, 1977; Fox, 2004; Levitzky, 2003). This 
replacement of goblet with Clara cells is due to the fact that Clara cells do not 
produce mucin, which would impair gaseous exchange in the alveoli (Breeze and 
Wheeldon, 1977).
With respect to this PhD research project, the principle site of investigation was
the bronchial epithelium, which contains ciliated, Clara, goblet, intermediate and
basal cells (Figure 1.2).
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Figure 1.2 The characteristic pseudo-stratified, muco-ciliary bronchial epithelium: NHBE culture. 
Displaying: GC = goblet cell (delineated); CC = ciliated cell; CIC = Clara Cell (delineated); BC = 
basal cell and IC = intermediate cell (Image by Z. Prytherch, Cardiff University, 2010).
1.3.1.1 C iliated  C ells
The ciliated cells are the most prevalent in the tracheobronchial epithelium, 
approximately 5 to every 1 mucous secreting cell (Rhodin, 1966). 
Morphologically, ciliated cells are roughly columnar, i.e. 20pm in height, 7pm in 
width, tapering to a width of 2pm at the basal end of the cell, where they attach to 
the basement membrane (Breeze and Wheeldon, 1977). The ciliated cell has an 
oval nucleus located towards the tapered (basal) end (Rhodin, 1966).
Cilia are present on the luminal (apical) surface of ciliated cells (Figure 1.2); their 
length and number varying according to the maturity of the cell. There are 
approximately 250 cilia (-6pm in length and 0.3pm in width) per cell (Rhodin, 
1966). An array of longitudinal microtubules are located inside the cilia, which 
form a ‘9 + 2 array’; consisting of 9 peripheral doublet microtubules surrounding 2 
central singular microtubules; the microtubules emerge from the basal bodies 
located just inside the apical region of the ciliated cells (Karp, 2005). Numerous 
mitochondria are located in the apical portion of the cell, surrounding the basal
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bodies. These mitochondria generate the energy (ATP) required for the cilia to 
beat and therefore move the mucus (Satir, 1989). Interspersed among the cilia 
are microvilli, which can extend to 2pm in height and 0.1pm in width and are 
particularly abundant on the apical surface of the ciliated cells; especially on 
immature cells (Breeze and Wheeldon, 1977). Actin filament bundles cross-linked 
by myosin, villin and fimbrin proteins constitute the internal structure of the 
microvilli (Karp, 2005).
1.3.1.2 G o b let  C ells
Goblet cells are located throughout the conducting airways (Rogers, 2003). Their 
prevalence decreases as the lower respiratory tract becomes the distal 
respiratory tract (i.e. between the 5th and 12th bronchial division), beyond which 
they normally disappear (Berne etal., 2004).
The term ‘goblet’ cell arose due to the cells typical ‘drinking cup’ (i.e. goblet) 
shape, which is a result of the accumulation of secretory mucous granules within 
the apical portion of the cell (Rhodin, 1966). However, immature goblet cells are 
generally more columnar in comparison (Breeze and Wheeldon, 1977). The 
nucleus is oval and found towards the base of the cell. The characteristic shape is 
also due to the basal portion of the cell tapering and occasionally appearing to 
twist around intermediate and basal cells, before contacting the basement 
membrane (Figure 1.2) (Rhodin, 1966). The main function of goblet cells is the 
production (and release) of mucopolysaccharides, which form the protective 
mucus barrier (Section 1.4.1.2) (Chilvers and O’Callaghan, 2000).
1.3.1.3 B asa l C e lls
Basal cells form along the basement membrane of the respiratory tract and have 
long been regarded as the progenitor cells of the adult bronchial epithelium 
(Ayers and Jeffery 1988; Baldwin, 1994; Breeze and Wheeldon, 1977; Inyama et 
ai, 1988). The basal cells contribute to a decreasing proportion of total epithelial 
cells along increasing airway generations. The mean percentage of basal cells, in 
epithelia of airways with diameters greater than 4mm, is approximately 31%
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(Boers et al., 1998). The epithelia of airways with diameters less than 0.5mm 
consists of roughly 6% basal cells (Boers et al., 1998). Under normal conditions 
the basal cells are the dominant (>50%) cell type in the proliferative compartment 
(actively proliferating cells), in airways with diameters greater than or equal to 
0.5mm (Boers et al., 1998).
Apart from locality, basal cells have a distinct, well-characterised morphology; 
being relatively small in size, round in shape and large nucleus-to-cytoplasm ratio 
(Figure 1.2) In addition, very few cytoplasmic organelles or granules are 
contained within these cells (Baldwin, 1994). Basal cell attachment to the basal 
lamina is mediated via hemidesmosomes (Section 1.4.1.1) (Boers etal., 1998).
1.3.1.4 C la r a  C e l ls
Further down the respiratory tract, in the bronchioles, the goblet cells become 
less frequent and are replaced by Clara cells. They are predominantly located in 
terminal (11% of total epithelium) and respiratory bronchioles (22% of total 
epithelium) (Widdicombe, 2002). Clara cells are non-cilliated, non-mucus, dome­
shaped, secretory epithelial cells. Their apical surface contains some microvilli 
and is characteristically dome-shaped (Figure 1.3). Electron-dense proteinacous 
granules are found within the Clara cells apical cytoplasm. Clara cells are 
renowned for being metabolically very active and contain numerous mitochondria 
for this purpose (Boers et al., 1999).
Although not all of the Clara cells functions are fully understood, their major roles 
include, secretion of the periciliary sol (Section 1.4.1.2), production of Clara cell 
specific proteins, cell renewal and metabolism of xenobiotics (Boers et al., 1999; 
Singh and Katyal, 2000; Widdicombe, 2002). Boers and co-workers (1999), 
concluded that in concordance with Clara cells in animal lungs, where present in 
human lungs, they contribute to cell renewal in normal conducting airway 
epithelium. However, in response to injury, Clara cells have been known to be 
replaced by goblet cells (Widdicombe, 2002).
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Figure 1.3 Scanning electron micrograph of the surface of a respiratory bronchiole from normal 
rat lung. Shows Clara cells (CIC) interspersed among ciliated epithelium (CC) (Image taken by D. 
Balharry and M. Hicks, Cardiff University, 2004).
Clara cells are known to secrete a variety of proteins: 10-kDa protein (CC10 or 
CCSP); 55-kDa protein; tryptase, (3-galactoside-binding lectin; Surfactant proteins 
A, B and D (SpA, SpB and SpD); and phospholipase. CC10 is one of the most 
prevalent proteins in the airway lining fluid (Berne et al., 2004; Watson et al., 
2001) with its main actions is thought to be, anti-inflammatory and immuno­
suppressive (Singh and Katyal, 2000).
1.3.1.5 E pithelial S erous  C ells
Morphologically, the epithelial serous cell has an irregularly outlined nucleus, a 
relatively electron-dense cytoplasm and highly electron-dense, membrane-bound 
secretory granules. The number of secretory granules varies between cells, and 
are principally situated at the cell apex, where a few microvilli also protruded 
(Jeffery and Reid, 1975). The serous cells main role is innate airway protection 
and they produce and secrete numerous protective proteins, including, lysozyme, 
lactoferrin, peroxidase and anti-leukoprotease (Basbaum et al., 1990). The airway 
serous cells are predominantly located in the airway submucosal glands 
(Basbaum et al., 1990), however, they are also located as part of the respiratory 
epithelium (Bals et al., 1998; Young and Heath, 2000).
10
In  I R O D U C l ION
1.3.1.6 In te rm ed ia te  C e lls
Intermediate cells are so-called because of their ‘intermediate’ location, with their 
nucleus above the basal cells, but not reaching the apical surface of the 
epithelium. These cells are basal cells that have begun, but not completed the 
process of differentiation into a ciliated, Clara, goblet or secretory cell (Breeze 
and Wheeldon, 1977).
1.4 P r o t e c t iv e  M ec h a n ism s
The lungs have developed many protective mechanisms against the inhalation of 
debris. Efficient removal of foreign material, without causing unnecessary 
inflammation, is essential in maintaining lung function. Initial protection is 
generally provided by mechanical barriers and components of the innate immune 
system (Section 1.4.2.1). Failure of the innate immune system to eliminate an 
inhalation hazard will result in the activation of the adaptive immune system 
(Section 1.4.2.2) (Janeway et al., 2005). These protective mechanisms are not 
mutually exclusive and work together to protect the lung. These systems can be 
divided into, physical/non-immunological and immunological mechanisms.
1.4.1 P h y s ic a l and N on-Im m unological D e fe n c e  Mechanisms
Structurally, the lungs have to balance between protection and function; ensuring 
adequate gaseous exchange to survive, whilst protecting from airborne debris 
and noxious gases. Initial, non-immunological mechanisms, which form part of 
the baseline protection and encompass both reflexive (e.g. sneezing) and non­
reflexive (e.g. humoral defence) responses.
Hairs of the nasal mucosa are the initial filtering system, trapping the vast majority 
of particulate matter over 20pm in diameter and as much as 50% of particles 
above 5pm in diameter, from progressing into the respiratory tract. In addition, 
mouth breathing prevents most particles over 10pm in diameter from trans­
locating beyond the trachea (Berne et al., 2004). Deposition of inhaled particles 
(90% of those above 2pm in diameter), which have by-passed the initial filters,
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collect on the mucus lining and are removed from the respiratory tract (via the 
muco-ciliary escalator) and ingested (Section 1.4.1.2) (Korpa§ and Honda, 1996).
Many reflex processes within the respiratory system execute an extremely rapid 
(milliseconds), defensive response to foreign inhalants. For instance, chemical 
irritants can cause rapid, shallow breathing, thereby preventing its access to the 
pulmonary region. Laryngo- and broncho-constriction cause an increase in airflow 
turbulence (compared to normal laminar flow), thereby increasing impaction and 
trapping of particles onto the mucus lining. Sneezing and coughing both violently 
expel contaminated air, with coughing also aiding in the expulsion of mucus and 
its associated detritus (Korpas and Honda, 1996). Muco-ciliary clearance is 
considered a non-immunological function, although, many mucus components 
are, in fact, immunological (Section 1.4.2).
1.4.1.1 C ell Ju n c tio n s  in the  Bro n ch ia l  E p ith e liu m
One of the major functions of the respiratory epithelium is its ability to ‘maintain a 
protective barrier’ between the airway lumen and the internal milieu. The cell 
junctions in vertebrate epithelial cells play a vital role in managing the structural 
integrity of an epithelial barrier and are defined as: 1) cell-cell junctions; tight 
junction, adherens junction and desmosomes, which collectively form the 
‘junctional complex’, as well as the gap junction and; 2) cell-matrix junctions; 
hemidesmosomes (Alberts et al., 2002) (Figure 1.4). With respect to this PhD 
research project the focus will be on the junctional complex, specifically tight 
junctions.
Tight junctions (or zonulae occludens) are the most apically located of all 
epithelial junctions (Farquar and Palade, 1963) and are essential in maintaining 
the barrier properties of epithelial sheets. The main functions of tight junctions are 
three-fold: 1) to establish a semi-permeable barrier for the paracellular transport 
of ions and solutes; 2) confer apico-basal polarity within the epithelium; and 3) co­
ordinate signalling and trafficking molecules involved in cellular differentiation, 
proliferation and gene expression (Chiba et al., 2008; Guillemot et al., 2008). In 
the bronchial epithelium, in particular, the regulatory role the tight junctions play in
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the paracellular transport of ions is of particular importance. This regulation helps 
maintain the level and limit the viscosity of the periciliary sol, which in itself 
enables the efficient removal of mucus along the muco-ciliary escalator (Section 
1.4.1.2) (Chilvers and O’Callaghan, 2000).
Airway
Lumen
Tight JunctionActin
Junctional
Complex Adherens Junction
Desmosome
Gap JunctionIntermediate
Filaments
Hemidesmosome
Basal Lamina
Figure 1.4 Schematic diagram of the various epithelial cell junctions. Tight junctions: essential in 
maintaining the barrier properties of epithelial sheets. Adherens junctions: associated with actin 
filaments, usually form an adhesion belt around the cells. Desmosomes: form cell-cell contacts 
and are associated with intermediate filiaments. Gap Juntions: allows passage of small water- 
soluble ions and molecules. Hemidesomosomes: resemble half a desmosome, form contacts 
between the cell and the extracellular matrix of the basal lamina (Adapted from Alberts et al., 
2002; drawn by Z. Prytherch, 2009).
Freeze fracture transmission electron microscopy (TEM) observations of epithelial 
tight junctions, reveals a series of lateral intra-membrane strands (Godfrey, 
1997). Claude (1978) discovered that the trans-epithelial electrical resistance 
(TEER) across an epithelium increases exponentially with the number of these 
strands, with TEER now considered a valid measurement for cell culture 
junctional formation (Gardner et al., 1997).
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Each adjacent epithelial cell contains a series of specific transmembrane proteins 
which interact with each other to confer its barrier role. The integral 
transmembrane proteins involved in mammalian tight junctions are occludin, 
claudins, junctional adhesion molecules and tricellulin (Chiba et al., 2008). The 
cytoplasmic ends of the tight junctions transmembrane proteins interact with a 
variety of proteins; the most common being the zonula occludens (ZO) proteins. 
The ZO proteins are integral to the formation and regulatory functions of tight 
junctions, as they link the transmembrane proteins to the actin cytoskeleton and 
also mediate signalling responses through the ZO-1 associated nucleic acid 
binding protein (Guillemot et al., 2008).
1.4.1.2 M u cin  a n d  t h e  M u c o -C iliary  E sc a la to r
The upper airways are lined by mucus, forming an important barrier to inhaled 
particles, aiding opsonisation and clearance of various foreign bodies from the 
respiratory tract (Fox, 2004). The major macromolecular constituents present in 
airway mucus are mucins. Mucins are high molecular weight glycoproteins (2 -  
20 x 105Da; Rose and Voynow, 2006), which upon release into the airway lumen 
combine with other lipid, protein and glycoconjugate compounds to produce a 
dilute aqueous solution, in the form of mucus (Rogers, 2003). Mucins can be 
membrane-bound (tethered), which are integrated into the cellular membrane or 
secretory, which are released apically in response to secretagogues (Rose and 
Voynow, 2006).
The general composition of mucus is; water (95%), glycoproteins (2%), lipids 
(1%), proteins (1%) and salts (1%) (Samet and Cheng, 1994). Mucus contains a 
comprehensive array of compounds essential for the protection of the respiratory 
epithelia. These compounds form part of the innate immune system (Section 
1.4.2.1) providing an initial defence to inhalants. These protective components 
include: immunoglobulin A (IgA), lysozyme, lactoferrin, a- and p-defensins and 
collectins (Boyton and Openshaw, 2002; Nicod, 1999).
Synthesis of pulmonary mucin occurs predominantly in goblet cells and the 
submucosal glands (Chilvers and O’Callaghan, 2000). Mature mucins are tightly
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packed into secretory vesicles or granules and are released rapidly via exocytosis 
in response to secretogogues. Rapid conformational changes occur to the mucins 
as they are released via exocytosis; expanding and swelling by hydration 
(Chilvers and O’Callaghan, 2000). The resultant mucus is relatively flexible and 
sticky (viscoelastic properties), which aggregate in the airways forming large 
inter-woven networks (Rose and Voynow, 2006). This visco-elasticity makes them 
ideal for trapping particulate matter within the lungs, as well as absorbing 
gaseous aerosols (Kim et al., 1997; Thompson e ta i,  1995).
Efficient function of the muco-ciliary escalator requires cilia to be immersed in the 
periciliary sol, with their tip in the mucus gel phase. This allows ease of propulsion 
through the low viscous sol and maintenance of contact with the mucus to aid its 
clearance (Figure 1.5). Therefore, regulation of the periciliary sol is essential to 
efficient muco-ciliary clearance (Chilvers and O’Callaghan, 2000), this is 
maintained by a combination of Na+ absorption (epithelial Na+ channels) and Cl' 
secretion (Cl' channels, e.g. cystic fibrosis transmembrane conductance 
regulator) (Boucher, 2003).
The main function of ciliated cells is propulsion, and therefore clearance of, 
mucus along the respiratory tract, for eventual ingestion. The cilia beat in a co­
ordinated fashion, with the frequency varying between 100-300pm x s'1 (Nicod,
1999). Ciliated cells have the ability to modify their basal beat frequency in 
response to pulmonary toxicants, thereby, increasing the rate of muco-ciliary 
clearance (Chilvers and O’Calaghan, 2000). Numerous mitochondria located 
around the basal bodies, at the root of the cilia, provide the energy (ATP) required 
for ciliary beating (Breeze and Wheeldon, 1977).
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Figure 1.5 Schematic diagram of the muco-ciliary escalator. Showing the involvement of cilia in 
the propulsion of mucus out of the airways and into the gastrointestinal tract (Drawn by, Z. 
Prytherch, 2010).
1.4.2 Im m u n o lo g ic a l  Defence  M ech an ism s
The immunological defence mechanisms can be divided into the innate and 
adaptive responses. Innate immunity involves ‘ever-present’ and non-specific 
components of the immune system. Adaptive immunity involves the generation of 
an immune response to a specific antigen and generally results in the formation 
of immunological memory (Janeway et al., 2005). Many components of the innate 
immune system can result in the activation of the adaptive immune system and 
are therefore, considered part of the adaptive response.
1.4.2.1 In n a t e  Im m u n e  S ys te m
Inhaled pathogens are generally detected and eliminated within minutes or hours 
after entry. This initial protective mechanism is performed by the innate immune 
system. The lungs innate immune system includes specific immune cells, the 
most important include, neutrophils, eosinophils, basophils, mast cells and natural 
killer cells (Berne et al., 2004; Janeway et al., 2005; Kroegel et al., 1994; Nicod, 
1999; Tosi, 2005; Warner and Kroegel, 1994). Protective proteins are released by 
these cells (such as the immunoglobulins (Ig); not covered here) and the cells of
1 6
In t r o d u c t io n
the respiratory epithelium (major proteins listed; Table 1.3) (Berne et al., 2004; 
Burnett, 1986; Gerritsen, 2002).
Innate  Imm unity  
Proteins K ey Featu r es
Surfactant
Protein
• Four surfactant proteins (SP), belong to the collectin 
family, synthesised by Type II, Clara and submucosal cells
• SP-A and -D  bind pathogens; enable opsonisation and 
phagocytosis
Lactoferrin
• Iron-chelating glycoprotein, produced by neutrophils, 
epithelial and serous cells
• Agglutinates bacteria, increases Gram-negative bacteria 
membrane permeability, also anti-viral and anti-fungal
Secretory
Leucoprotease
Inhibitor
• Expressed by macrophages, neutrophils, goblet cells, 
Clara cells and serous cells
• Inhibits, neutrophil elastase, mast cell chymase, cathpesin 
G, chymotrypsin and trypsin
• Anti-bacterial, anti-viral and anti-inflammatory
|B-Defensins
• Mainly secreted by epithelial cells
• Potently antimicrobial to Gram-negative bacteria and 
chemotactic for leukocytes, T-cells and dendritic cells.
CCL20 • Bacteriocidal chemokine, produced by epithelial cells and neutrophils, upregulated by pro-inflammatory cytokines
Table 1.2 Table describing the principle proteins involved in innate immunity produced by 
bronchial epithelial cells. (Boyton and Openshaw, 2002; Cole and Waring, 2002; Eggleton and 
Reid, 1999; Gerritsen, 2000; Rogan et al., 2006; Salvi and Holgate, 1999; Singh et al., 1998; 
Thompson etal., 1995; Wright, 2005).
1.4.2.2 A daptive  Imm une  System
Failure of the innate immune system to contain and stop an attack, results in the 
activation of the adaptive immune response. This involves the production of 
specific antibodies to specific antigens, involving lymphocytes, antigen presenting 
cells and their associated mediators (Table 1.3) (Janeway et al., 2005). The 
failure of these systems, or their prolonged activation of these defence 
mechanisms can transform the physiological defence mechanisms into a 
pathological response (e.g. Chronic Obstructive Pulmonary Disease; COPD) 
(Korpas and Honda, 1996). The adaptive immune system is the body’s primary
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defence mechanism in non-mucosal tissues. In mucosal tissues, such as the 
lung, the adaptive immune system plays a secondary role, this is essential to 
protect the lungs’ function. Once activated the adaptive immune response is the 
same in the lung as in any other systemic organ (Berne et al., 2004).
C ell  T ype K ey F eatu r e
T-Cells
• Cytotoxic T-cells (CD8+) detect antigens displayed by 
MHC class I on APCs; activates caspases (cell death)
• T helper (TH) cells (CD4+) activate other immune cells, 
are subdivided into TH1 and TH2 cells
•  Th1 cells: involved in cell mediated immunitv: induced 
by IL-12; on activation produces IL-2, IFN-y, GM-CSF 
and TNF-(3; causes B-cells to secrete specific lgG2a, 
activates CD8+ cells and attracts neutrophils and 
monocytes
• Th2 cells: involved in humoral immunitv: on activation 
produces IL-4, -5, -6, -10 and -13; causes B-cells to 
secrete specific IgGi and IgE and attracts basophils 
and eosinophils
• Th1 and Th2 cells suppress the development of each 
other, via the cytokines they produce
B-Cells
• Activated by direct antibody-antigen contact or co­
stimulation by Th cells
• Activation; initial IgM expression, can then undergo 
isotype switch to IgG, IgA, IgE or memory B-cells
• Release of Ig’s leads to agglutination, neutralisation, 
opsonisation or complement activation and the 
formation of the ‘membrane attack complex’
Dendritic Cells
• Immature Dendritic cells located above and below the 
basement membrane, extend finger like projections 
into conducting airway lumen, constitute a highly 
reactive population in the lung, more prevalent in 
upper airways
• Poor phagocytes, but most potent APCs in the airway
• Express antigen-MHC complex to activate T-cells
Table 1.3 Principle cells of the adaptive immune system in the airways and their key features. 
MHC = major histocompatibility complex; APC = antigen presenting cell (Berne et al., 2004; 
Boyton and Openshaw, 2002; Gordon and Read, 2002; Holtzman, 2001; Janeway et al., 2005; 
Moore etal., 2001; Nicod, 1999; Nicod, 2005; Wright, 2005).
T-cells are the most prevalent lymphocytes in normal airways and mostly express 
the a(3 T-cell receptor (TCR) (Baraldo et al., 2007). These T-cells can be divided
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into CD4 and CD8 T-cell populations, with the CD4’ population having the ability 
to become either Th1 or Th2 (T-helper) cells, their specific roles and functions are 
summarised (Table 1.3). Excessive activation of the Th1 population can result in 
sarcoidosis, whilst in the TH2 population can cause atopic asthma (Boytori and 
Openshaw, 2002). Another population of T-cells are those expressing the y5 
TCR, these are known as innate-like lymphocytes and have specific 
immunosurveillance properties and are particularly associated with epithelial 
surfaces, such as the bronchial epithelium. y6 TCR T-cells may recognise 
antigens without co-stimulation from MHC molecules and have been shown to 
suppress the IgE response to inhaled antigens (Berne et al., 2004; Janeway et 
al., 2005).
1.5 In v e s t ig a t iv e  M o dels  o f  P u l m o n a r y  T o x ic it y
Methods of accurately studying inhalation toxicology, with respect to humans, 
have proven difficult. Testing on humans (in vivo) is obviously the most accurate 
(BeruBe et al., 2009; Seagrave et al., 2005); but, ethically can not be employed to 
study toxic compounds. Historically, animals, especially mammals, with 
pulmonary anatomy similar to that of humans have been utilised (Section 1.5.1). 
The results would then be extrapolated to predict human responses, such as 
toxicologic or immunologic responses. Many researchers continue to use whole 
animal models as a method of investigating human pulmonary responses 
(Section 1.5.1.1). Alternative methods of investigation do exist and involve 
perfused organs/tissues (Section 1.5.1.2) and cell culture (Section 1.5.2 -  1.5.3) 
techniques. Current models all possess advantages and disadvantages, with 
some degree of adaptation, to the actual human in vivo response, still wanting.
1.5.1 A n im al M o d e ls
1.5.1.1 W h o le  A n im a ls
Mammals commonly used by researches include, rats (Chu et al., 2007), rabbits 
(Lin et al., 2007), guinea pigs (Fiala et al., 2005), dogs (Humphrey et al., 1981), 
sheep (Jerome et al., 1996) and non-human primates (Kreyling et al., 1992). Test
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compounds would be administered either by inhalation or intratracheal instillation, 
to a set number of test animals; control animals would undergo the same process 
minus the compound. Animals would be sacrificed and lungs removed in order to 
obtain bronchoalveolar lavage and tissue samples for microscopical and 
toxicological analysis (Housley et al., 2002; Leong et al., 1998; Xu etal., 2004).
One of the most challenging aspects of using animals to predict human 
responses is to accurately extrapolate the data (Miller et al., 1983). There are 
many discrepancies between humans and animals that will affect the reliability of 
these models including, particle deposition (Schlesinger, 1985); anatomical 
difference in the branching of the tracheobronchial tree (Brody, 1984); types and 
composition of cells present (Breeze and Wheeldon, 1977; Thomassen and 
Nettshiem, 1990); differences in biotransformation enzymes (Castell etal., 2005); 
physiological defences such as changes in breathing pattern and reduction in 
metabolic rates (Mautz, 2003).
1.5.1.2 P e r fu s e d  O rg a n s
Isolated perfused organs are used to investigate the xenobiotic effects on the 
whole lung (Nakata and Dahms, 2000; Parker et al., 1999; Rimar and Gillis, 1995; 
Steinhorn et al., 2000; Yamane and Kawata, 1999). The lungs and the heart are 
removed from the animal and maintained (artificially) physiologically and 
anatomically as close to the in vivo situation as possible. The lungs undergo 
controlled ventilation and are perfused under constant flow rates and pressure. 
Many factors need to be carefully chosen and regulated to maintain close in vivo 
accuracy (e.g. perfusate, temperature and pH) (Niemeier, 1984). The perfused 
organ technique allows investigators to apply xenobiotics in numerous manners 
(e.g. inhalation, instillation and via the circulation) and also to monitor the effect 
on the lungs as well as diffusion across the air-blood barrier (Sakagami, 2006).
However, the technique is time-limited ( 2 - 3  hours), with only acute toxicant 
exposures possible, difficulties in determining the specific location of drug 
interactions, the need for a highly qualified operator (Sakagami, 2006) and they
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have the problem of accurate extrapolation to human responses (Niemeier,
1984).
1.5.2 M o n o l a y e r  C ell  C ultu re  M o d els
Monolayer cell culture models are much less complex than whole animals and 
perfused organs, with only one or a few cell types involved and the systemic 
effect removed. They provide an economic advantage, in so far as, replicate 
numbers are easier to obtain, much smaller quantities of compounds are used 
(due to direct application) and no animal-housing fees are paid. Additionally, the 
specific interactions of the xenobiotic with a particular cell type or epithelium and 
its response, in turn, can be elucidated with greater ease. The cells used perform
many normal processes, such as proliferation. Cell cultures can be grown on solid
substrates to which the cells attach or cultured in suspension (Freshney, 2005). 
Human cell culture models can be divided into three main groups: 1) carcinoma- 
derived; 2) virus-transformed; and 3) primary.
In addition to the three main cell culture models there is a rat tracheal epithelial 
(RTE) cell line which arose from spontaneous immortalisation of primary RTE 
cells. This cell line is known as SPOC1 and has upregulated mucin production 
compared to primary RTE cells (Doherty etal., 1995; Randell et al., 1996).
1.5.2.1 C a rc in o m a -D e r iv e d  C e l l  L ines
Carcinoma-derived cell lines have been established from normal human cells that 
have become carcinogenic. These cells have been immortalised and can be 
Passaged indefinitely; a great advantage in cell culture work (Freshney, 2005). A 
major disadvantage is that the cell lines generally represent one cell type and 
therefore, do not represent the multi-cellular reactions present in vivo. Tight 
junctions do not always form and if present, are not always fully-functional. Due to 
their neoplastic nature, carcinoma-derived cells are likely to display untypical 
phenotypes, with discrepancies in the cell cycle, redox mechanisms, and 
metabolic functions (Forbes, 2000; Simon et al., 1981). Two widely-used 
carcinoma-derived pulmonary cell lines are the Calu-3 and A549.
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The Calu-3’s are derived from a human bronchial adenocarcinoma (Forbes, 
2000). They posses many features characteristically found in the human 
tracheobronchial region; form confluent polarised monolayers, possess TEER 
(with discrepancies between laboratories; BeruBe et al., 2009), contain P450 
enzymes (Foster et al., 2000), transport systems and efflux pumps (Florea et al., 
2003), produce and secrete mucus glycoproteins and contain microvilli (Grainger 
et al., 2006). Consequently, Calu-3 cells are widely used as a pulmonary drug- 
transport model. However, limitations of this model include, monolayer cultures, 
lack of some biotransforming enzymes, no cilia as well as some uncharacteristic 
phenotypes due to carcinogenic origin of cell type (Forbes, 2000; Grainger et al., 
2006).
The A549 cell line is derived from a human Type II cell adenocarcinoma. These 
cells are known to form confluent monolayers, demonstrate some barrier 
resistance (but low TEER values), contain lamellar bodies (Foster, 1998) and 
retain the majority of Type II metabolising enzymes (i.e. the CYP family of 
enzymes). Therefore, they are a relatively good model to investigate the 
metabolising of xenobiotics within the respiratory region of the lung (Hukkanan et 
al., 2000). Disadvantages of the A549 include a lack of fully-functional tight 
junctions (Wang and Zhang, 2004) and in vivo Type II cells only account for 
approximately 5% of the total surface area of the alveoli, therefore, this model 
does not represent predominant alveolar cell type (by surface area), the Type I 
cell (Forbes, 2000).
1.5.2.2 V iru s -T ra n s fo rm e d  C e l l  L ines
Viral genes or vectors have commonly been used to transform or ‘immortalise’ 
cells for use in cell culture. By immortalising the cells, the major problem of a 
limited Passage number with primary cells is overcome. 16HBE14o- cells are 
human bronchial epithelia cells transformed by SV40 (Westmoreland et al., 1999) 
and were originally developed to study the cystic fibrosis conductance regulator 
(CFTR) (Gruenert, 1988). This cell culture system is known to form a polarised, 
multilayered culture, containing tight junctions and expresses many drug- 
transporters and drug-related proteins (Ehrhardt et al., 2003; Forbes, 2000; Wan
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et al., 2000). The major disadvantages associated with this cell line are, 
deficiency in producing the protective mucus covering as well as the possibility 
that important transcription factors of relevant genes may be altered or not 
expressed (Forbes, 2000).
1.5.2.3 P r im a r y  C ells
Primary cells are removed from humans or animals either during a surgical 
procedure or immediately after death. The cells undergo a series of enzymatic 
digestion and filtration treatments to separate them from contaminating cells 
(Elbert et al., 1999). Primary cells can only undergo a definite number of 
Passages before they begin to lose their viable characteristics; the major draw­
back to primary cell cultures (Freshney, 2005).
Human alveolar (Elbert et al., 1999) and tracheobronchial epithelial (Gray et al., 
2004; Hill et al., 1998) primary cell cultures have been utilised as investigative 
models. Both of which have been demonstrated to form confluent cultures, 
providing relatively-accurate, in v/Vo-like morphological and physiological 
properties. In addition to this numerous researchers have cultured animal primary 
tracheobronchial cells in order to create in wVo-like models. Primary dog (Welsh,
1985), guinea pig (Adler et al., 1987), bovine (Kondo et al., 1993) and rat 
(Kaartinen et al., 1993) tracheobronchial cells have all been cultured successfully 
in vitro to create morphologically and biochemically accurate models.
1.5.3 H u m a n  T is s u e  Eq u iva len t  M o d els
Public opinion along with Government legislation has driven the need for the 
development of alternative in vitro models in order to refine, replace and reduce 
the number of animals used in scientific research (EU Directive 76/768/EEC, 
2003; FRAME, 2010; NC3R, 2010). Tissue equivalent models are one way of 
answering this need, producing a reliable in vitro model predictive of in vivo 
toxicity. There are a number of commercially available cell models that 
researchers may purchase. Currently, the industry leaders are the MatTek 
Corporation (USA), who provide a tissue equivalent model and Lonza
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(Switzerland), who provide primary human bronchial epithelial cells, from which 
we tissue-engineered a human bronchial epithelium model, the focal point of this 
research. Both systems imitate the in vivo characteristics of the human 
tracheobronchial/bronchial epithelium.
_  _  TM
1.5.3.1 MatT e k E piA irway T issue M odel
The EpiAirway™ model system is a primary, normal human tracheal/bronchial 
epithelial (NHTBE) cell system, currently available from MatTek Corporation 
(Ashland, MA, USA). The airway model involves growing the cells on 
polycarbonate membranes or ‘inserts’, at an ‘air-liquid interface’ (ALI) (Figure
1.6).
M atTek’s EpiAirway™ Tissue model
”
Tissue Culture Well
Medium
apical surface 
nucleus
basal surface 
membrane
™Figure 1.6 MatTek EpiAirway model. A: Diagrammatic representation of the insert system used 
to grow the NHTBE cells at an ALI and B: Light microscope image of MatTek EpiAirway™ cell 
cultures (MatTek, 2008).
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MatTek claim that their system contains, highly-differentiated cells that are 
pseudo-stratified, of muco-ciliary phenotype, form tight junctions, as well as 
express human cytokines. However, from the images on their website the model 
appears more stratified than pseudo-stratified and also displays evidence of basal 
cell hypertrophy. Additional drawbacks of the system are its great expense and 
relatively small viability window, during which time the cultures can used 
experimentally (e.g. 72 hours) (BeruBe et al., 2009). The standard purchase price 
is $1,500 USD for 24 cell culture inserts (6.5mm).
1.5.3.2 NHBE C e l ls
Lonza (Basel, Switzerland) provide commercially available normal human 
bronchial epithelial (NHBE) cells as part of their ‘Clonetics® Primary Cell and 
Media Systems’. These can be purchased as cryopreserved primary cells 
(£500,000 cells/ampoule) or as proliferating cells (second passage; T-25 flask).
Normal bronchial epithelial cells, removed by enzymatic digestion have been 
cultured in vitro previously (Adler et al., 1987; Engelhardt et al., 1991; Terzaghi et 
al., 1978; Wu et al., 1986). These were all cultured at an ALI and all produced a 
pseudo-stratified epithelium of muco-ciliary phenotype. The downside is that it 
required 4 weeks of cell culture routines to obtain a working system (Figure 1.7). 
Advantages of this system compared to the MatTek NHTBE are its the greater 
exposure window (e.g. 7 days versus 72 hours) and the lower cost per insert 
(£600/300 inserts v $1,500/24 inserts). The downside to this system when 
compared to the MatTek version is that the MatTek model comes ‘ready-to-use’, 
whereas our system needs to be cultured for -4  weeks prior to being fully- 
differentiated.
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confluent 
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Figure 1.7 Basic outline of the operational procedures of cell culture manipulations using the 
NHBE model system. NHBE cells were thawed from a cryovial and third Passage NHBE cells 
seeded into Millipore® inserts. Once the culture was fully-differentiated, cells were treated with 
xenobiotic/controls followed by toxicological and morphological analysis.
1 .6  V a l id a t io n  o f  a  ‘ N e w ’ R e s p ir a t o r y  M o d e l
Once a ‘new’ in vitro model has been developed it is important that the model 
undergoes full-characterisation, morphologically, biochemically and 
toxicologically, in order to validate it as a suitable alternative model. In order to 
utilise the model in toxicological testing it must be evaluated in response to 
known, classical pulmonary toxicants, blind-tested to unknown pulmonary 
toxicants and if possible compared to current in vivo models of respiratory 
toxicology.
1.6.1 B io chem istry  and  Morphology
Extensive characterisation of an alternative, in vitro model for in vivo inhalation 
toxicology is essential in order to ensure that it not only morphologically 
resembles, but also behaves biochemically as the in vivo respiratory epithelium.
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1.6.1.1 B io c h e m is tr y
Important biochemical parameters (Chapter 2) to assess in an airway epithelial 
model are TEER (Gardener et al., 1997) and analysis of the apical secretions (if 
present) (Rogers, 2003). TEER is used to measure junctional formation in cell 
cultures and considered a valid and sensitive method (Gardner et al., 1997; 
Pasternak and Miller, 1995). A Bradford assay (detects protein) on apical washes 
could indicate that the model produced mucus (a proteinaceous substance) from 
mucus secreting cells, such as goblet cells (Balharry et al., 2008).
1.6.1.2 M o r p h o lo g y
Morphologically (Chapter 3), it is not only necessary to detect that region-specific 
cell types expected within the bronchial epithelium were present, but also to 
ensure that the structure resembled the epithelium. In the case of the bronchial 
epithelium, the model needs to be pseudo-stratified and of muco-ciliary 
phenotype. This can be established via microscopical analysis (light, transmission 
electron and scanning electron microscopy), throughout the models 
morphogenesis.
The identification of specific cell types within the model can be established 
through the basic microscopical analysis. However, it was important to confirm 
these observations through precise identification, for instance, using 
histochemistry or immunohistochemistry (Chapter 4). A cytokeratin (CK) 5/6 
antibody can be used to identify these specific CK, known to be present in the 
basal and supra-basal cells of non-keratinising epithelia (Chu and Weiss, 2002); 
such as the respiratory tract epithelium (Sun et al., 1979). CK 5/6 is also known to 
be typically expressed by hyper-proliferative cells (Neudeck et al., 1997). Basal 
cells, which are regarded as the progenitor cells of the bronchial epithelium, can 
be detected through the presence of p63 (Ayers and Jeffery 1988; Baldwin, 1994; 
Breeze and Wheeldon, 1977; Inyama et al., 1988; Yang et al., 1998). Mucus 
secreting goblet cells can be identified by the periodic-acid Schiff stain, which is 
known to stain mucopolysaccharides and glycogen, the main components of 
mucus produced and secreted by goblet cells (Zugibe, 1970). An antibody against
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the 10kDa Clara cell specific protein, CC10, can be used to detect the presence 
of Clara cells (Singh and Katyal, 1997; Singh and Katyal, 2000). Additionally, 
antibodies against tight junction proteins such as ZO-1, claudin and occludin can 
be used in order to detect the presence and formation of tight junctions within the 
epithelial model.
1.6.2 Ex p o s u r e  to  C lassic al  P u lm o n a r y  T o x ic a n ts
Once the biochemical and morphological analysis had deemed the model 
reflective of the in vivo situation, the next step should be to expose the fully- 
differentiated, mature, model to known pulmonary toxicants (Chapter 5). The 
response would then be monitored using conventional toxicological techniques. A 
panel of classical pulmonary compounds should be selected based on their 
differential biological effects, such as immunotoxic, cytotoxic, redox reactive and 
phospholipidotic. The panel choosen was Lipopolysaccharide (immunotoxic; 
Eisenbarth et al., 2002), cadmium chloride (cytotoxic; Croute et al., 2000), 
paraquat (redox reactive; Cappelletti et al., 1998), Amiodarone (phospolipidotic; 
Camus et al., 2004) and finally cigarette smoke, which initiates a plethora of 
effects and is the most common pulmonary toxicant leading to human exposure 
(IARC, 2004).
1.6.2.1 Ba c t e r ia l  D er ived  L ip o po lysac c h ar id e
Lipopolysaccharide (LPS) is a well classified inhalable irritant, known to cause 
immunotoxic effects (Becker et al., 2000; Eisenbarth et al., 2002; Khair et al., 
1996; O’Grady et al., 2001). The major component of Gram-negative bacteria (i.e. 
Escherichia Coli, Haemophilus Influenzae, Salmonella Entericia and 
Pseudomonas Aeruginosa) outer membrane is LPS, accounting for approximately 
three-quarters of the bacterial surface. The general structure of LPS is a 
hydrophilic heteropolysaccharide, covalently attached to this is a lipid component, 
lipid A. The heteropolysaccharide segment in enterobacteriaceae can be further 
subdivided into the O-specific chain and the core oligosaccharide (Figure 1.8) 
(Rietschel etal., 1994).
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Figure 1.8 Schematic diagram of the LPS component of a bacterial cell wall. M: monosaccharide, 
P: phosphate, O: oxygen, H: hydrogen, N: nitrogen (Microbiology and Immunology Online, 2007).
Within the environment significantly high levels of LPS can be found in 
agricultural dust (e.g. grain, poultry, swine, dairy, potato), cotton mills, 
compost/refuse collections, woodworking, manufacturing industries (e.g. metal, 
paper, nylon and fibreglass), office/home dust and cigarette smoke (Reed and 
Milton, 2001). Inhalation of LPS can have a variety of consequences, which are 
dependant on many factors that include dose of LPS, allergy, hypersensitivity, 
pre-existing lung disease (e.g. asthma) and/or smoking. Within ‘normal’ 
individuals the initial response to low doses of LPS is the activation of the innate 
immune system (removes LPS without causing an unnecessary inflammatory 
response), prolonged/high-dose exposure, as well as, allergy/hypersensitivity 
results in the activation of the adaptive immune response. This results in 
permanent airway remodelling and potentially COPD (Liu, 2002). Systemic LPS 
exposure results in septic shock (collapse of the cardiovascular system) 
(Janeway et al., 2005).
LPS triggers an increase in numerous inflammatory cells and mediators, 
occurring within 6 hours of exposure (in animal instillation models), basal levels 
are restored within 48 hours (O’Grady et al., 2001). Phagocytic and epithelial cells 
express pattern-recognition receptors on their cell surface; these are part of the 
immune system and recognise well-defined, common antigens such as LPS. In 
the case of LPS these pattern-recognition receptors are, CD 14 and TLR-4, both
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are expressed on phagocytic and bronchial epithelial cell surfaces. LPS can bind 
un-assisted to its co-receptor CD14, or alternatively first binding with the LPS- 
binding protein, which transfers it to CD14 (Schalz et al., 2002). Binding of LPS to 
CD 14 results in the activation of TLR-4; this binds (intracellularly) to the 
accessory protein MyD88. This results in the subsequent activation of the nuclear 
factor (NF)-kB pathway which up-regulates pro-inflammatory genes (Eisenbarth 
et al., 2002).
1.6.2.2 Ca d m iu m
Cadmium is a toxic heavy metal (Shin et al., 2003), naturally found in the 
environment as a mineral combined with other elements; oxygen (CdO), chlorine 
(CdCI2) and sulphur (CdS04). The major sources of cadmium within the 
atmosphere arise from mining and the combustion of fossil fuels, with some 
entering the eco-system from certain fertilisers (ATSDR, 1999). Cadmium is 
cytotoxic for many organs including, liver, kidneys, lungs, bones and the 
reproductive organs (Croute et al., 2000), it is also a known human carcinogen 
(IARC, 1997). Occupational exposure is highest in those involved in the 
manufacture of cadmium containing products such as; coatings, plastics and 
nickel-cadmium batteries (ATSDR, 1999). Within the general population, the 
major risk of cadmium exposure is from food, smoking cigarettes and industrial 
pollution (Shin et al., 2003).
Inhalation and ingestion are main routes of entry into the body for cadmium and 
cadmium containing compounds (Zalups and Ahmad, 2003). The fate of inhaled 
cadmium is dependent on where in the respiratory tract it is deposited. Deposition 
within the alveoli results in as much as 90% of the cadmium being absorbed into 
the blood (Waalkes, 2000). However, the majority of cadmium deposited in the 
upper respiratory tract is cleared via the muco-ciliary escalator and subsequently 
ingested (ATSDR, 1999). Cadmium absorbed into the pulmonary blood stream is 
rapidly cleared and it becomes concentrated in various tissues; especially the 
kidney and liver. Absorption through ingestion is much lower with only about 5 -  
10% of total cadmium ingested actually absorbed. On average Europeans absorb 
1pg/day of cadmium via ingested food, with roughly an additional 1.4pg of
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cadmium absorbed per pack of cigarettes (WHO, 2000). Smokers can thereby 
effectively double the amount of cadmium they absorb per day.
There are very few mechanisms within the body to deal with cadmium. It can not 
undergo direct metabolic degradation such as oxidation, reduction or alkylation to 
a lesser toxic compound (ATSDR, 1999; Waalkes, 2003). With the added 
disadvantage of having a biological half-life of over 25 years within mammals 
(Meplan et al., 1999), long term storage and therefore damage within the body 
occurs. Inhalation is known to cause inflammation, chronic oedema, bronchitis 
(Shin et al., 2003), COPD and cancer within the lung (Burge, 1994; IARC, 1997). 
Ingestion, either directly or indirectly and accumulation of cadmium within other 
areas of the body is thought to have a variety of adverse effects including kidney 
disease, liver damage, fragile bones, immune disorders and multiple organ 
carcinogenicity (Croute et al., 2000).
Through in vitro and in vivo studies certain actions of cadmium have been 
determined. Cadmium is thought to enter target cells by interacting and 
competing for binding sites on membrane proteins involved in the transportation 
of vital elements (e.g. calcium, zinc and iron) through ionic mimicry. Cadmium is 
also thought to bind to proteins involved in endocytic transport, thereby entering 
through homology or mimicry (Zalups and Ahmad, 2003). Cadmium has been 
shown to activate transcription factors which normally require zinc, with 29 
cadmium-inducible genes identified. Genes known to be involved in inflammation, 
cell survival, apoptosis and mitogenesis are known to be induced by cadmium 
(Shin et al., 2003; Waalkes, 2000). The mechanisms of cadmium carcinogenesis 
could be mediated through its ability to up-regulate cell survival, glucose 
metabolism (Shin et al., 2003), proliferation (Waalkes, 2003) and heat shock 
proteins (Wagner et al., 1999), along with the inhibition of; apoptosis and DNA 
repair (Waalkes, 2000).
1.6.2.3 Pa r a q u a t
Paraquat (Pq; 1,T-dimythyl-4,4’-bipyridilium dichloride) (Figure 1.9) is a potent 
herbicide and therefore, an occupational hazard with large doses known to be
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fatal due to lung and kidney damage (Dalvie et at., 1999). Pq toxicity can either 
be local (skin, nails, nose and eyes) or systemic. Whether absorbed through the 
skin, inhaled or ingested, the outcome is relatively similar and dose-dependent. 
Local effects are generally contact-irritation (lesions/sores) with systemic injury 
resulting in selective toxicity to the lung, liver and kidney (Kuo et a!., 1995).
Paraquat
Figure 1.9 Chemical structure of paraquat; 1,1’-dimythyl-4,4’-bipyridilium dichloride (PubChem, 
2007a).
Irrespective of the method Pq is administered, it is rapidly distributed to most 
tissues, but is specifically concentrated in the lungs and kidneys (Gram et at., 
1986; Suntres, 2002). Histologically, Pq toxicity within the lung typically causes 
oedema, a proteinaceous lining within the alveoli, alveolar thickening, collagen 
deposition, cellular infiltration of the alveolar airspace and pulmonary fibrosis. 
This essentially obliterates the alveolar and bronchilolar spaces, with the lung 
becoming a solid glandular-like organ incapable of gas exchange, resulting in 
death (Gram etal., 1986; Marrs and Adjei, 2003; Takahashi et at., 1994).
Pq uptake by lung is an active, energy-dependent process and is specifically 
accumulated in the Clara cells as well as Type I and Type II alveolar cells, 
explaining the specific accumulation of Pq in the lung irrespective of its route of 
entry (Gram etal., 1986; Masek and Richards, 1990; Sauntres, 2002; Smith eta!., 
1990). Pq toxicity within the lung occurs in two distinct phases: 1) The first phase 
occurs within a few days of Pq poisoning is known as the ‘destructive phase’, 
whereby the Clara and alveolar Type I and II cells are specifically damaged. If the
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Pq concentration is high enough the alveolitis and infiltration of inflammatory cells 
is extensive enough to cause death; 2) The second phase is known as the 
‘proliferative phase’ and is characterised by a massive infiltration and proliferation 
of fibroblasts, resulting in extensive collagen deposition and obliteration of the 
alveolar and bronchiolar spaces (Masek and Richards, 1990; Smith etal., 1990).
Pq has been demonstrated, in vitro, to cause apoptotic cell death within human 
alveolar and Clara cells, which is thought to be mediated by oxidative stress and 
possibly via lipid peroxidation, protein inactivation or DNA damage (Cappelletti et 
a l, 1998; Kuo et al., 1995; Masek and Richards, 1990). Reactive oxygen 
intermediates are generated from the Pq initiated redox-cycling reaction with 
several toxic outcomes. The first of which is the generation of the superoxide 
anion, which in itself can result in the generation of more toxic reactive species 
(such as, hydrogen peroxide and hydroxyl radical). The next is the disruption of 
NADPH-requiring biochemical processes via the oxidation of cellular NADPH and 
the third is lipid peroxidation (Kuo et al., 1995; Suntres, 2002; Wang et al., 1992). 
Other biochemical effects that enhance Pq’s cytotoxicity is its ability to potentiate 
the generation of ROS by phagocytes (Wang et al., 1992) and activation of 
cellular proliferation and differentiation (Kuo et al., 1995). Wang and co-workers 
(1992) deduced that the mitochondria are the initial toxic site of Pq (in vitro and in 
vivo), which may explain Pq’s selective cell toxicity.
1.6.2.4 Am iodarone
Amiodarone (Am) is a benzofuron derivative (Figure 1.10) with class III 
antiarrhythmic activity and is used to treat cardiac arrhythmias (Bargout et al.,
2000). Am belongs to a group of drugs known as a cationic amphiphilic drugs, 
which characteristically have a hydrophilic region containing a primary or 
substituted nitrogen group, along with an aromatic or aliphatic ring that constitutes 
the hydrophobic region. Am, can interact with lipid cellular components due to its 
hydrophobic region and molecular polarity (Casartelli et al., 2003). Am is limited in 
its use as a cardiac drug due to the fact that it has many adverse effects, 
including hepatitis and Am-induced pulmonary toxicity (AIPT), which can progress 
to irreversible pulmonary fibrosis (Trivier et al., 1997). Patients receiving a
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minimum of 400mg/day of Am have up to, a 25% chance of developing AIPT and 
possibly pulmonary fibrosis (Nicolesau et al., 2007).
Amiodarone
Figure 1.10 Chemical structure of amiodarone. (PubChem, 2007b)
Am and its primary metabolite A/-desethylamiodarone (mainly hepatic 
biotransformation; Nicolescu et al., 2007) are known to have many adverse 
effects and are especially toxic to the liver and lungs. The lung is the primary site 
of Am accumulation, especially within pulmonary macrophages (Leeder et al., 
1996). However, Bolt and colleagues (2001) demonstrated that both Clara cells 
and Type II alveolar cells were more susceptible to the toxic effects of Am and N- 
desethylamiodarone. Due to its long biological half-life and slow efflux, Am 
remains within the tissue up to a year after cessation of treatment. AIPT can 
present itself with a variety of histopathological features including, septal 
thickening (as a result of interstitial oedema), inflammation, interstitial fibrosis and 
phospholipidosis (Camus et al., 2004). Other indications of Am toxicity include 
necrosis, apoptosis (Bargout et al., 2000), cellular infiltration (including 
eosinophils) (Camus etal., 2004), DNAfragmentation (increases in bax, caspase- 
3, TGF -(31) (Choi et al., 2002), decreases in mitochondrial membrane potential 
and ATP levels (Card et al., 2003). However, the exact mechanisms of Am and 
N-desethylamiodarone toxicity is unknown.
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1.6.2.5 C ig a re tte  Smoke
It is estimated that around 1.3 billion people smoke tobacco worldwide (Boyle and 
Levin, 2008), with half of these expected to die from its effects. Tobacco is the 
second major cause of death in the world (WHO, 2010a). Cigarette smoke is 
known to cause 13 different cancers (lung, oral and nasal cavities, nasal sinuses, 
pharynx, larynx, oesophagus, stomach, pancreas, liver, urinary bladder, kidney, 
uterine cervix and myeloid leukaemia). The major diseases caused are lung 
cancer, bronchitis, emphysema, heart disease, COPD, microbial infections and 
atherosclerosis (Boyle and Levin, 2008; IARC, 2004; Sopori, 2002; WHO, 2010b). 
The causal relationship between tobacco smoking and lung cancer was 
established by the Medical Research Council in the 1950’s (MRC, 1957).
Within developed countries, the most common use of tobacco is in cigarettes, 
which are defined as “any role of tobacco wrapped in paper or any other non­
tobacco material, which when lit the burning process produces smoke that is 
inhaled through the unlit end” (IARC, 2004). When lit a cigarette produces three 
varieties of smoke: 1) mainstream -  the smoke released from the mouth-end of 
the cigarette during puffing; 2) sidestream -  the smoke released from the lit-end 
and through the cigarette paper; and 3) second hand (or environmental tobacco 
smoke) -  a mixture of sidestream and exhaled mainstream smoke diluted with the 
air and combined with native airborne constituents (IARC, 2004).
Mainstream cigarette smoke (CS) is known to comprise around 4000 different 
substances, accounting for more than 95% of its mass and are mainly dispersed 
in the gas (or vapour) phase (Domagala-Kulawik, 2008; IARC, 2004). This gas 
phase primarily consists of nitrogen, oxygen and carbon dioxide (Hecht, 1999). 
Nicotine, tar, aromatic hydrocarbons, phenols and cresol are some of the 
important constituents of the particle phase of CS, with 10 -  30% of CS particles 
depositing in the lung (Domagala-Kulawik, 2008). Qualitatively the components of 
mainstream, sidestream and second hand CS are essentially identical; however, 
the quantitative composition may vary greatly. This is mainly due to the rapid 
dilution and possible interaction of sidestream and exhaled mainstream CS with 
the surrounding air. Inhalation of second hand CS exposes non-smoking
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individuals to the same numerous carcinogens and toxic compounds as a smoker 
(IARC, 2004), with around 10 -  15% of lung cancer in non-smokers attributed to 
second hand smoke. The WHO state that there is “no safe level of exposure to 
tobacco smoke” (WHO, 2005).
Due to the complex nature and numerous compounds present in CS its 
mechanism of action on the body, lungs and more specifically the bronchial 
epithelium is difficult to elucidate. However, some of the effects of CS on the 
bronchial epithelium are: bronchial carcinoma; induction of terminal squamous 
differentiation; inhibition of cell growth; induction of DNA damage; particularly 
toxic to Clara cells, reduction in CC10 production; toxic to pulmonary cilia (due to 
acrolein); induction of oxidative damage; goblet cell hyperplasia, metaplasia and 
hypertrophy; increased mucin expression; apoptosis and/or necrosis; inhibition of 
mitochondrial function; genetic changes, including the induction of xenobiotic- 
metabolising and red ox-regulating genes, down regulation of tumour suppressor 
and inflammatory genes; downregulation of tight junction proteins and increase in 
epithelial permeability (Bernard et al., 1994; Hecht, 1999; Innes et al., 2006; 
Maunders et al., 2007; Takeyama et al., 2001; van der Toom et al., 2007; Willey 
etal., 1987).
1.6.3 B l in d -E x p o s u r e  to  Po ssib le  P u lm o n a r y  T o x ic a n ts
Another method in the validation process would be to blind-test the model on a 
variety of pulmonary toxicants, non-toxic compounds and possible pulmonary 
toxicants, the last one focusing more the use of the model as a test system. 
Funding of this work by the pharmaceutical company AstraZeneca (AZ) enabled 
the blind-exposure of these three categories of compounds, with the additional 
benefit of using the model as an irritancy screen for possible pulmonary drugs 
(Chapter 6).
After blind-exposure and analysis of the results, the model’s efficiency in 
distinguishing between pulmonary toxicants would be elucidated. Additionally, the 
results would be compared to AZ in-house in vivo results using the same panel of 
compounds and the accuracy of our model determined.
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1.7 R e s e a r c h  Hy p o t h e s is , A im s  a n d  O b je c tiv e s
1.7.1 Hy p o t h e s is
The experimental hypotheses for the research project were:
1. That primary normal human bronchial epithelial (NHBE) cells can be 
cultured at an air-liquid interface in order to create a fully-differentiated 
bronchial epithelium of muco-ciliary phenotype containing basal, 
intermediate, Clara, serous, goblet and ciliated cells.
2. The NHBE cell model will predict drug irritancy outcomes for rat in vivo 
airway exposures.
1.7.2 S p e c if ic  P r o jec t  A im s  a n d  O b jec tiv es
The first principal aim of the proposed research project was to establish and 
characterise the NHBE cell model as a viable alternative to in vivo rat airway 
exposure. Once the model had been established, the objective was to fully- 
characterise the biochemical and morphological parameters. This was 
undertaken during cell culture morphogenesis and was achieved by measuring 
TEER and apical protein content, followed by morphological evaluation using light 
microscopy (LM), transmission electron microscopy (TEM) and scanning electron 
microscopy (SEM), along with concomitant cell and epithelium specific 
histochemistry and immunohistochemistry (Figure 1.11; Part I).
The second principal aim of the research project involved monitoring the 
biochemical and morphological response of the NHBE model to pulmonary 
toxicants. The first part involved the exposure to classical pulmonary toxicants 
and the second part to unknown candidate respiratory drugs (provided by AZ). 
Analysis was achieved by utilising conventional toxicology tools such as, TEER, 
culture viability (ATP assay) and morphological changes (Figure 1.11; Part II).
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Figure 1.11 Flow chart of specific project aims and their relevant experimental research chapters.
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2.1 In tr o d u c tio n
Scientists have explored and continue to explore in vitro systems in order to 
model/study the in vivo situation (Agius, 1987; BeruBe et al., 2009; Lantelme et 
al., 2008; Roguet and Schaefer, 1997). In the field of respiratory biology early in 
vitro studies involved explant cultures (Duncan and Hild, 1960; Thomas and 
Howard, 1974). During the 1980’s major advances were made with respect to 
culture conditions and media, allowing differentiation of cells and formation of 
tissue-like constructs. The use of serum-free media supplemented with selected 
growth factors, hormones and antibiotics have allowed fine-tuning of this 
technique. The main factors added during this time were, hydrocortisone, insulin, 
epidermal growth factor, transferrin, cholera toxin, bovine hypothalamus extract, 
triiodothyronine and retinoic acid (Lechner, 1983; Wu et al., 1986). Hill and 
colleagues (1998) demonstrated the importance of sufficient retinoic acid within 
the media. Retinoic acid-sufficient cultures displayed muco-ciliary differentiation; 
columnar cell cultures secreting substantial quantities of mucus. Retinoic acid- 
deficient cultures were shown to undergo metaplastic squamous differentiation 
(Hill et al., 1998). Cell density was also deemed an important parameter, 
whereby insufficient densities caused cells to undergo squamous differentiation in 
response to foetal calf serum (FCS) or TGF-0 (Ke et al., 1990).
Multi-layered normal bronchial epithelial cell cultures, displaying in vivo 
differentiated characteristics, were originally achieved by using denuded tracheal 
grafts to culture cells (Engelhardt et al., 1991; Terzaghi et al., 1978). Wu and 
colleagues (1986) demonstrated that this phenomenon could be replicated by use 
of a collagen gel substrata. However, cells also required culturing at an air-liquid 
interface (ALI). This was achieved by the development of a ‘special chamber’ on 
which a nitrocellulose membrane was glued and cross-linked with gelatine; the 
collagen gel substratum was formed atop of the membrane. A spacer was placed 
in a tissue culture dish and the chamber rested on the spacer, allowing the culture 
to be fed basally (Adler et al., 1987). This culture system demonstrated a polarity 
(i.e. apical and basal regions) in the differentiation of the cultured cells. Polarity 
confers development of cilia and the secretion of mucus granules on the apical
4 0
T i s s u e - E n g i n e e r i n g  o f  H u m a n  L u n g  C o n s t r u c t s
surface. Furthermore, the columnar appearance of apical cells could be 
demonstrated (Wu et al., 1986). This allowed the development of ALI cultures 
originally with guinea pig tracheal epithelial cells (Adler et al., 1987). ALI cultures 
were rapidly adopted for use with primate (Martin et al., 1991), human (Gray et 
al., 1996; Yamaya et al., 1992), rat (Kaartinen et al., 1993), bovine (Kondo et al., 
1993) and canine tracheal epithelial cells (Mochizuki et al., 1994).
A combination of all of the parameters mentioned must be used in order to 
produce a well-differentiated culture of normal human bronchial epithelia that 
accurately reflect their in vivo counterparts. Development of primary normal 
human bronchial epithelial (NHBE) cell cultures for toxicological applications 
requires the following culturing considerations: 1) media and hormone 
supplementation through basal means; 2) cell density and passage number; 3) 
ALI culturing; 4) ciliogenesis; and 5) secreted proteins. Each of these factors must 
be fulfilled in order to develop a fully functional (i.e. active cilia, mucus secretion, 
cytokine expression, polarity) primary NHBE cell culture for use in assessing the 
toxicity of xenobiotics.
The focus of this chapter was to establish a differentiated culture, as determined 
by morphological characteristics (e.g. cobblestone appearance) (Lee etal., 1986), 
trans-epithelial electrical resistance (TEER) (Gardener et al., 1997) and apical 
protein secretions (Rogers, 2003) as validation of a functional NHBE lung- 
construct; accepted features of a viable construct (BeruBe et al., 2009).
2.2 M a t e r ia l s  a n d  S to c k  S o lu tio n s
2.2.1 M a te r ia ls
M a te r ia ls S u pplier
NHBE Cells, Cryopreserved in Bronchial 
Epithelial Growth Medium® (BEGM®), 
with Retinoic Acid
Lonza Group Ltd., Switzerland
Table 2.1 Table of materials used and their suppliers.
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M a te r ia ls S u pp lier
T75 and T175 Cell Culture Flasks Fisher Scientific, Manchester, UK
CellBind®T75 and T175 Cell Culture Flasks 
Costar®Transwell® Cell Culture Inserts; 
6.5mm, 0.4 |jm pore size
Corning Life Sciences, 
Schipol-Rijk, The Netherlands
Millicell Hanging Cell Culture Insert, 
Polyethylene Terephthalate; 6.5mm 
diameter, 0.4pm pore size
Millipore Ltd., Watford, UK
24-Well Cell Culture Plate 
96-Well Plate
Grenier Bio-one Ltd., UK
Table 2.1 Continued table of materials used and their suppliers.
2.2.2 S to c k  s o lu tio n s
St o c k  S o lu tio n s S u pp lie r
PureCol™ Biomaterials, Fremont, USA
Bronchial Epithelial Basal Medium (BEBM) 
BEGM® SingleQuots®
AccuGENE® Molecular Biology Water 
Dulbecco’s Modified Eagle’s Medium 
(DMEM), with 4.5g/L Glucose, L-Glutamine, 
without Pyruvate
Penicillin-Steptomycin-Amphoteracin B
Lonza Group Ltd., Switzerland 
(Formerly Cambrex Bioscience, 
Workingham, Berkshire, UK)
Hank’s Balanced Salt Solution (HBSS)
Trypsin-EDTA
RPMI-1640
Phosphate Buffered Saline (PBS), pH 7.4, 
without CaCI2 or MgCI2
Invitrogen Ltd., Paisley, Scotland
Foetal Calf Serum (FCS) JRH BioScience, Kansas, USA
Retinoic Acid 
Bradford Reagent 
Bovine Serum Albumin
Sigma, Dorset, UK
Table 2.2 Table of stock solutions used and their suppliers.
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2.2.3  Eq u ip m e n t
E q u ip m e n t S u pp lie r
Rotanta 460R Centrifuge
Hettich Zentrifuga, Tuttlingen, 
Germany
Phase Contrast Light Microscope 
(DM2500)
Leica Image Analysis Software
Leica Ltd., Milton Keynes, UK
ENDOHM-6 Endohm Chamber 
EVOM Epithelial Voltohmmeter
World Percision Instruments, 
Stevenage, UK
Opsys MR-Dynex Microplate Reader
Dynex Technologies, Worthing, 
UK
Table 2.3 Table of equipment used and their suppliers.
2.3 M e th o d s
2.3.1 C e ll  C u ltu r e
2.3.1.1 In it ia l  S ee d in g  and  C u l t u r e  t o  C o n f lu e n c e  o f  NHBE C e l ls
An initial experiment involved the seeding of thawed NHBE cells in either a 
collagen coated T75 cell culture flask (1:100; v/v) PureCol™/Sterilised water 
solution was poured into T75 flasks and left to set (2 hours), excess water was 
removed from the flasks prior to addition of cells) or a T75 CellBind® (pre-coated 
with collagen) flask. Later experiments involved seeding thawed NHBE cells in 
non-treated T75 cell culture flasks. Bronchial Epithelial Growth Medium® (BEGM®) 
was prepared with commercially purchased Bronchial Epithelium Basal Medium 
(BEBM) and BEGM® SingleQuots® (10ml BEGM: 10ml BEBM, 40pl Bovine 
Pituitary Extract and 10pl of insulin, hydrocortisone, transferrin, triodothyronine, 
epinephrine, epidermal growth factor, Gentamicin/Amphoteracin and retinoic 
acid). A cryovial of NHBE cells (~500,000 cells) was rapidly ( 2 - 3  minutes) 
thawed (37°C) and suspended in 30ml of BEGM® (37°C). NHBE-BEGM® mixture 
(15ml) was transferred into each T75 flask. During an overnight incubation (~18
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hours), the NHBE cells attached to the base of the flask. The BEGM® (15ml) was 
replaced with 15ml fresh BEGM® medium and was then replaced (20ml) every 
third day until the cells reach 70% confluency (~2 -  3 days).
2.3.1.2 Second  Passage
Confluent cell cultures were rinsed twice with 5ml HBSS (37°C). Trypsinisation of 
cells was achieved by addition of 3ml Trypsin-EDTA solution for 3 -  5 minutes at 
room temperature (RT), until 90% of the cells were detached. FCS (10%) in RPMI 
(30ml) was added to neutralise the trypsinisation and the cell suspension was 
removed into a 50ml universal centrifuge tube. Cell suspensions were centrifuged 
(72 x g for 4 minutes) and the supernatant removed. Cell pellets were re­
suspended in a total of 2ml BEGM® (37°C) and added to the remaining 178ml 
BEGM® (37°C). BEGM®-cell suspension (30ml) was placed into each of six T175 
cell culture flasks (The initial experiment involved 3x PureCol ™ coated T175 
flasks and 3x CellBind® flasks). During an overnight incubation (~18 hours) the 
NHBE cells attached to the base of the T175 flasks. The BEGM® (30ml) was 
replaced with 30ml fresh BEGM® medium. BEGM® (30ml) was replaced every 
third day until the cells reached 70% confluency (~ 2 -  3 days).
2.3 .1 .3  S e e d in g  in to  C ell C ultu re  In ser ts
Confluent cell cultures were rinsed twice with 5ml HBSS (37°C). Trypsinisation of 
cells from the collagen layer was achieved by addition of 4ml Trypsin-EDTA 
solution for 3 -  5 minutes (RT), until 90% of the cells were detached. FCS (10%) 
in RPMI (30ml) was added to neutralise the trypsinisation and the cell suspension 
was removed into a 50ml universal centrifuge tube. Cell suspensions were 
centrifuged (72 x g for 4 minutes) and the supernatant removed. Cell pellets were 
re-suspended and combined in a total of 4ml BEGM® (37°C). The cell 
concentration of the BEGM®-cell suspension was determined by using a 5x5 grid 
on a haemocytometer. The required seeding density for imputing into inserts was
0.5 million cells/ml. BEGM®-cell suspension was added to the required volume of 
BEGM® for seeding and 150pl BEGM®-cell suspension was placed into each 
insert, with 500pl of BEGM® placed in each well beneath the insert (24-well cell
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culture plate). During the overnight incubation (-18 hours) the NHBE cells 
attached to the insert membrane. NHBE cells were seeded into Millipore® inserts, 
as well as into 6x Transwell® inserts, as Transwell® inserts allow visualisation of 
the cells using phase contrast microscopy (Section 2.3.2).
2 .3 .1 .4  C o n f l u e n t  In s e r t  C u ltu r es
Following seeding into inserts, apical media was removed to create an ALI culture 
(Day 1; Figure 2.1). The basal media (BEGM®) was replaced with 300pl of ALI 
media (20ml ALI media: 10ml BEBM, 10 ml DMEM, 80pl Bovine Pituitary Extract 
and 20pl of insulin, hydrocortisone, transferrin, triodothyronine, epinephrine, 
epidermal growth factor, Gentamicin/Amphoteracin and retinoic acid). Basal ALI 
media was changed daily, adding 300pl of fresh ALI media into each well for the 
first week, then 6 days a week. Once the cells began to show mucin secretion (a 
layer of clear viscous liquid on the apical surface of the cultures), it was carefully 
removed by aspiration every second day to prevent mucin accumulation (as there 
was no muco-ciliary escalator to remove the mucin).
Figure 2.1 Schematic diagram depicting the inserts within a 24-well plate, the cultures at Day 0 
(seeding of cells) and Day 1 (removal of apical media) (Drawn by Z. Prytherch, 2010).
2.3.2 P hase  C o n tra st  L ight  M icroscopy
Cell cultures were visually monitored and images taken using a phase contrast 
light microscope (Leica Ltd., UK), to evaluate the stages of growth and
4 5
T i s s u e - E n g i n e e r i n g  o f  H u m a n  L u n g  C o n s t r u c t s
development in cell culture flasks (T75 and T175), as well as in cell culture 
inserts. This was done daily and allowed monitoring of the health (adherence and 
shape of cells) and confluency (percentage area occupied by cells). These were 
important observations in the determination of when to split Passage 1 and 2 
cultures. In the Passage 3 cells, or cell insert cultures, the microscope was used 
to capture images of the cultures every 3 days (including Day 1).
2.3.3 T r a n s -E p it h e l ia l  E le c tr ic a l  R e sista n c e
Membrane channels, pumps and junctions enable cells to concentrate ions either 
intracellularly or extracellularly, this creates a difference in voltage between the 
interior and exterior of the cell and is known as a membrane potential. This 
membrane potential allows a cell to function as a battery. This battery property 
enables the use of Ohm’s law (/ = V/R\ where I = current, V = voltage and R = 
resistance) to determine the electrical resistance of a cell or culture.
The TEER values of cell cultures were evaluated using the Endohm chamber 
(Figure 2.2). The chamber was filled with 1ml of PBS solution immersing the 
bottom electrode. A cell insert was then placed inside the Endohm chamber and 
PBS solution (150pl) was placed on the apical region of the cultures (i.e. into the 
insert). The top electrode (lid) was placed on top of the insert and the TEER 
reading was taken by pressing the ‘current release’ button on the EVOM 
(epithelial voltohmeter), releasing the current. The EVOM detected the strength of 
the current reaching the bottom electrode, converting it into the resistance (Q) 
created by the insert (Figure 2.3). Prior to measuring the resistance values for the 
cell cultures, a ‘blank’ reading was recorded by using an insert without cells (with 
PBS as above) and was later subtracted from that of the cell culture inserts prior 
to conversion of values from Q to Q.cm2.
4 6
T is s u e -E n g in e e r in g  o f  H u m a n  Lu n g  C o n s t r u c t s
EVOM i_ ir= ----- 1Cap j
Electrode
Endohm Chamber
Electrode
J
Figure 2.2 Schematic diagram of the EVOM and Endohm chamber used to record TEER (Drawn 
by Z. Prytherch, 2010).
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Figure 2.3 Schematic diagram depicting the differences in TEER readings between a healthy 
(-20000) confluent epithelial culture and a culture with disrupted tight junctions (~300Q) (Drawn 
by Z. Prytherch, 2010).
2.3.4 B r a d f o r d  A s s a y
Apical washes were collected from the cell inserts at defined time-points in order 
to collect any secretions which may be present on the apical cell surface. An 
apical wash was achieved by removing the apically added PBS (150pl) from the
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TEER reading, and storing in an eppindorf tube (4°C) to be analysed later. The 
Bradford assay was performed to provide an indication of the total protein 
produced by cells over the time-course of the model (Pingoud etal., 2002).
In order to accurately measure protein concentration using the Bradford reagent, 
(colorimetric chemical agent), a number of standards were run to establish a 
concentration curve. This was accomplished using a bovine serum albumin 
protein standard of 2mg/ml that was diluted into the following concentrations: 2, 4, 
6, 8, 10, 12, 14 and 16pg/ml. Bradford reagent (50pl) was added to each 
standard (150pl). The protein standard with the Bradford reagent was placed in 
the plate reader and read at 590nm wavelength. A standard curve was 
established from which unknown sample protein concentrations could be 
determined.
In order to determine the unknown sample protein concentrations, apical wash: 
PBS 1:10 (v/v) solution (200pl) was placed in a well of a 96-well plate; Bradford 
reagent (50pl) was added and mixed into each sample. These were read in a 
plate reader at 590nm. Assuming all readings returned below 1, the protein 
concentration was determined by extrapolation from the earlier prepared 
standards.
2.4  R e s u l ts
2.4.1 C ell  C u ltu r e  a n d  P hase  C o n tr a s t  L ig ht  M ic r o sc o py
Previous uses of NHBE cells to create an accurate lung construct involved three 
passages: Passage 1; re-hydrating one cryovial into one T75 flask, Passage 2; 
transferring into one T175 flask, Passage 3; seeding into inserts (Richter, 2005). 
In order to make this system more financially viable by increasing the number of 
inserts gained from each cryovial, the three Passages are now: Passage 1; 
seeding one cryovial into two T75 flasks, Passage 2; seeding each T75 into three 
T175 flasks, Passage 3; seeding into inserts. This greatly increased the insert 
yield for all experiments (60:300 inserts Richter:Prytherch).
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The first cryovial of cells was seeded into one PureCol™ coated T75 and one 
CellBind® T75. The PureCol™ coated flask was then Passaged into 3x PureCol™ 
coated T175 flasks and likewise the CellBind® T75 was Passaged into 3x 
CellBind® T175 flasks. NHBE cells grown in PureCol™coated flasks reached 70% 
confluence when the CellBind® flasks were only approximately 60% confluent. 
However, both flasks were Passaged at the same time. During Passage 2, the 
PureCol™ coated flasks reached 70% confluence two days before the CellBind® 
flasks achieved the same level of confluency. The three PureCol™ flasks were 
seeded into Transwell® inserts, once the CellBind® flasks obtained 70% 
confluency they were also seeded into Transwell® inserts. Once seeded into 
inserts the 2 sets behaved similarly (Figure 2.4).
A second set of cells were cultured in non-coated flasks (the rest of the method 
remained the same). NHBE cells cultured in non-coated flasks reached 70% 
confluency 24 hours after NHBE cells cultured in both the PureCol™ and 
CellBind® flasks. After seeding into the T175 flasks (Passage 2), the NHBE cells 
in the non-coated flasks obtained 70% confluency at the same time frame as the 
PureCol™ coated flasks (96 hours post-seeding into T175 flasks). The NHBE cells 
from the non-coated flasks were mainly seeded into Millipore® inserts, with 6x 
Transwell® inserts also seeded. Once seeded into inserts NHBE cells from all 
three different culture methods behaved similarly (Figure 2.4).
All NHBE cells 24 hours post-seeding into inserts, began to take on a regular 
pavement or ‘cobblestone’ style appearance, remaining viable until the end of the 
experiment (Day 42; Figure 2.5). Real-time observations using the phase contrast 
light microscope revealed ciliary action at Day 15, which manifested as tiny 
‘flickers’. Once the cobblestone organisation and ciliary flicks appeared, the 
culture sustained these features until its demise (Day 42).
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Figure 2.4 Phase contrast light microscopy images of NHBE cells grown in either CellBind 
(Green), PureCol™ coated (Blue), or non-coated (Pink) flasks until seeding into Transwell® inserts. 
Time under each image refers to hours post-seeding. Cells in PureCol™ coated and non-coated 
flasks appear of similar confluence throughout, CellBind® slightly less confluent. By Day 1 (24 
hours post-seeding) in cell culture insert all developed the characteristic cobblestone appearance.
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Figure 2.5 Phase contrast light microscopy images of NHBE cells grown in Transwell® inserts. 
Days are post-seeding into inserts.
2.4.2 T r a n s -E p ith e lia l  E le c t r ic a l  R es is tance
TEERs were measured on cultures in inserts (n = 3) every three days on donors 
5F, 8F and 9F over a 42 day period (Figure 2.6); In respect to donors, 5, 8 and 9 
refer to the year in 2000 in which they were isolated, all were non-smoking 
donors. The data revealed that all donors provided similar TEER trends 
throughout the development of the model.
The 5F donor’s TEER increased gradually from Day 1 (-20 Q.cm2) to Day 9 
(-1200 Q.cm2). There was a large increase in TEER values at Day 12 (-5950 
Q.cm2), which continued until Day 15 (-8,800 Q.cm2). A plateau was reached 
between Days 21 -  39, with average TEER values remaining within the range
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6,900 -  8,000 Q.cm2. Although the average TEER value for Day 42 had only 
decreased slightly from the plateau range (-6,000 Q.cm2), the actual TEER 
readings ranged greatly between inserts (-6 -  12,950 Q.cm2; Figure 2.6).
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Figure 2.6 Graph displaying average TEER values for three sets of cells over the culture period 
(Days 1 - 42). 5F Donor (■), 8F Donor (♦), 9F Donor (A); n = 3. Error bars display standard 
deviation. The growth, plateau and demise periods have been identified for each key TEER 
period.
<
The 8F donor’s TEER increased gradually from Day 1 (-15 Q.cm2) to Day 6 
(-180 Q.cm2). A steeper increase in TEER values occurred to Day 9 (-3,230 
Q.cm2) followed by a relatively steady rise to Day 18 (-7,550 Q.cm2). There was a 
drop in average TEER values at Day 21 (-6,150 Q.cm2), with the TEERs 
reaching a plateau between Days 24 -  30; average values remaining within the 
range 6,880 -  7,630 Q.cm2. After Day 30, there was a gradual decline in TEER 
values, reaching -  2,720Q.cm2 by Day 42 (Figure 2.6).
The 9F donor’s TEER increased gradually from Day 1 (-20 Q.cm2) to Day 9 
(-1,950 Q.cm2), followed by a sharper increase to Day 12 (-5,250 Q.cm2). 
TEERs gradually increased from Day 15 (-5,150 Q.cm2) until Day 24 (-7,600 
Q.cm2), where they plateaued until Day 39 (-7,000 -  7,800 Q.cm2). There was 
then a slight rise in TEER values at Day 42 (-8,250 Q.m2; Figure 2.6).
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2.4.3 B r ad fo r d  A ssay
The protein content of apical washes was determined on culture inserts (n = 3), 
via the Bradford assay. This was undertaken on 3 donors, 5Fa, 5Fb and 8F over 
the 42 day culture period (Figure 2.7).
45
3 5  “ “  m
Day
Figure 2.7 Average protein concentrations for three sets of cells over the culture period (Days 1 - 
42). 5Fa Donor (■), 5Fb Donor (■), 8F Donor (■); n = 3. Error bars display standard deviation.
The apical media used for seeding was removed on Day 1 prior to taking an 
apical wash for the 5Fa donor. No protein was detected on the apical surface of 
NHBE cultures until Day 6 (~1.1pg/ml), the protein content remained relatively 
low until Days 15 and 18 (~4.6pg/ml and 16.5pg/ml, respectively) were a definite 
increase was observed. At this time a clear visco-elastic fluid was observed on 
the apical surface and was removed every 2 - 3  days to prevent excess mucin 
build-up. There was a plateau period in the apical protein content between Days 
21 -  39, where the average protein content remained within 6.5 -  13.4pg/ml. 
There was then an increase in the apical protein content on Day 42, with the 
average at 19.4pg/ml.
The apical media used for seeding was not removed on Day 1 prior to taking the 
apical wash for the 5Fb donor. Therefore, the protein concentration at Day 1 was 
high (~34.1pg/ml). No protein was then detected on the apical surface of NHBE
5 3
T i s s u e - E n g i n e e r i n g  o f  H u m a n  L u n g  C o n s t r u c t s
cultures until Day 6 (~1.4pg/ml), the protein content remained relatively low until 
Days 15 and 18 (~18.4pg/ml and 20.5pg/ml, respectively) were there was a 
definite increase. At this time a clear visco-elastic fluid was observed on the 
apical surface and was removed 24 hours prior to removal of the apical wash. 
This was done to prevent excess mucin build-up and keep protein readings 
reflective of mucin production over 24 hours. There was a plateau period in the 
apical protein content between Days 21 -  33, where the average protein content 
remained within 4.9 -  10pg/ml. There was then a decrease in the apical protein 
content from Day 36 (~2.5pg/ml) to none by Day 39. This was followed by an 
increase in apical protein content on Day 42, with the average around 11.5pg/ml, 
higher than the average reading within the plateau period.
The apical media used for seeding was removed on Day 1 prior to taking an 
apical wash for the 8F donor. No protein was detected on the apical surface of 
NHBE cultures until Day 9 (~0.2pg/ml), the protein content remained relatively 
low until Days 15 and 18 (~18.7pg/ml and 25.3pg/ml, respectively) were a definite 
increase was observed. At this time a clear visco-elastic fluid was observed on 
the apical surface and was removed every 2 - 4  days to prevent excess mucin 
build-up. Between Days 21 and 42 the range in the apical protein concentration 
was large (Opg/ml -  39.7pg/ml), this was probably an artefact of the mucin 
removal schedule.
2.5 D is c u s s io n
The principal challenge of working with an in vitro human lung model for 
inhalation toxicology was the correlation of in vitro data to the in vivo situation. 
The cellular model will only provide an insight into a very small piece of the 
overall toxicological puzzle of the human response; “by working with a very 
simplified cellular model, one removes many confounding factors and biodynamic 
interactions, which would be taking place in the human” (Adler and Li, 2001). 
Despite these obstacles, cellular models provide an important insight into the 
human physiological response to inhaled toxicants.
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The airway epithelium is thought to provide the first line of defence to inhaled 
toxicants (Janeway et al., 2005). The response of the cells lining the human 
respiratory tract to inhaled particles could conceivably provide an accurate insight 
into physiological changes that occur in vivo. Monitoring the early responses of 
these cells to various inhaled toxicants would enable increasingly accurate 
evaluation of drug toxicity, the identification of possible biomarkers to early 
pulmonary injury and the identification of new therapeutic molecular targets. The 
use of conventional toxicological measurements such as TEER and protein 
secretion was employed to evaluate the integrity of the NHBE model, when not 
being challenged with a toxicant, which could then be used as parameters for 
assessing injury to the model.
2.5.1 C e ll  C u ltu r e
Visual monitoring of cellular confluence in both T75 and T175 flasks was 
achieved by phase contrast light microscopy. The difference in growth rates 
between the PureCol ™ and CellBind® flasks could also be visualised in this way. 
Monitoring the physical and chemical changes in cultures throughout the timeline, 
including culturing within inserts, forming confluent cultures with multiple-layers 
(‘hills and valleys’; Figure 2.5), production of mucin and the presence of cilia was 
an effective approach. These biochemical and morphological features parallel the 
human lung epithelia in vivo (Breeze and Wheeldon, 1977).
Flasks coated in PureCol ™ increased cellular growth of NHBE cells when 
compared to the commercially available CellBind® flasks. This increased time (48 
hours) that the cells remained in Cellbind® flasks, prior to seeding into inserts, had 
no adverse effect on the establishment of the tissue model (plateau period; Days 
21 -  36). Maintenance of NHBE cell cultures at the ALI in Transwell® inserts and 
the use of BEGM®/ALI media, proved to be a successful combination for 
establishing viable, differentiated cultures, as demonstrated by the multi-layered, 
mucus secreting and functional cilia.
However, when NHBE cells were cultured without collagen in the flasks, no 
adverse effect was observed. Despite the fact that the NHBE cells required an
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additional 24 hours in T75 flasks compared to the PureCol™ and CellBind® flasks, 
once seeded into T175 flasks they reached confluency the same time as the 
PureCol™ coated flasks (96 hours post-seeding). Therefore, as no collagen 
coating was necessary for the culturing of the NHBE cells, this was removed from 
the protocol. Moreover, non-coated flasks are less expensive and remove a 
potential source of contamination. Prior to the culturing of NHBE cells in non- 
coated flasks a colleague determined that: the culturing of NHBE cells in 
Millipore® inserts produced better cultures than those in Transwell® inserts 
(culture viability and TEER; Hughes, 2009). Based on these observations it was 
decided to culture NHBE cells in Millipore® inserts. However, Millipore® inserts do 
not allow visualisation of cultures via phase contrast light microscopy, and as 
such Transwell® inserts (n = 6) were also seeded from every batch to allow this.
2.5.2 T r a n s -E p ith e lia l  E lec trica l  R esis ta n c e
TEER values are considered to be a valid measurement of junctional formation in 
cell cultures (Gardner et al., 1997). It was apparent from the TEER values over 
the development of the model that junctions form in the NHBE lung construct 
(Figure 2.6). Different sets of NHBE cells produced similar TEER profiles 
throughout the development of the model. The rapid increase in TEER values 
before the plateau stage (Days 6 - 1 8 )  implied that cellular junctions were forming 
during this period. Tissue integrity, with respect to junction formation, was 
maintained during the plateau phase (Days 24 -  33). Variation in TEER values 
was observed after this period (Days 36 -  42), with some values exceeding and 
others below the plateau range. An increase in the TEER at this stage could 
indicate a defence mechanism, whereby cultures are attempting to ‘rescue’ 
themselves from culture deterioration. Those cultures that produced a low or non­
existent TEER reading are thought to have undergone culture demise.
2.5.3 B r a d fo r d  A ssa y
The Bradford assay confirmed that NHBE cells secreted a proteinaceous 
substance onto their apical surface. As a general rule there was no significant 
amounts of protein present on the apical surface until around Day 15/18, this
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suggested that goblet cells may now be present within the cultures. More 
significance should be taken on the apical protein concentrations of the 5Fb 
donor, as the apical mucin from this donor was the most consistently removed. 
However, the others must not be discarded, but interpreted with caution. As a 
general rule, from all three donors, the protein concentration increased gradually 
before reaching a plateau level between Days 21 -  33. During the tail-end of the 
culture life the protein concentration decreased (Days 36 -  39) before increasing 
at Day 42. This general pattern correlated relatively well with the TEER pattern, 
with both parameters following similar profiles. The changes in protein content 
near the end of the culture period could also indicate problems with the cultures 
and the beginning of their demise. Prior to Day 36, mucin was thought to be the 
source of the protein secreted apically, as upon close inspection the clear 
substance appeared highly viscous (Widdicombe, 2002). However, further 
confirmation, via a PAS stain (Chapter 4), was required to prove this assumption. 
From Day 36 onwards, this viscous substance was produced by some, but not all 
cultures, indicating an alternative reason for the protein content obtained in apical 
washes. Combining this information with the TEER data, it was deducted that 
increases in protein at Day 42 may be due to cellular debris, in co-ordinance with 
the deterioration of the culture.
2.6 C o n c l u s io n s
Data from the cell culture optimisation and physiochemical characterisation 
experiments suggested that the NHBE cell culture system may represent a viable 
in vitro model for further exploration as an alternative for in vivo inhalation 
toxicology studies. The collective findings over a 42 day characterisation period 
suggested that experimentation might be performed within a relatively large time 
frame; the consistent plateau in data occurring between Day 21 and Day 33. This 
wider experimental window presents an advantage to working with this system 
versus commercial models (e.g. MatTek® system), allowing both acute and 
chronic injury/repair mechanisms to be investigated. Additionally, the close 
correlation observed between the 3 donors indicated that there was little donor 
variation and as long as definite parameters are set-out during experimentation 
this does not need to be considered further. During the latter part of the culture
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period, the NHBE culture appeared to undergo culture demise. This was not 
wholly unexpected, since primary cells only possess a finite number of cellular 
divisions (Freshney, 2005).
Changes in growth parameters such as, TEER, cell viability and protein secretion 
provide a better understanding of the response of human bronchial epithelial cells 
to possible toxins. Other characterisation parameters need to be explored to 
further validate this model as a viable in vitro alternative of the human 
tracheobronchial epithelia. These will include detailed morphological analysis of 
the mixed muco-ciliary phenotype (Chapter 3 and 4), formation of tight junctions 
(Chapter 4) and the confirmation of mucin producing goblet cells (Chapter 4).
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3.1 In tro d u c tio n
Previous work (Chapter 2), determined the key biophysical properties of the 
NHBE construct. In order to compliment these parameters, parallel, 
morphological analysis was undertaken. Characterisation of the cell culture 
morphogenesis involved light and electron microscopic evaluation of the key 
cellular events (e.g. cell-cell contacts, confluency, tight junction formation, 
ciliogenesis, differentiation, etc) as denoted by the biophysical data. 
Morphogenesis was characterised every 3 days for 42 days of culture growth. 
The culture development was also compared to the in vivo regeneration of the 
respiratory epithelium from biopsy samples removed from a chronic obstructive 
pulmonary disease (COPD) patient.
Light microscopy (LM) provided a general picture of the cell viability and tissue 
morphology of the culture system, allowing cell numbers, layers and shape to be 
visualised. Cultures were fixed, sectioned, mounted on glass slides and stained 
for histological evaluation. LM histological assessment provided cross-sectional 
views of the cultures at the microscopic level. Comparison of NHBE sections 
against human lung biopsy samples enabled a direct comparison with the in vivo 
situation.
Transmission electron microscopy (TEM) allowed cross-sectional observation of 
the cellular ultrastructure at the sub-micron level. This permitted identification of 
the fine structural details of the cells/tissue not visible at the LM level. Intra­
cellular components found in eukaryotic animal cells, as well as the determination 
of inter-cellular junctions, could be elucidated. Apical structures such as microvilli 
and cilia were also observed. Scanning electron microscopy (SEM) enabled the 
3-dimensional observation of the surface topography of the NHBE constructs at 
the sub-micron level, thus, enabling a more complete picture of the culture 
morphology at the interior and exterior levels.
The specific research aim of the following chapter of work was to obtain a working 
knowledge of the physio-chemical growth parameters of the cell culture model. 
This was done firstly to validate the NHBE model as an in vivo alternative and
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secondly in order to evaluate any changes, in response to toxicological 
challenges (Chapters 5 and 6).
3.2 M a te r ia ls  and  S to c k  S o lu tio n s
3.2.1 M a te r ia ls
M a te r ia ls S u pplier
Copper Grids, 200-mesh, 3.05mm 
Whatman N° 1 Filter Paper, 90mm 
LEIT Adhesive Carbon Tabs, 12mm 
Aluminium Stubs, 12.5mm diameter, 8mm 
pin length
Agar Scientific, UK
Table 3.1 Table of materials used and their suppliers.
3.2.2  S t o c k  S o lu tio n s
S o lu tio n s S u pplier
1 % Gluteraldehyde
EM Services, Heath Campus, 
Cardiff University, UK
2% Osmium Tetroxide 
2% Uranyl Acetate (UA) 
Propylene Oxide 
Araldite CY212
Dodycenyl Succinic Anhydride 
Benzyl Dimethylamine 
Reynold’s Lead Citrate
Agar Scientific, UK
Sodium Acetate 
Maleic Acid
Fisher Scientific, Manchester, UK
0.5% Toluidine Blue 
DPX Mountant
VWR International Ltd., Poole, 
UK
Table 3.2 Table of stock solutions used and their suppliers.
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S o lu tio n s S u pplier
1 % Borax
10% Neutral Buffered Formalin 
Xylene (Mixture of Isomers)
Sigma, Dorset, UK
Micromount
Surgipath Europe Ltd., 
Peterborough, UK
Table 3.2 Continued table of stock solutions used and their suppliers. 
3.2.3 Equipm ent
E q u ip m e n t S u pplier
Diamond Knife, 2.5mm edge, 45° 
blade angle
Agar Scientific, UK
Leica RM2135 Microtome 
Phase Contrast LM (DM2500) 
Digital Camera (Leica DFC 320)
Leica Ltd., Milton Keynes, UK
TEM 208 Phillips, UK
Critical Point Drier (CPD 030) Balzers, Liechtenstein
EMScope (Sputter Coater) EMScope Laboratories, Ashford, UK
FE-SEM Philips XL-30
Philips Electron Optics, Eindhoven, 
Netherlands
Table 3.3 Table of equipment used and their suppliers.
3.3 M e th o d s
3.3.1 L ig h t  M ic r o s c o p y : To lu id in e  B lue
Optimisation of the methods in this section was aided by Dr. A. Hann 
(Biosciences Electron Microscopy Unit) and Mr. C. von Ruhland (Heath Campus 
Electron Microscopy Unit, Cardiff University, UK), along with technical help and 
support.
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3.3.1.1 T issu e  P ro c essin g
Cell culture inserts were immersed in 1% gluteraldehyde (RT) for 2 hours. This 
method of fixation preserved the cellular structure of the tissue by cross-linking 
proteins via their amine groups. The sample was then removed from the 
gluteraldehyde and placed in a fresh 25ml Universal tube with 2ml phosphate 
buffered saline (PBS) and stored at 4°C.
Culture inserts were placed in a 24 well plate and immersed in fresh PBS (10 
minutes). Post-fixation was carried out by osmicating (1% osmium tetroxide in 
PBS) for 2 hours (RT). This was removed and cultures washed with 0.05M 
sodium acetate (pH 5.9) for 15 minutes (x4).
3.3.1.2 Sta in in g
Culture inserts were stained with 0.5% uranyl acetate (UA), pH 6.2. UA (0.5%) 
was made with 2% UA 1:4 v/v with maleic acid. The final sodium acetate (0.5M) 
wash was removed and replaced with 0.5% UA (45 minutes, RT).
3.3.1 .3  D e h y d r a tio n
UA (0.5%) was removed and discarded in a radioactive waste container and 
replaced with 0.05M sodium acetate (pH 5.9). Inserts containing cultures were 
passed through a series of graded alcohols; 30% —> 50% —> 70% —► 90% —> 
100% (x2), 10 minutes in each. Once dehydrated, culture inserts were pinned 
upside-down with tweezers in a beaker of 100% ethanol; a scalpel was used to 
cut the membrane out from the insert.
3 .3 .1.4 Resin In f i lt ra t io n
Membranes were placed in 100% ethanol, which was pipetted off and replaced 
with propylene oxide for 10 minutes (x2). Membranes were then left overnight in a 
1:1 (v/v) resin:propylene oxide mixture. The resin contained, araldite CY212 
(10g), dodycenyl succinic anhydride (10g), benzyl dimethylamine (0.3g). During
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the overnight incubation (-12 -  18 hours), in fume cupboard (RT), the propylene 
oxide slowly evaporated leaving only the resin.
3.3.1.5 R esin  E m b edd in g
The resin used for embedding the cultures was prepared (5g araldite CY212, 5g 
dodycenyl succinic anhydride, 0.15g benzyl dimethylamine) and mixed with a 
wooden spatula, causing bubbles to form in the resin mixture. The resin was 
placed in an oven (60°C) until the bubbles disappeared. A section of the culture 
(-2.5 x 8mm) was cut to ensure it fitted in the resin mould (12 x 5 x 3mm). The 
resin mould was half filled with resin prior to placing the membrane slice into it. 
Once the membrane slice was placed into the mould, it was filled with resin, 
ensuring no bubbles formed. The resin embedded cultures were placed in an 
oven (60°C) for 48 hours.
3.3.1.6 S e m i-T  hin  S ec tio n in g
Following resin polymerisation, the resin block containing the culture section was 
removed from the mould. Excess resin was trimmed from the blocks until the 
tissue was exposed. Resin blocks were sectioned into 2pm sections using a 
diamond knife. Toluidine blue staining was performed by drying the sections on to 
the slide by placing them on a 60°C hotplate. Once the slides had dried, several 
drops of 0.5% toluidine blue (in 1% borax) was placed onto the sections for 1 -  2 
minutes depending on depth of colour required (slides remained on the hotplate 
throughout this process). The excess stain was removed by gentle, but thorough 
rinsing with distilled water, the slides were then air-dried and cover-slips mounted 
with Micromount (20pl).
3.3.2 T r a n sm is s io n  E lectron  M ic r o sc o py
Methods in this section and technical support were provided by Dr. A. Hann 
(Biosciences Electron Microscopy Unit, Cardiff University, UK).
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3.3.2.1 T issue  P r o c essin g
NHBE cultures to be processed for TEM were initially prepared in the same way 
as those for light microscopy: toluidine blue, up until the end of the resin 
embedding step (Sections 3.3.1.1 -  3.3.1.5). The culture membranes were then 
sectioned (Section 3.3.2.2).
3.3.2 .2  U l t r a - T h in  S e c t io n in g
Resin blocks were sectioned to 60 -  90nm on a Leica RM2135 microtome using a 
diamond knife. Sections were floated on a water trough and collected onto clean 
200-mesh, 3.05mm copper grids.
3.3.2 .3  C o u n t e r -S tain ing
Prior to visualisation of the tissue sections via TEM, heavy metal staining or 
“counter-staining” was required to help resolve the ultrastructure of the cells. 
Counter staining was achieved by using Reynold’s lead citrate and 2% aqueous 
UA. These heavy metal stains are general purpose and not very specific.
Droplets of each stain were placed in rows on the sterile side of parafilm and the 
grids were floated section side down on a given drop. Sections were stained for 
10 minutes with UA, followed by staining with Reynolds Lead Citrate for 5 
minutes. Finally, the grids were washed by transferring over 3 drops of filtered de­
ionised water. The grids were allowed to air dry at room temperature in filter 
paper-lined Petri dishes prior to viewing in the TEM. The sections were imaged 
using a Phillips TEM 208 at an acceleration voltage of 80 KeV.
3.3.3 S c a n n in g  E lectro n  M ic r o sc o py
3.3.3.1 T is s u e  P ro c e s s in g
NHBE cultures to be processed for SEM were initially prepared in the same 
manner as those for light microscopy: toluidine blue, up until the end of the
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dehydration step (Sections 3.3.1.1 -  3.3.1.3). The culture membranes were then
immersed in 100% ethanol in preparation for critical point drying (CPD).
3.3.3.2 C ritic al  Po in t  D rying
Still immersed in 100% ethanol, the membranes were transferred into individual 
wells in a 6-well metal specimen holder. The specimen holder containing the 
membranes was placed into the specimen chamber of the critical point drier, 
which was filled with 100% ethanol. The critical point dryer (CPD 030) was 
programmed to cool the chamber to 4°C. The ‘medium in’ button was pressed, 
which added liquid carbon dioxide (CO2) to the specimen chamber, until the air 
bubbles disappeared. The ‘medium in’ button, followed by the ‘medium out’ button 
was pressed in order to purge the ethanol out of the specimen chamber. Filter 
paper was used to detect the presence of ethanol exiting the specimen chamber 
at the outlet tube (wetness = ethanol). Once all the ethanol had been flushed out, 
the chamber was re-filled with liquid CO2. The CPD was programmed to gradually 
raise both the temperature (to 37°C) and the pressure (to 80 bar). Once these 
conditions were met, the CPD gradually (over 2 hours) lowered both the 
temperature and pressure back to normal (21 °C and 0 bar). The dried (CPD) 
membranes were removed from the specimen holder ready for mounting.
3.3.3 .3  M o u n tin g
A double-sided adhesive carbon ‘sticker’ was secured onto a labelled, SEM 
specimen stub (aluminium; 12mm diameter). Dried membranes were examined 
under a stereoscope in order to locate the cell-side of the membrane (dull side). 
Tweezers were then used to transfer the membrane and stick it cell-side-up onto 
the adhesive carbon tab. Taking care to only ever touch the outer-edge of the 
membrane, the edges were pressed down gently to ensure adequate attachment 
to the carbon sticker.
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3.3.3 .4  S pu tter  C oating
The metal SEM sample stubs, with attached membranes, were placed into the 
sample chamber (maximum 6 stubs) of the sputter coater machine (EMScope). 
The sample chamber lid was closed and the ‘start cycle’ button pressed. The 
argon gas replaced the air within the sample chamber; once replaced by argon, a 
current generated the release of gold particles onto the top of the specimen, 
coating them in a 0.5pm layer of gold. The vacuum inside the specimen chamber 
was then released, causing the lid to open. Samples were coated twice with gold 
before being removed from the sputter coater specimen chamber. The samples 
were now deemed ready for viewing and images were taken with the Field 
Emission-SEM (Phillips XL-30) with an accelerating voltage of 20kV, spot size of 
4.0 and a working distance between 5 and 10.1mm.
3.3 .4  L ig h t  M ic r o s c o p y : In  Vivo-In V itro  C o r r ela tio n s
Images of archival, human, lung biopsy samples from a COPD patient were 
provided by AstraZeneca (Dr. Martyn Foster, AstraZeneca R&D, Loughborough, 
UK). Samples had previously been sectioned and stained for standard LM 
histological examination (by AstraZeneca) using Haematoxylin and Eosin (H&E); 
a routine stain chosen for its ability to stain various cellular components of tissue. 
Haematoxylin is a basic dye that stains nuclear heterochromatin and cytoplasm 
rich in ribonucleoprotein blue. Eosin is an acid dye that stains cytoplasm, muscle 
and connective tissue various shades of pink. Photomicroscopy was undertaken 
by Dr. Martyn Foster, chief pathologist (AstraZeneca R&D, Loughborough, UK). 
The COPD H&E stained sections were compared with NHBE H&E sections 
(Section 3.3.4.1 -  3.3.4.6) over the models development (Days 1 -  42).
3.3.4.1 T issue  P r o c essin g
Cell culture inserts were immersed in 10% neutral buffered formalin (4°C) for 24 
hours, in preparation for paraffin embedding and sectioning. Tissue processing,
i.e. paraffin embedding, sectioning and staining, was carried out by a 
histotechnologist, Mr Derek Scarborough (School of Biosciences, Cardiff
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University, UK). A brief overview of these procedures has been outlined below in 
Sections 3.3.3.1 -  3.3.4.6.
Once the tissue was fixed (Section 3.3.4.1), it had to be processed into a form in 
which it could be made into thin microscope sections. This was achieved by 
embedding tissues in paraffin, that was similar in density to tissue and could be 
sectioned at anywhere from 3 -  10pm. The main steps in the processes dealing 
with wet-fixed tissue were ‘dehydration’, ‘clearing’ and ‘paraffin infiltration’.
Wet-fixed tissues, such as the NHBE cell cultures from this study, could not be 
directly infiltrated with paraffin. The water from the tissues had to be removed by 
‘dehydration’ via a series of alcohols (e.g. 70% to 95% to 100%). Following 
dehydration, the next step was ‘clearing’ and consisted of replacement of the 
dehydrant (i.e. alcohol), with a substance that would be miscible with the paraffin. 
The common clearing agent was xylene and the tissues were processed through 
several changes of this. The final step in processing was to infiltrate the tissue 
with molten paraffin wax at 60°C; several changes of wax were used. All the 
above processes were undertaken by placing the NHBE cultures in plastic 
processing cassettes and placed in an automated, fully-enclosed, Vacuum Tissue 
Processor (Leica TP1050, Leica UK).
3.3.4.2 P a r a f f in  Embedding
It was essential for the tissue to be fully supported by paraffin wax to prevent 
tissue shredding during sectioning. This was achieved by placing the “cleared” 
tissue into a vacuum to remove all air pockets. The NHBE cell culture membrane 
was then placed into a plastic ‘embedding mould’ and embedded in warm paraffin 
wax (Leica EG1140 Embedding Centre, Leica, UK). After allowing the wax to set 
(30 minutes on a cold plate), the tissue was removed from the embedding mould 
and the sample was ready for sectioning.
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3.3.4 .3  S ec tio n in g
Following tissue processing and paraffin embedding, the NHBE cell culture had to 
be cut into sections that could be placed on a glass slide for the purpose of LM. 
Sectioning was achieved using a Leica RM2135 microtome. The embedded lung 
tissue samples were placed on ice to ensure uniform sections were obtained. The 
ice hardened the wax and softened the tissue, so the entire sample was of the 
same consistency for sectioning. The tissue was then cut into 5pm sections using 
the microtome.
Once sections were cut, they were floated on a warm water bath (40 -  50°C) that 
facilitated the removal of any wrinkles and air bubbles produced during 
sectioning. Paraffin embedded sections were then collected on to a pre-coated, 
poly-L-lysine, glass microscope slides; for improved adhesion of sections. 
Samples were then left to bind to the slides on a hot plate for 15 -  30 minutes, 
then in an oven (37 -  45°C) for a minimum of 24 hours.
3.3.4 .4  D e-W a xin g
The embedding process must be reversed (de-waxing) in order to remove 
paraffin wax from the tissue allowing water soluble dyes to penetrate the sections. 
Therefore, before any staining could be accomplished, the slides were 
“deparaffinized” by running them through xylene (x2) followed by series of graded 
alcohol; 100% (x2) —► 95% —► 70%. The slides were immersed in each of these 
solutions for 2 minutes, followed by being placed under running tap water for 2 
minutes.
3.3.4 .5  Ha em a to xylin  and  Eosin  S tain ing
Once de-waxed, tissue sections were immersed with Mayer’s haematoxylin for
1.5 minutes. Excess dye was removed by placing the slides in running tap water 
for 5 minutes.
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3.3.4 .6  D ehyd ra tio n
The H&E stained slides were dehydrated by immersing (2 minutes) in an 
increasing series of alcohol; 70% —> 95% —> 100% (x2) and xylene (x2).
Slides remained in xylene until ready for cover-slips to be fixed onto them. A 
small drop (20pl) of DPX mountant was placed on a cover-slip and the slide 
carefully lowered onto the cover-slip and DPX. The sections were viewed using a 
Leica Phase Contrast LM (DM2500) attached to a digital camera (Leica DFC 320) 
and images saved as TIF files.
3.4 R e s u l ts
3.4.1 L ig h t  M ic r o s c o p y : Tolu id in e  B lue
3.4.1.1 Da ys  1 - 6
NHBE cells prepared from Day 1 (24 hours post-seeding) inserts demonstrated a 
monolayer of cells with a patchy adherence (i.e. gaps between cells). Cellular 
integrity was verified by intact cellular membranes and nuclear components. Free 
surfaces of the cells (i.e. not in contact with the insert membrane) appeared to 
have many cellular projections, with some of these beginning to form cell-cell 
contacts and inter-cellular gaps separated other cells (Figure 3.1 [A]).
By Day 3, a confluent culture had formed, with two distinct layers visible. Small 
inter-cellular gaps were still observed between cells (Figure 3.1 [B]). Cells at Day 
6 remained squamous in shape, with the two distinct cell layers more compact 
and inter-cellular gaps receding into the basal regions. However, intermediate 
cells could be observed in between the two distinct cell layers. Additionally, 
microvilli could be defined on the apical surface (Figure 3.1 [C]).
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3.4.1.2 D ays 1 5 - 3 0
No major changes were noted between Days 6 and 18, at the microscopic level, 
apart from culture compaction and cell de-squamation (evident at Day 15; Figure 
3.2[A]). By Day 18 cells appeared more columnar and cultures displayed 
evidence of differential cell types within. Basal cells were evident in the 
basolateral region of the cultures and were more rounded in comparison to the 
cells forming the apical barrier (Figure 3.2[B]). Further development into a fully- 
differentiated, pseudo-stratified, bronchial epithelium occurred after Day 18 and 
was clearly evident in cultures at Day 30 (Figure 3.2[C]). This differential 
morphology remained until Day 36.
3.4.1.3 Da ys  3 6 - 4 2
The tissue became slightly distorted at Day 36, with the two nuclear layers 
becoming less distinct. Inter-cellular gaps began to appear around the basal cells 
(Figure 3.3[A]).
Day 39 cultures displayed further deterioration, with vacuoles developing inside 
the cells at the apical region and between the basal and surrounding cells. The 
basal cells became squamated and the previously columnar-shaped cells at the 
apex, also developed a squamous phenotype (Figure 3.3[B]).
By Day 42, cultures deteriorated significantly, as denoted by an undifferentiated 
monolayer culture. Demise in culture viability was apparent given that the nuclei 
were barely detectable and the toluidine blue staining was very faint (Figure 
3.3[C]).
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Figure 3.1 LM images of NHBE cultures stained with toluidine blue. [A] Day 1; cells attached to 
the membrane, covered with cellular projections forming cell-cell contacts. [B] Day 3; smaller intra­
cellular gaps and two distinct cell layers formed. [C] Day 6; cellular attachments compact the 
culture further, inter-cellular gaps more basal and microvilli visible on the apical surface.
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Figure 3.2 LM images of NHBE cultures stained with toluidine blue. [A] Day 15; cell-cell junctions 
tighter. [B] Day 18; columnar and basal cells distinguishable, mucin granules on apical surface of 
some cells. [C] Day 30; fully-differentiated, pseudo-stratified epithelium, containing goblet cells 
(GC), ciliated cells (CC), Clara cells (CIC), intermediate cell (IC) and basal cells (BC).
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Figure 3.3 LM images of NHBE cultures stained with toluidine blue. [A] Day 36; cultures begun to 
deteriorate, formation of inter-cellular gaps. [B] Day 39; cells were relatively squamous containing 
vacuoles and inter-cellular gaps throughout cultures. [C] Day 42; cultures were undifferentiated 
and squamous. Multi-layered regions deteriorated to squamous monolayered regions.
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3.4.2 Transm ission E le c tro n  M icroscopy
3.4.2.1 D ays 1 - 9
Day 1 revealed a single cell layer adhered to the insert membrane. Inter-cellular 
gaps were present between neighbouring cells, with numerous cellular 
projections protruding from the cell surface (Figure 3.4[A]).
Culture structure changed drastically by Day 3, with the loss of inter-cellular gaps 
and an increase in cellular organelles (Figure 3.4[B]). Microvilli were clearly 
observed along the apical surface of the cells (Figure 3.4[C]).
Further development was apparent at Day 6, as revealed by two nuclear layers 
and evidence of cellular differentiation. Basal cells appeared more rounded and 
were present at the basolateral surface (Figure 3.5[A]). Clara cells were identified 
by their numerous electron-lucent and -dense membrane bound inclusions 
(confirmed experimentally, Chapter 4, Section 4.4.2). By Day 9, initial tight 
junction formation, as well as other cell-cell attachments in the form of adherens 
junctions and desmosomes, were apparent (Figure 3.5[B] -  [C]).
3.4.2 .2  Da y s  1 2 - 2 1
The models complexity increased greatly by Day 12, with immature goblet cells 
identified (Figure 3.6[A]). Mature tight and adherens junctions were observed at 
the most apical co-joining of cells. Desmosomes, inter-cellular junctions and 
interdigitations were present at cell-cell attachments throughout (Figure 3.6). A 
serous cell, with apically located electron-dense, secretary granules was 
identified, with high magnification revealing the glycocalyx around microvilli 
(Figure 3.6[D]).
Cilia were clearly visible at Day 18, enabling concise identification of ciliated cells. 
Cilia were anchored by basal bodies, with numerous mitochondria located in the 
apical region of ciliated cells (Figure 3.7[A]). Intermediate cells were also easily
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identified due to their location between the basal and apical regions, as well as 
their loose cell-cell contacts (to allow migration and expansion) (Figure 3.7[B]).
Cultures were well-differentiated at Day 21, containing basal cells (image not 
shown), cilia covered ciliated cells, goblet cells (image not shown) and Clara 
cells. The Clara cell depicted was identifiable by its cytoplasmic content, domed­
shaped apex with finger-like projections that protruded above the ciliated cell and 
the interdigitations with the bordering ciliated cell (Figure 3.7[C]).
3.4.2 .3  Da y s  3 0 - 3 3
Cultures at Day 30 displayed a well-defined, pseudo-stratified epithelium,
containing: basal, goblet, Clara and ciliated cells, with all cells appearing to attach 
to the membrane and non-basal cells being columnar in shape (Figure 3.8[A]). 
Mucin release was evident (Figure 3.8[B]) along with mature cilia, surrounded by 
mucin and/or glycocalyx (Figure 3.8[C]).
Day 33 cultures displayed the differentiated phenotype, with tight junctions and 
interdigitations clearly observed (Figure 3.9[A]). High magnification cross-sections 
of cilia revealed the characteristic “9+2” structure of the axonemes (Figure 3.9[B]).
3.4.2.4 Da y s  3 6 - 4 2
Morphological observations at Day 36, revealed the onset of cell/epithelial 
deterioration. Cells appeared squamous, with less distinction between basal and 
non-basal cells, vacuoles appeared within the cytoplasmic compartments of cells, 
as well as the formation of inter-cellular gaps (Figure 3.9[C]).
At Day 39 the dedifferentiation process was in full force, as denoted by; wide­
spread deterioration and squamation, development of large vacuoles, indistinct 
cellular organelles and structures and an increase in goblet cells (Figure 3.10[A]). 
However, interdigitations could still be observed between cells (Figure 3.10[B]). 
Cultures at Day 42 revealed continued deterioration (Figure 3.10[C]).
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Figure 3.4 TEM images of NHBE cultures on Day 1 and 3. [A] Day 1; inter-cellular gaps appear 
between cells, numerous cell surface projections beginning to form cell-cell contacts. [B] Day 3; 
overview of cultures, cell-cell contacts formed, microvilli visible on the apical surface. [C] Day 3; 
high magnification of the apical surface, clearly showing microvilli and evidence of organelle 
development.
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Figure 3.5 TEM images of NHBE cultures on Day 6 and 9. [A] Day 6; overview of the culture, 
basal cells (B) and a Clara cell can be observed. [B] Day 9; high magnification of the cell-cell 
contacts between two adjacent cells displaying a tight junction (TJ), adherens junction (AJ) and 
desomosomes (D). [C] Day 9; high magnification of a desmosome observed between two 
adjacent cells.
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Figure 3.6 TEM images of NHBE cultures on Day 12. [A] An immature goblet cell is observed as 
well as interdigitations (ID) between it and the neighbouring cell. [B] Higher magnification 
displaying an inter-cellular junction. [C] High magnification depicting a classic tight junction, 
adherens junction (AJ), desmosome (D) and mucin granules. [D] High magnification of a serous 
cell with electron-dense secretory granules (SG) potentially containing lysozyme at the apical 
surface. Glycocalyx (Gx) can be observed on the apical surface.
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Clara Cell
Figure 3.7 TEM images of NHBE cultures on Day 18 and Day 21. [A] Day 18; higher 
magnification of the apical region of a ciliated cell. Cilia are clearly observed, stemming from basal 
bodies, numerous mitochondria (Mi) are located in the apical region of the cell. [B] Day 18; 
displaying an intermediate cell (IC). [C] Day 21; NHBE culture displaying a ciliated cell next to a 
Clara cell.
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Figure 3.8 TEM images of NHBE cultures on Day 30. [A] Overview of the culture clearly 
displaying basal (B) and ciliated cells. [B] High magnification of cilia with anchoring basal bodies, 
located at the apical surface of a ciliated cell. Mucin and glycocalyx (Gx) can be observed 
between the cilia.
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Figure 3.9 TEM images of NHBE cultures on Day 33 and 36. [A] Day 33; high magnification 
clearly displaying interdigitations (ID) and a tight junction between cells. [B] Day 33; high 
magnification of the cilia, where a transverse section of the cilia reveals the classic “9+2” axoneme 
configuration. [C] Day 36; overview of the model with a goblet cell as it begins to deteriorate. Cells 
are more squamous and inter-cellular gaps have appeared between cells.
8 2
C h a r a c te r is a t io n  o f  M o rp h o g e n e s is  in th e  NHBE M o d e l
Goblet
Cells
Cell Death
[B]
Interdigitations
I------- 1
500nm
Squamous
cell
Mucin
Figure 3.10 TEM images of NHBE cultures on Day 39 and Day 42. [A] Day 39; overview of the 
culture containing, goblet cells, basal cells were squamous and large vacuoles located throughout. 
[B] Day 39; high magnification displays that interdigitations were present. [C] Day 42; overview of 
the culture displaying the deterioration and dedifferentiation of the culture.
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3.4.3 S c a n n in g  E lec tro n  M ic r o s c o py
3.4.3.1 Da ys  1 - 1 2
The presence of a monolayer of rounded cells was observed at Day 1. The cells 
did not form cell-cell contacts and inter-cellular gaps could be seen clearly. Closer 
inspection of the cells revealed that their surface was highly-ruffled, containing 
many cellular projections (Figure 3.11).
By Day 3, individual cells could not be distinguished and cells exhibited cell-cell 
attachments. The cells were no longer rounded and appeared flattened. Cell 
surfaces did not display a highly-convoluted topography; however, microvilli were
now visible (Figure 3.12). Cultures at Day 6 were denoted by the same
morphological characteristics (images not shown).
On Days 9 (images not shown) and 12, the surface of the culture appeared 
continuous, with no inter-cellular gaps. Microvilli were abundantly dispersed 
across the apical surface, with individual cells delineated by a dense and raised 
area of microvilli. The surface of some cells were more densely covered with 
microvilli than others (Figure 3.13).
3.4.3.2 Da ys  1 5 - 3 3
By Day 15, the apical surface of the culture had changed, where the enclosed 
surfaces of the cells became either depressed or raised. Cilia were present on the 
surface of the more differentiated ciliated cells. The surfaces of these ciliated cells 
were raised and microvilli populations inter-mingled between the cilia (Figure 
3.14).
Cultures at Day 24 were topographically similar to those at Day 15. 
Observationally the number of ciliated cells, the density of cilia-per-cell and the 
length of the cilia all increased (Figure 3.15). At higher magnifications, mucin 
globules were observed on the surface of the culture (Figure 3.15[C]), as well as 
at the tips of the cilia (Figure 3.15[D]).
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The cell surface became increasingly variable by Day 27. Ciliated cells were fully- 
differentiated (Figure 3.16).
By Day 33, the culture surface took on its most complex appearance, with every 
apical surface either being densely covered in some form of cellular projection or 
actively secreting mucus. A ‘new’ cell type appeared from Day 30 that was also 
present on Day 33. This cell had many rounded projections that were each 
covered in what appeared to be short, closely packed microvilli-like structures 
(Figure 3.17).
3.4.3 .3  Da ys  3 6 - 4 2
The culture underwent a level of dedifferentiation at Day 36. Apart from the 
presence of a few ciliated cells, the surface of the other cells were only covered in 
microvilli. For the first time since Day 9, the cells lost their microvillus delineation 
(Figure 3.18). Cultures at Day 39 exhibited the same morphology (images not 
shown).
The cellular delineation re-appeared or became more prominent by Day 42. A 
few, yet very sparse ciliated cells could still be observed, but microvilli remained 
the common feature on the culture surface. Numerous pore-like ruptures were 
visible throughout the apical surface (Figure 3.19).
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Figure 3.11 SEM images of the apical region of NHBE cultures at Day 1. [A] A monolayer of 
rounded cells can be seen with inter-cellular gaps between them. [B] A closer image of the 
rounded cells. [C] Higher magnification displaying a single cell and the inter-cellular gap around it. 
[D] High magnification of the surface of the cells revealed many cellular projections.
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Figure 3.12 SEM images of the apical region of NHBE cultures at Day 3. [A] Overview of cultures; 
individual cells could no longer be identified. Cells appeared flattened with large cellular 
projections forming cell-cell contacts. [B] The cellular projections could be observed ‘stretching’ 
between cells. [C] High magnification revealed cellular projections on the surface of the cell. 
[D] High magnification observations suggested the presence of microvilli on the surface of the 
cells.
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Figure 3.13 SEM images of the apical region of NHBE cultures at Day 12. [A] Overview of culture; 
cell-cell contacts formed and cells appeared delineated by a dense-raised area of microvilli. 
Microvilli were uniformly dispersed across the surface of the culture. [B] Cells were delineated by 
a border of dense-raised microvilli. [C] and [D] Higher magnification images of microvilli on the 
surface of the cells.
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Figure 3.14 SEM images of the apical region of NHBE cultures at Day 15. [A] and [B] Overview of 
cultures; cells remained delineated by dense-raised areas of microvilli. The surface of cells within 
these delineated regions became either depressed or raised and were all covered by microvilli. A 
ciliated cell could be distinguished by the presence of cilia. [C] and [D] Higher magnification of 
ciliated cell denoted the presence of cilia on the raised surface of cell. Note that the microvilli 
appeared to surround the cilia.
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Figure 3.15 SEM images of the apical region of NHBE cultures at Day 24. [A] and [B] Overview of 
cultures; the morphology was similar to cells at Day 15 (Figure 3.14), apart from the increase in a 
number of ciliated cells and the number of cilia on these cells. [C] and [D] High magnification 
demonstrating potential cell secreted products on the surface next to the ciliated cells (highlighted) 
and also on top of the cilia themselves (circled).
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Figure 3.16 SEM images of the apical region of NHBE cultures at Day 27. [A] Overview of the 
culture; there was a vast surface variability between cells; raised/depressed, cilia and/or microvilli 
and mucus secreting cells. [B] Overview of the culture; goblet cell secreting mucin globules 
(circled). [C] and [D] High magnification of a ciliated cell and mucin globules on the apical surface. 
Note the difference in size between cilia (foreground) and microvilli (background).
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Figure 3.17 SEM images of the apical region of NHBE cultures at Day 33. [A] and [B] Overview of 
the culture; representing the most complex and diverse surface organisation of the culture during 
the viable time-line. Every cell was either covered in some form of cellular projection (microvilli, 
cilia) or secreting mucin. [C] High magnification; an unknown cell type with numerous large round 
projections for which each was covered in small microvilli-like projections and a mucus secreting 
goblet cell could also be observed. [D] High magnification image of a ciliated cell.
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Figure 3.18 SEM images of the apical region of NHBE cultures at Day 36. [A] and [B] Overview of 
culture; a decrease in the prevalence of ciliated cells and an increase in de-differentiated cells 
along with a loss of microvillus delineation, at cell borders. [C] and [D] High magnification of 
ciliated cell; cilia appeared fully-formed, but the cell was no longer raised.
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Figure 3.19 SEM images of the apical region of NHBE cultures at Day 42. [A] Overview of culture; 
the surface was covered in microvilli, faint delineation of cells was visible. [B] Ruptures in the 
apical surface could be observed. [C] High magnification of these pore-like openings and microvilli 
interspersed on the surface. [D] Ciliated cells were few and far between, their morphology was 
intact.
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3.4 .4  L ig h t M icroscopy: In  Viv o -In  Vitr o  C o r r e la t io n s
The development of NHBE cultures (in vitro) were compared to the re- 
epithelialisation in the bronchi of a COPD patient (in vivo).
NHBE cultures at Day 1 displayed a monolayer of cells with a large nuclear-to- 
cytoplasm ratio (Figure 3.20[E]). Corresponding in vivo sections of re- 
epithelialisation of the airway also displayed a monolayer of cells with a large 
nuclear-to-cytoplasm ratio (Figure 3.20[A]).
By Day 6 in vitro cultures had formed two squamous cell layers with cells, 
characterised by a large nuclear-to-cytoplasm ratio (Figure 3.20[F]). In vivo 
sections displayed similar morphological features (Figure 3.20[B]).
Day 12 NHBE cultures and corresponding in vivo (COPD biopsy) samples 
developed an epithelium with two distinct nuclear layers. The cells with more 
apically located nuclei were becoming increasingly columnar (Figure 3.20[C] and
[G ])■
The NHBE culture exhibited a fully-differentiated, pseudo-stratified, muco-ciliary 
culture at Day 27. Basal, ciliated and goblet cells could all be identified (Figure 
3.20[H]). The fully-differentiated epithelium in vivo exhibited the same mixed-cell 
phenotypes (Figure 3.20[D]).
C h a r a c t e r is a t io n  o f  M o r p h o g e n e s is  in th e  N H BE M o d e l
COPD PATIENT BIOPSY NHBE Culture
[A]
y  4m
[E]
• «pr
................H  '  J
[B] [F]
m
[C] [G]
r
w .
J S
Figure 3.20 LM images of human biopsy sections ([A-D]) and NHBE cultures ([E-H]) stained with 
H&E. [A] Initial re-epithelialisation. [E] Day 1; monolayer of cells with inter-cellular gaps. [B] Two 
cell layers. [F] Day 6; two cell layers. [C] Two cell layers. [G] Day 12; squamous basal cells, apical 
cells becoming columnar. [D] Fully-differentiated epithelium, cilia present on apical surface and 
goblet cells observed. [H] Day 27; Pseudo-stratified epithelia, cilia present on apical surface, 
goblet and basal cells were observed. Scale bar = 20pm.
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3.5 D is c u ss io n
Morphological characterisation of the NHBE human lung construct complimented 
the biochemical characterisation already undertaken (Chapter 2). This further 
characterisation was essential in providing a more complete and accurate picture 
of the NHBE construct, with the aim to validate the model as a suitable in vitro 
alternative to other in vivo (animal) models. This extensive characterisation could 
enable the mechanisms of injury and repair in response to inhaled xenobiotics to 
be elucidated.
3.5.1 L ig h t  M ic r o s c o p y : T o lu id in e  Blue
Analysis by LM enabled an initial insight into the structure and morphology of the 
construct at the microscopic level. This analysis was conducted throughout the 
models’ development and subsequent demise. Initially, the culture began as a 
monolayer of adherent cells with inter-cellular gaps (Day 1), which quickly formed 
a confluent, multilayered culture without inter-cellular gaps. Morphologically, the 
next prominent change was the basal cells becoming rounded and the non-basal 
cells taking on a more columnar shape. Mucus secreting cells could be
distinguished due to the presence of mucin granules and intermediate cells were
observed in between the basal and apical layers (Breeze and Wheeldon, 1977). 
Deterioration of the culture could be observed from Day 36 onward. This included 
the formation of vacuoles throughout the culture, dedifferentiation of the muco­
ciliary phenotype, squamation of cells and a reversal to a monolayer phenotype.
3.5.2 TRANSMISSION ELECTRON MICROSCOPY
TEM analysis has been used to visualise the ultrastructure of the respiratory 
epithelia by many scientists (Breeze and Wheeldon 1977; Rhodin, 1966; Rogers, 
2003). TEM analysis of the NHBE constructs enabled a detailed observation of 
fine cellular structures and components. The general morphology of the construct 
correlated with that determined by LM, but at a more robust and detailed level. 
TEM demonstrated the formation of microvilli and confirmation of cilia. Individual 
microtubules could be identified, along with the characteristic “9+2” axoneme and
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anchoring basal bodies. The presence of cellular junctions and relative 
cytoskeletal filaments as well as cellular organelles (e.g. mitochondria, Golgi, 
endoplasmic reticulum, etc) were also observed. Mucin granules were also 
observed within goblet cells (Rogers, 2003).
The deterioration of the cultures as defined by LM observations was supported by 
TEM, from Day 36 onwards. The formation of vacuoles throughout the culture, 
dedifferentiation of the muco-ciliary phenotype, squamation of the cells and the 
loss of intra-cellular organelles and structures, were clearly defined events at the 
TEM level.
Comparison with the biochemical observations (Chapter 2) revealed some 
correlation with the morphological data (Table 3.1). Morphologically, the 
appearance of the tripartite junctional complex occurred between Day 9 and 12 
(Figure 3.5 -  6). The tripartite junctional complex consists of the tight junction, 
adherens junction and desmosome (Farquahr and Palade, 1963). The tight 
junctions are the most apically located component and were characterised by the 
fusion of the two adjacent cell membranes and elimination of the inter-cellular 
space (Farquahr and Palade, 1963). Desmosomes are the most basally located 
of the three junctions. They appear as two electron dense plaques on adjacent 
cell membranes with a more translucent inter-cellular gap, intermediate filaments 
can be observed spanning out from the plaques into the cytoplasm (Garrod and 
Chidgey, 2008). Adherens junctions are located between the tight junction and 
the desmosomes and were identified at the TEM level in this location, where the 
adjacent membranes were completely parallel for -0.2 -  0.5pm (Niessen and 
Gottardi, 2008). The appearance and maturation of these cellular junctions from 
Day 9 (Figure 3.5) corresponded with the large increase in average TEER values 
determined between Days 9 to 18 (Figure 2.6), indicating that tight junctions had 
formed during this period. However, the initiation of these cell-cell contacts, later 
to become cell junctions, is thought to begin as early as Day 1. TEM images of 
Day 1 cultures revealed that numerous cellular projections appear on the outer- 
surface of the cells, these were thought to be due to actin filament accumulation 
that create these filopodia projections during nascent adhesion and subsequent 
junction formation (Miyoshi and Takai, 2008).
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Clara cells are non-cilliated, non-mucus, secretory epithelial cells and appear 
from Day 6 (Figure 3.5), mature Clara cells were observed from Day 21 in 
cultures. Their apical surfaces contained few microvilli and were characteristically 
dome-shaped. Electron-dense proteinacous granules were found within the Clara 
cells apical cytoplasm and being very metabolically active, contained numerous 
mitochondria (Boers et al., 1999). The appearance of Clara cells (confirmed 
experimentally Chapter 4, Section 4.4.2) at Day 6 also corresponded to the slight 
increase observed in apical protein content (Figure 2.7). Goblet cells developed 
later and were identified by TEM around Day 12/15 (Figure 3.6). Morphologically, 
goblet cells were identified by their typical ‘drinking cup’ (i.e. goblet) shape, that 
results from the accumulation of secretory mucous granules in the apical portion 
of the cell, with the basal portion tapering around intermediate and basal cells 
(Rhodin, 1966). However, immature or discharged goblet cells were generally 
more columnar in comparison (Breeze and Wheeldon, 1977). Goblet cells 
contained numerous electron-lucent mucin granules (Rogers, 1994). The 
appearance of goblet cells in the NHBE culture was associated with a larger 
increase in the apical protein content (Figure 2.7). Their continued maturation and 
increased incidence, up until Day 18, also paralleled the gradual increase in 
apical protein. Networks of polysaccharides were observed around the cilia and 
microvilli (Figure 3.6 and 3.8) and are known as ‘glycocalyx’ and they occur 
normally in the human airway lumen in this manner (Martins and Abairos, 2002).
Ciliated cells were more readily confirmed by TEM than via LM. Cilia were 
identified at the electron microscope level not only by their increased length 
compared to microvilli, but due to their distinct morphology. Electron-dense 
striations were observed along the length of cilia (Figure 3.7 -  3.9), due to the 
microtubules that formed their axoneme (Hasleton and Curry, 1996). Transverse 
TEM sections revealed the classical “9+2” axoneme formation (Figure 3.9). Cilia 
were also anchored into the ciliated cell via basal bodies and surrounded by 
numerous mitochondria (Figure 3.9) (Hasleton and Curry, 1996; Sorokin, 1968). 
The NHBE model matured and entered a period of relative stability, according to 
biochemical and morphological characterisation, between Days 27 and 33. 
Beyond Day 33, the cultures deteriorated and underwent dedifferentiation (Figure 
3.9 -  3.10), most likely due to the limited amount of doublings primary cells
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undergo (Chepko and Smith, 1999). There was a slight increase in apical protein 
observed between Days 36 to 42, which correlated with culture demise; 
confirmed morphologically at both the LM and TEM levels. These observations 
suggested that the increase in protein was likely due to an increase in cellular 
debris.
Consequently, any toxicological experimentation should be undertaken between 
Days 27 and 33, when the model was fully-differentiated and of muco-ciliary 
phenotype.
3.5.3 S c a n n in g  E l e c t r o n  M ic r o s c o p y
SEM was utilised to examine the surface topography of the NHBE human lung 
construct. The information gathered by SEM analysis provided a new dimension 
to the morphological characterisation not provided by LM and TEM.
SEM images of Day 1 cultures demonstrated the existence of numerous cellular 
projections/ruffles which encompassed the free surfaces of every cell; this may 
represent the initial attempts to create cell-cell contacts, through the formation of 
actin filaments (Miyoshi and Takai, 2008). TEM images of Days 3 and 6 gave the 
impression that cell-cell contacts had been established and that the apical surface 
was smooth. SEM images revealed that the formation of these cell-cell contacts 
were still on-going and continued to be so until Day 9. The surface topography of 
cultures at Day 9 displayed the delineation of individual cells by a dense-raised 
border of microvilli, which had not been perceptible from LM or TEM images. This 
delineated border may be characteristic of immature ciliated or basal cells 
(Breeze and Wheeldon, 1977) or an even artefact of tight junction formation 
(Farquahr and Palade, 1963).
Cilia were clearly observed from Day 15 onwards by all three microscopical 
methods. Contrary to TEM observations, SEM images allowed the visualisation of 
mucin globules resident on the apical surface, clearly seen from Day 24. At Day 
30, a ‘new’ or previously unobserved, cell type became apparent. Surface 
topography of this cell was unlike the ciliated or goblet cell; it appeared raised,
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covered in many large rounded projections, each enveloped in small microvilli-like 
structures. This cell may be a ‘brush cell’ or an ‘exhausted goblet cell’, as 
described by Breeze and Wheeldon (1977). Which stated, that exhausted goblet 
cells had a “dense population of microvilli on the luminal surface”, also that “brush 
cell microvilli are taller, wider and more uniform and contain more prominent 
intracellular axial filaments than the microvilli of goblet cells or potential ciliated 
cells” (Breeze and Wheeldon, 1977).
The topographical complexity of the constructs was discernable by SEM, 
especially at Days 30 to 33. Visualisation of this complexity created a vast 
contrast with cultures at Day 36, where the dedifferentiation of the cultures could 
be clearly observed, with only cilia and microvilli remaining on the surface. 
Observation of cultures at Day 42 revealed numerous ‘pores’ or ‘holes’ across the 
surface of many cells. The presence of which, correlated to both, the low TEER 
values (Section 2.4.2) and the high apical protein concentration (Section 2.4.3), 
observed at Day 42. Based on SEM characterisation, any toxicological 
experimentation should be undertaken between Days 27 and 33, where the 
model appeared to have a fully-differentiated, muco-ciliary phenotype. SEM 
images of the mature NHBE surface topography displayed similar features to the 
human bronchial epithelium in vivo (Jeffery and Li, 1997).
3.5.4 In  V itr o - In  V ivo  C o rre la t io n
Analysis of overall NHBE tissue morphology revealed several similarities to 
excised (biopsy) human tracheobronchial epithelium. The NHBE construct 
displayed a polarised, pseudo-stratified culture of muco-ciliary phenotype, similar 
to the in vivo situation. Architecturally, the only difference to in-situ human tissue 
was that the NHBE construct appeared less columnar and Clara cells were not 
identified. However, this could be due to LM processing artefacts, as semi-thin 
sections revealed an accurate morphological picture as well as identification of 
Clara cells (Figure 3.2[C]).
Comparison of individual cell types present within LM semi-thin sections of NHBE 
cultures, revealed the presence of ciliated, goblet, basal and intermediate cells;
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all of which are located in the human bronchial epithelium. These cells exhibited 
similar characteristics and structures to their counterparts found in vivo (Breeze 
and Wheeldon, 1977). Non-basal cells appeared more columnar, ciliated cells 
displayed cilia (Rhodin, 1959), goblet cells were also identified due to their paler 
appearance; possibly due to the presence of mucin granules (Rogers, 2003). 
Basal cells were located at the basal end of the culture and appeared round in 
comparison to non-basal cells (Baldwin, 1994).
3.6 C o n c lu s io n s
Morphological characterisation demonstrated that the ‘in-house’ NHBE model 
was able to develop into a stable, well-differentiated, muco-ciliary phenotype 
epithelium, suggesting that it is a viable in vitro alternative of the human bronchial 
epithelium. Characterisation at all levels (i.e. biochemical and morphological) was 
undertaken in order to elucidate the response of the construct to a given 
xenobiotic (Chapter 5 and 6). This would enable a clearer understanding of the 
morphological modifications that may occur during any injury and repair 
processes. Further characterisation of the NHBE culture was undertaken over the 
time course in order to more specifically identify and further confirm the different 
cell types present (Chapter 4).
The main advantages to this NHBE model were: 1) accurate reflection of the 
bronchial epithelium in vivo; 2) a relatively long exposure window (Day 27 -  33); 
and 3) high number of inserts (~300) produced, from a single cryovial (~500,000 
cells). The main disadvantages to this model were its long morphogenesis cycle 
leading to maturity, and therefore, its subsequent demise from Day 36.
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4.1 In tro d u c tio n
In previous experimental work, the biochemical and physiological properties 
(Chapter 2), along with the morphological development (Chapter 3) of the NHBE 
model, was assessed over the 42 days of ALI culture. This revealed that the 
NHBE model was fully-differentiated and of muco-ciliary phenotype. Additional 
characterisation work would now include complimentary histochemical and 
immunohistochemical procedures in order to: 1) detect integral cytoskeletal 
components; 2) establish the presence of Clara cells; 3) confirm mucin producing 
goblet cells; 4) identify the models progenitor cells; and 5) verify the existence of 
integral tight junction proteins.
An anti-cytokeratin (CK) 5/6 antibody was used to identify these specific 
cytokeratins which are known to be present in the basal and supra-basal cells of 
non-keratinising epithelia (Chu and Weiss, 2002), such as the respiratory tract 
epithelium (Sun et al., 1979). CK 5/6 is also known to be typically expressed by 
hyper-proliferative cells (Neudeck e ta l., 1997).
The 10kDa Clara cell specific protein, CC10, was utilised in order to detect their 
presence within the NHBE model (Singh and Katyal, 1997; Singh and Katyal, 
2000). As one descends down the respiratory tract goblet cells become less 
frequent and are replaced by Clara cells. Clara cells are predominantly located in 
the terminal and respiratory bronchioles (Boers etal., 1999; Widdicombe, 2002).
The identification of inter- and intra-cellular mucin and therefore, presence and 
development of goblet cells, was achieved by a positive Periodic-Acid Schiff 
(PAS) stain. PAS is known to stain mucopolysaccharides and glycogen, which 
are the main components of the mucus produced and secreted by goblet cells 
(Zugibe, 1970).
In order to determine the role of basal cells during the development of the fully- 
differentiated, NHBE model, a basal cell specific marker, p63 (Yang et al., 1998; 
Yang et al., 1999; Wang et al., 2002), was monitored. Yang and co-workers 
(1999) deduced that p63 preserved the self-renewal capacity (i.e. progenitor
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activity) of cells as p63 was highly expressed in basal cells, yet rapidly degraded 
upon differentiation.
One of the major functions of the respiratory epithelium is its ability to ‘maintain a 
barrier’ between the airway lumen and the internal milieu. The tight junctions are 
the most apically located of all epithelial junctions and were first discovered by 
Farquar and Palade in 1963. Despite this, the specific proteins involved in tight 
junctions were not discovered until much later; ZO-1 (Stevenson et al., 1986), 
occludin (Furuse et al., 1993) and claudin (Furuse et al., 1998). These are the 
three integral tight junction proteins that will be the focus in this Chapter. ZO-1 is 
a tight junction associated protein present on the cytoplasmic side (Anderson et 
al., 1988) and occludin and claudin are both 4-pass transmembrane proteins 
present at the point of tight junction membrane contacts (Furuse et al., 1993; 
Furuse et al., 1998).
4 .2  M a te r ia ls  and S to c k  S o lu tio n s
4.2.1 S to c k  S o lu tio n s
S o lu tio n s S u p p l ie r
EDTA Fisher Scientific, Manchester, UK
Tween 20
PBS with 1% BSA 
Mayer’s Hematoxylin 
Gill’s Hematoxylin 
Paraformaldehyde 
Trition X-100
Sigma, Dorset, UK
Normal Goat Serum 
Mouse Anti-Human Cytokeratin 5/6 
Mouse IgGi (Negative Control) 
Streptavidin:Biotynylated Enzyme Complex 
Liquid DAB Chromagen
Dako, Ely, UK
Table 4.1 Table of stock solutions used and their suppliers.
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S o lu tio n s S u p p lie r
Biotinylated Goat Anti-Mouse IgG 
Rabbit IgG (Negative Control) 
Vectorshield Mounting Medium with DAPI
Vector Laboratories, 
Peterborough, UK
Clara Cell Protein (CC10) BioVendor, Heidelberg, Germany
Histostain® Plus Rabbit Primary Kit 
Rabbit Anti-Human ZO-1 (Mid)
Rabbit Anti-Human Claudin-1 
Mouse Anti-Human Occludin 
AlexaFluor® 594, Goat Anti-Rabbit IgG 
AlexaFluor® 488, Goat Anti-Mouse IgGi
Invitrogen, Paisley, UK
1% Periodic-Acid Schiffs Reagent
Pioneer Research Chemicals 
Ltd., Essex, UK
Mouse Anti-Human p63 (Clone 4A4) BD Pharmingen™, Oxford, UK
Mouse lgG2a (Negative Control) Bio-Stat, Stockport, UK
DPX Mountant
VWR International Ltd., Poole, 
UK
Table 4.1 Continued table of stock solutions used and their suppliers.
4.2.2 Eq u ip m e n t
E q u ip m e n t S u p p l ie r
Humidity Chamber
Mechanical Workshop, Cardiff 
University, UK
Phase Contrast LM (DM2500)
Digital Camera (DFC 320)
Q550 IW Workstation 
QWin Image Analysis Software (v.3) 
Confocal Microscope (DM6000) 
Confocal System (TCS SP2 A0BS) 
LCS Lite Confocal Software (v.2.6.1)
Leica Ltd., Milton Keynes, UK
Table 4.2 Table of equipment used and their suppliers.
1 0 7
D e v e l o p m e n t a l  H i s t o l o g y  o f  t h e  N H B E  M o d e l
4 .3  M eth od s
4.3.1 T issue  P r o c es sin g  fo r  L ig h t  M ic r o s c o py
Cell culture inserts were immersed in 10% neutral buffered formalin (4°C) for 24 
hours in preparation for paraffin embedding and sectioning, outlined previously 
(Sections 3.3.4.1 -  3.3.4.4). Following this, culture sections can then undergo 
immunohistochemical or histochemical detection (Sections 4.3.2 -  4.3.5). All 
washes were done with sections in a slide rack within a glass jar and all 
incubations were performed in a LM humidity chamber.
4.3.2 Im m u n o h is t o c h e m its r y : C yto k er a tin  5/6
EDTA (1mmol/L, pH 9.0) was heated to boiling before immersing NHBE 
specimen (5pm sections; n = 3) slides in the solution (2 minutes). Slides were 
rinsed twice with buffer wash (PBS pH 7.4 with 0.05% Tween), followed by 
immersion in 0.5% H2C>2 in methanol for 10 minutes (to block endogenous 
peroxidase activity), and then washed in wash buffer 2 minutes (x3). Non-specific 
binding of the 2° antibody was blocked by incubating in 20% normal goat serum 
(200pl) for 20 minutes.
Excess serum was removed and sections incubated with either 100pl of 2.2pg/ml 
cytokeratin 5/6 1° antibody (diluted using antibody dilutant: 1% BSA in PBS [pH 
7.4] with 0.05% Tween), or mouse IgGi negative control for 1 hour. Sections were 
washed with buffer wash for 2 minutes (x3). Slides were incubated with 100pl of 
15pg/ml biotinylated goat anti-mouse IgG 2° antibody (diluted with antibody 
dilutant) for 20 minutes, followed by washing in buffer wash for 2 minutes (x3).
Tissue sections were covered with 100pl of the streptavidin: biotinylated enzyme 
complex for 20 minutes (complex allowed to form for 30 minutes prior to 
incubation). Slides were washed with buffer wash for 2 minutes (x3). Sections 
were incubated with liquid DAB chromagen (100pl) for 3 minutes and then
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washed in distilled water. Counterstaining was done with Mayer’s hematoxylin for 
45 seconds, followed by rinsing in running tap water (20 seconds).
Tissue sections underwent dehydration and cover-slips were mounted before 
images were captured (Section 4.3.6). LM images were captured using the Q550 
IW Workstation at x40 magnification and saved as TIFF images. A specific length 
of each membrane (15cm on screen) was selected for analysis within the QWin3 
program. The ‘colour detect’ feature was used to detect the quantity (area, pm2) 
of CK 5/6 staining in each image. The total surface area (pm2) of culture was also 
detected and the quantity of CK 5/6 staining calculated as a percentage of this.
4.3.3 Im m u n o h is t o c h e m is t r y : CC10
NHBE specimen slides (5pm sections; n = 3) were immersed in 0.5% H2O2 in 
methanol for 10 minutes (to block endogenous peroxidase activity), and then 
washed in buffer wash (PBS pH 7.4 with 0.05% Tween) 2 minutes (x3). Non­
specific binding of the 2° antibody was blocked by incubating in 20% normal goat 
serum (200pl) for 20 minutes.
Excess serum was removed and sections incubated with either 100pl of 10pg/ml 
CC10 1° antibody (diluted using antibody dilutant: 1% BSA in PBS [pH 7.4] with 
0.05% Tween), or rabbit IgG negative control for 30 minutes. Sections were 
washed with buffer wash for 2 minutes (x3). Sections were incubated with 100pl 
of 10pg/ml biotinylated goat anti-rabbit IgG 2° antibody (Histostain® Plus Rabbit 
Primary kit) for 20 minutes, followed by washing in buffer wash for 2 minutes (x3).
Tissue sections were covered with 100pl of the streptavidin peroxidase-HRP for 
20 minutes (Histostain® Plus Rabbit Primary kit). Slides were washed with buffer 
wash for 2 minutes (x3). Sections were incubated with liquid DAB chromagen 
(1 OOpI) for 3 minutes then washed in distilled water. Counterstaining was done 
with Mayer’s hematoxylin for 45 seconds, followed by rinsing in running tap water 
(20 seconds).
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Tissue sections underwent dehydration and cover-slips were mounted before 
images were captured (Section 4.3.6). LM images were captured using the Q550 
IW Workstation at x40 magnification and saved as TIFF images. A specific length 
(15cm on screen) of each membrane was selected for analysis within the QWin3 
program; the number of CC10+ stained cells within this area were counted. The 
total number of cells was determined and the number CC10+ stained cells 
calculated as a percentage of this.
4.3 .4  P e r io d ic -A c id  S c hiff  Sta in in g
NHBE culture sections (5pm) were prepared for PAS staining and n = 1 section 
was stained for each insert. PAS staining was performed by histotechnologist Ms. 
Hilary Marshall (AstraZeneca, R&D Loughborough, UK), as outlined below.
Sections were treated with 1% periodic-acid for 5 minutes, followed by several 
washes in dH20. Then sections were treated with Schiffs reagent for 8 minutes, 
followed by washing in running tap water for 10 minutes. Counterstaining was 
undertaken with Gill’s hematoxylin for 2 minutes, followed by washing in running 
tap water for 10 minutes.
Sections underwent dehydration and cover-slips were mounted before images 
were captured. LM images were captured using the Q550 IW Workstation at x40 
magnification and saved as TIFF images.
4.3 .5  Im m u n o h is t o c h e m its r y : p63
NHBE specimen slides (5pm sections; n = 3) were immersed in 6% H2O2 in 
methanol for 10 minutes (block endogenous peroxidase activity), followed by 
washing in buffer wash (PBS [pH 7.4] with 0.05% Tween) for 2 minutes (x3). Non­
specific binding of the 2° antibody was blocked by incubating in 20% normal goat 
serum (200pl) for 20 minutes.
Excess serum was removed and sections were incubated with either, 100pl of 
5pg/ml p63 1° antibody (diluted using antibody dilutant: 1% BSA in PBS [pH 7.4]
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with 0.05% Tween), or mouse lgG2a negative control overnight (4°C). Slides were 
then washed with buffer wash for 2 minutes (x3). Sections were incubated with 
100|jl of 15|jg/ml biotinylated goat anti-mouse 2° antibody (diluted using antibody 
dilutant) for 20 minutes, followed by washing slides in buffer wash for 2 minutes 
(x3).
Tissue sections were covered with 100|jl of the streptavidin: biotinylated enzyme 
complex for 20 minutes (complex allowed to form for 30 minutes prior to 
incubation). Slides were washed with buffer wash for 2 minutes (x3). Sections 
were incubated with liquid DAB chromagen (100pl) for 2 minutes then washed in 
distilled water (2 minutes). Counterstaining was done with Mayer’s hematoxylin 
for 45 seconds, followed by rinsing in running tap water (20 seconds).
Tissue sections underwent dehydration and cover-slips were mounted before 
images were captured (Section 4.3.6). LM images were captured using the Q550 
IW Workstation at x40 magnification and saved as TIFF images. A specific length 
(15cm on screen) of each membrane was selected for analysis within the QWin3 
program; the number of p63+ stained nuclei within this area were counted. The 
total number of nuclei was determined and the number of p63+ cells calculated as 
a percentage of this.
4.3.6 D e h y d r a tio n  a nd  A d ditio n  of C o v e r -S lips
Treated sections must be covered with a glass cover-slip to, protect the tissue, 
provide better optical quality for viewing under the LM and to preserve the tissue 
section for archival purposes. The treated slides were dehydrated by immersing 
(2 minutes) in an increasing series of alcohol; 70% —► 95% —> 100% (x2) and 
xylene (x2).
Slides remained in xylene until ready for cover-slips to be attached. A small 
amount (20pl) of DPX mountant was placed on a cover-slip and the slide carefully 
lowered onto the cover-slip and DPX. The slide is left cover-slip side up overnight 
(RT). Sections were viewed using a Leica Phase Contrast LM (DM2500) attached 
to a digital camera (Leica DFC 320) and images saved as TIF files.
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4.3.7  St a t is t ic a l  A n a lysis
Data was assessed for normality with the Anderson-Darling test for homogeneity 
in Minitab 15 (Microsoft Inc., WA, USA); none of the data tested was normally 
distributed. Therefore, the non-parametric Mann-Whitney test (SPSS 15.0, SPSS 
Inc. IL, USA) was performed in order to assess if there was any significant 
differences between the NHBE cultures at different days. Significance was 
accepted at p £0.05, whilst p £0.01 indicated high statistical significance (Dytham, 
2003). Standard deviation was used to represent experimental variation.
4.3.8  C o n fo c a l  M ic r o s c o p y : T ig h t  J u nc tio n s
NHBE culture inserts were fixed and tested for the presence of the tight junction 
proteins; ZO-1, claudin-1 or occludin (n = 2), over the development of the model 
(Day 1 -  42). The cultures were either used for the detection of one tight junction 
protein; ZO-1 or claudin-1 (Section 4.3.8.1 -4 .3 .8 .2) or two tight junction proteins; 
ZO-1 and occludin or claudin-1 and occludin (Section 4.3.8.1 -4 .3 .8 .3). Detection 
was the same for both methods (Section 4.3.8.4).
4.3.8.1 In it ia l  C u ltu r e  pr o c essin g  for  C o n fo c a l  M ic r o s c o p y
Cell culture inserts were immersed in 4% paraformaldehyde (RT) for 10 minutes 
and stored in PBS (pH 7.4) at 4°C until used (stored for no longer than 72 hours). 
After storing, inserts were washed in PBS (pH 7.4) for 2 minutes (x3). Cultures 
were permeabilised with 200pl Trition X 0.1% in antibody dilutant (1% BSA in 
PBS [pH 7.4] with 0.05% Tween) for 20 minutes (RT) and then removed. Non­
specific binding of the 2° antibody was blocked by incubating in 20% normal goat 
serum (200pl) for 20 minutes.
4.3 .8 .2  In c u b a tio n  w ith  F ir st  P r im a r y  a n d  S e c o n d a r y  A n tib o d ie s
Excess serum was removed and inserts (n = 2 for each 1° antibody) were 
incubated with either 150pl of 2.5pg/ml ZO-1 1° antibody (diluted using antibody 
dilutant), 2.5pg/ml claudin-1 1° antibody (diluted using antibody dilutant), or
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2.5|jg/ml rabbit IgGi negative control for 1 hour. Cultures were washed with PBS 
(pH 7.4) for 2 minutes (x3). Followed by, incubation with 150|jl of 1:200 Alexa 
Fluor® 594 2° antibody (diluted using antibody dilutant) for 1 hour (dark), followed 
by washing in PBS (pH 7.4) for 2 minutes in the dark (x3). If an NHBE inserts was 
being used for the detection of a second 1 ° antibody, the protocol followed on to 
Section 4.3.8.3. If only one 1° antibody was being detected, the protocol skipped 
onto Section 4.3.8.4.
4.3 .8 .3  In c u b a tio n  w ith  S eco nd  P r im a r y  a n d  S e c o n d a r y  A n tib o d ies
Inserts were incubated with either 150pl of 5pg/ml occludin 1° antibody (diluted 
using antibody dilutant), or 5pg/ml rabbit IgGi negative control for 1 hour (dark). 
Cultures were washed with PBS (pH 7.4) for 2 minutes in the dark (x3). Followed 
by, incubation with 150pl of 1:200 Alexa Fluor® 488 2° antibody (diluted using 
antibody dilutant) for 1 hour (dark), followed by washing inserts in PBS (pH 7.4) 
for 2 minutes in the dark (x3).
4.3 .8 .4  C o u n te r s t a in in g , M o u n tin g  a n d  D etec tio n
Inserts were incubated with 300nM DAPI nuclear stain (200pl) for 2 minutes 
(dark). The membrane was then cut from the insert using a scalpel and mounted 
using Vectorshield with DAPI, cell side up. Slides were stored in the dark (4°C) 
until images were taken. NHBE cultures were viewed and images taken as TIFF 
files using the Leica DM6000 Microscope, Leica TCS SP2 A0BS Confocal 
System and Leica Confocal Software v.2.6.1.
4 .4  R e su lts
NHBE cultures (n = 7) were collected every 3 days over a 42 day period; n = 2 
inserts were prepared for LM using standard techniques (Chapter 3) and the 
other 5 inserts were prepared for confocal microscopy (Section 4.3.6). 
Histological and immunological analysis was undertaken on every time point over 
the 42 day culture period. Ck 5/6 detection enabled identification of basal and 
intermediate cells of epithelial origin; CC10 antibody revealed the presence of
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Clara cells; PAS staining highlighted mucin secreting goblet cells; p63 antibody 
highlighted the basal/progenitor cells within the cultures and ZO-1, occludin and 
claudin-1 were used to verify the formation of tight junctions. All negative controls 
resulted in a negative response (images not shown). However, some Day 42 
control inserts from the tight junction work displayed some autofluorescence that 
was associated with dead/dying cells.
4.4.1 C y to k e r a tin  5/6: E pith elia l  C ells
The almost confluent monolayer of NHBE cells at Day 1 (24 hours post-seeding) 
displayed CK 5/6+ staining throughout the cytoplasm of all cells present. The 
nuclei of cells remained unstained, resulting in -70%  of the total culture area 
being positively stained (Figure 4.1 [A]). The percentage total of CK 5/6+ staining 
gradually decreased to -50% by Day 9, with the staining receding to the basal 
and supra-basal layers (Figure 4.1 [B]). The accumulation of staining within the 
basal and supra-basal layers continued until about Day 18, where the total stain 
amounted to 45% (Figure 4.1 [C]). CK 5/6+ staining within cultures stabilised, both 
in location and percentage coverage between Days 12 -  24 at approximately 
45% (Figure 4.3).
From Day 24 CK 5/6+ staining gradually decreased from 44% (Day 24) to -28%  
by Day 36 (Figure 4.3). Visually, staining remained of the same quantity and 
location, however, as the apical cells underwent pseudo-stratification, the total 
area of the culture increased, with the total percentage area of CK 5/6+ staining 
decreasing. Day 36 revealed culture deterioration, with CK 5/6+ staining 
becoming less intense within the supra-basal layer, but remaining within the basal 
layer (Figure 4.2[A]). Further deterioration and squamation of cultures occurred 
by Day 39, with CK 5/6+ staining focally accumulated in the basal layer (Figure 
4.2[B]). NHBE cultures at Day 42 appeared squamous, however, CK 5/6+ staining 
within the culture displayed a highly significant increase (p<0.001) from Day 39, 
from -22%  to -40%, with defined staining observed within the basal and supra- 
basal layers (Figure 4.2[C]).
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Figure 4.1 LM images of NHBE cultures stained for CK 5/6 (red/brown colour). [A] Day 1; staining 
in cytoplasm of all cells. [B] Day 9; staining observed in the cytoplasm in the majority of cells, less 
so in the apical layer. [C] Day 18; staining predominantly in the cytoplasm of basal and supra- 
basal cells.
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Figure 4.2 LM images of NHBE cultures stained for CK 5/6 (red/brown colour). [A] Day 36; 
staining in cytoplasm of basal and some supra-basal cells. [B] Day 39; focal accumulation of stain 
observed in some basal cells. [C] Day 42; intense staining observed in the cytoplasm of basal and 
supra-basal cells.
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Figure 4.3 Graph displaying percentage area of CK 5/6+ staining within NHBE cultures over the 
culture period (Days 1 -  42). Standard deviation was displayed (I), ** denotes high significant 
difference (p<0.001), n = 3.
4.4.2 CC 10: C la r a  C ells
The almost confluent monolayer of NHBE cells at Day 1 (24 hours post-seeding) 
displayed no CC10+ staining (Figure 4.4[A]). No positive staining was observed
until Day 9 (Figure 4.4[B]), where around 7% of cells were stained. The
percentage total of CC10+ staining remained at this level until Day 21 (Figure 
4.6), with the staining intensity increasing (Figure 4.4[C]).
Cultures at Day 24 revealed an increase in the number of CC10+ cells (Figure 
4.5[A]), with the percentage of these cells remaining at -17% until Day 36 (image 
not shown) (Figure 4.6). Day 39 revealed culture deterioration, with the
percentage of CC10+ cells increasing significantly (p<0.001) from the stable 
period; Days 24 -  36 (Figure 4.5[B]). However, the number of CC10+ cells 
remained the same as Days 24 -  36, but due to the culture deterioration and 
squamation, the percentage of CC10+ cells appeared to increase. Cultures at Day 
42 were very squamated and the number and percentage of CC10+ cells 
displayed a highly significant (p<0.001) decrease compared to Days 24 - 39 
(Figure 4.5[C] and 4.6).
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Figure 4.4 LM images of NHBE cultures stained for CC10 (red/brown colour). [A] Day 1; no 
staining observed. [B] Day 9; staining observed in the cytoplasm of an apically located cell. [C] 
Day 21; staining observed in an apically located cell, with the cytoplasm stained all the way 
throughout the cell, until it reached the membrane.
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Figure 4.5 LM images of NHBE cultures stained for CC10 (red/brown colour). [A] Day 24; staining 
observed in the cytoplasm of some apically located cells. [B] Day 39; staining observed in the 
cytoplasm of some cells and others becoming squamous. [C] Day 42; staining observed in fewer 
cells, culture appeared squamous.
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Figure 4.6 Graph displaying percentage of CC10+ cells within NHBE cultures over the culture 
period (Days 1 -  42). Standard deviation was displayed (I), ** denotes high significant difference 
(p<0.001), n = 3.
4.4.3 P e r io d ic -A c id  S c h if f : G o b l e t  C e l ls
NHBE cultures, 24 hours post-seeding (Day 1) displayed no positive PAS staining 
(Figure 4.7[A]). No positive PAS staining was observed within the culture until 
Day 12. At Day 12 positive staining could be observed within a few cells, however 
staining did not fill the entire cell and no staining could be observed on the apical 
surface of the culture (Figure 4.7[B]). By Day 15, entire cells in the apical layer 
were positively stained, with an almost consistent thin layer of positive staining on 
the apical surface (Figure 4.7[C]).
PAS staining within cultures remained relatively consistent until Day 42. The only 
difference was a slight increase in the number of positively stained cells up to Day 
21, where it remained relatively constant until Day 42 (Figure 4.8[A]). Cultures 
began to deteriorate structurally from Day 36. On Day 42, cultures either 
displayed a large increase in positively stained cells or cultures deteriorated to a 
squamous monolayer, with a low level of staining (Figure 4.8[B] and [C]).
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Figure 4.7 LM images of NHBE cultures stained with PAS (dark purple colour). [A] Day 1; no 
positive staining observed. [B] Day 12; some staining observed within the culture, but not definite 
goblet cells. [C] Day 15; numerous cells intensely stained throughout the culture.
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Figure 4.8 LM images of NHBE cultures stained with PAS (dark purple colour). [A] Day 27; 
several cells intensely stained throughout the culture. [B] Day 42; numerous cells heavily stained 
throughout the culture. [C] Day 42; culture deterioration, less cells positively stained.
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4 .4 .4  p63: Ba sa l /P r o g e n ito r  C ells
NHBE cultures at Day 1 (24 hours post-seeding) were nearly completely 
comprised of p63+ cells with approximately 98% of nuclei stained (Figure 4.9[A]). 
As the model developed with an increase in the number of cells, the percentage 
of p63+ cells in the construct gradually decreased. Positive p63 staining at Day 6  
was detected in the nuclei of basal and supra-basal cells, with -60%  of total 
nuclei stained (Figure 4.9[B]). Positive staining continued to decrease to -50%  by 
Day 9, with staining retreating to the basal layer (Figure 4.9[C]).
A gradual decrease in p63+ cells occurred after Day 1 and continued until Day 15, 
where it accounted for around 38% of cells, the p63+ cells are observed in the 
basal layer (Figure 4.10[A]). Positive p63 staining stabilised both in location and 
number of cells between Day 15 and Day 39 (Figure 4.10[A] and [B]). Positive 
staining was mainly contained to the basal cells, with some supra-basal cells 
positively stained; the quantity of staining remained between 25 -  38% (Figure
4.11). Deterioration of the NHBE culture by Day 42 coincided with an increase in 
p63+ staining; all basal cells were stained as well as some supra-basal cells (now 
apical cells) (Figure 4.10[C]). Cultures at Day 42 exhibited a significant (p<0.05) 
increase in the percentage of p63+ cells when compared to Days 1 5 - 3 9  (Figure
4.11).
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Figure 4.6 LM images of NHBE cultures stained with p63 (red/brown colour). [A] Day 1; staining 
seen in nuclei of all cells present. [B] Day 6; nuclear staining observed in basal cells and some 
supra-basal cells. [C] Day 9; nuclear staining observed mainly in basal cells, with some staining of 
supra-basal cells.
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Figure 4.7 LM images of NHBE cultures stained with p63 (red/brown colour). [A] Day 15; staining 
located in nuclei of basal cells. [B] Day 39; nuclear staining detected in basal cells and some 
supra-basal cells. [C] Day 42; nuclear staining observed in basal cells, with light staining of supra- 
basal cells (i.e. apical cells).
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Figure 4.8 Graph displaying percentage of p63+cells within NHBE cultures over the culture period 
(Days 1 -4 2 ). Standard deviation displayed (I), * denotes significant difference (p<0.05), n = 3.
4.4.5 T ig ht  J unction  P roteins
NHBE cultures at Day 1 (24 hours post-seeding) displayed some positive staining 
for all three of the tight junction proteins investigated (Figure 4.9; Day 1). ‘Hot­
spots’ of positive ZO-1 could be observed throughout the cytoplasm of most cells 
on Day 1. Occludin was positively detected in the cytoplasm of some cells, with 
the staining intensified around the periphery of the cells, the majority staining. 
However, the level of occludin staining throughout the cultures was less than that 
of either ZO-1 or claudin-1. Positive claudin-1 staining was detected throughout 
the cytoplasm of the majority of cells on Day 1, with the staining more dispersed 
and hot-spots more intense when compared to ZO-1.
After Day 1, the positive staining for the tight junction proteins appeared to 
accumulate at the cell periphery, rather than throughout the cytoplasm; as was 
observed on Day 6 (Figure 4.9; Day 6). ZO-1 was still present throughout the 
cytoplasm, with a few intense areas appearing on the periphery of some cells. 
The presence of occludin within NHBE cultures was still lower than the other tight 
junction proteins, however, a few very intense areas of staining were evident at 
the borders of some cells. Occludin appeared to co-localise in the same regions
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as ZO-1, but were not always in the exact same spot, with occludin appearing in 
more places at the cell periphery without ZO-1, than ZO-1 appeared without 
occludin (overlay image not shown). Claudin-1 staining had migrated to the edge 
of the cells, yet staining did not form the clear lines that ZO-1 and occludin did; 
with staining remaining as numerous individual spots.
The migration of the tight junction proteins to the edge of the cells continued after 
Day 6 , with clear delineation of cells by Day 15, especially with ZO-1 and occludin 
(Figure 4.9; Day 15). This characteristic delineation of the cells by ZO-1 and 
occludin could be observed over most of the culture surface, however, it was not 
present throughout. Occludin staining was again more widespread than ZO-1. 
Claudin-1 staining did not appear to follow the exact same pattern as both ZO-1 
and occludin, with staining remaining within the cytoplasm and any delineation 
persisted as a ‘dotted’ rather than a ‘solid’ line.
The stable period for the NHBE cultures, in so far as these tight junction proteins 
were concerned, was Days 24 -  33 (Figure 4.9; Days 24 -  33). Both ZO-1 and 
occludin proteins formed a network of positive staining along the borders of the 
cells. Claudin-1 staining was more intense at the cell borders, forming ‘dotted’ as 
apposed to ‘solid’ lines, although considerable staining was observed within the 
cytoplasm of the cells.
The deterioration of the tight junction proteins ZO-1 and occludin was not 
observed until Day 42, claudin-1 staining revealed the beginning of deterioration 
earlier, by Day 36. In the more ‘healthy’ cultures, the characteristic staining 
network of ZO-1 and occludin could still be observed on Day 42, however, there 
were gaps in the network (Figure 4.9; Day 42). In the ‘not-so healthy’ cultures this 
staining pattern had practically disappeared, with most of the fluorescence 
appearing as autofluorescence; associated with dead/dying cells (image not 
shown). The deterioration of the claudin-1 staining was observed from Day 36 
(image not shown) until Day 42 (Figure 4.9; Day 42). The positive staining 
receded from the cell periphery, with most of the other staining attributed to the 
autofluorescence associated with dead/dying cells.
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Figure 4.9 Confocal LM images of NHBE cultures stained with DAPI and the tight junction 
proteins. NHBE cultures on Days 1,6, 15, 24 -  33 and 42 displayed stained with the nuclear stain 
DAPI (blue fluorescence) and either of the tight junction (TJ) proteins; ZO-1, claudin-1 (both red 
fluorescence) or occludin (green fluorescence). Day 1; positive staining observed for all TJ 
proteins. Day 6 and 15; migration and accumulation of staining at the cell periphery. Day 24 -  33; 
maturation of characteristic staining pattern. Day 42; deterioration of TJ staining. Scale bar = 
20pm.
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4 .5  D is c u ss io n
Previous work on the NHBE model concentrated on the morphogenic and 
biochemical characteristics of the human tissue equivalent of the respiratory 
epithelia (Chapters 2 and 3). This chapter’s component of characterisation, during 
the model development, involved the confirmation of crucial functional 
characteristics and further affirmation of specific cell types. These included 
epithelial cytoskeletal components, presence of Clara, mucin secreting and 
progenitor cells (basal cells), as well as tight junction formation.
4.5.1 C y to k e r a t in  5/6: E pith elia l  C ells
Observations were made on the presence of CK 5/6 within the NHBE model over 
the 42 days of ALI culture. This was conducted both in terms of total distribution 
and locality. CK 5/6 was present throughout the cytoplasm of all cells present in 
cultures 24 hour post-seeding (Day 1), with only 70% total culture staining, due to 
the lack of staining within the nuclei. The total staining within the cytoplasm of all 
cells present at this stage coincided with CK 5/6 being a marker of hyper- 
proliferative epithelial cells (Neudeck et al., 1997). Nelson and Sun (1983) 
demonstrated that certain embryonic epithelial cells expressed the CK 5/14 pair 
prior to stratification and that its expression appeared to be co-ordinated with the 
potential to stratify, with Stosiek and co-workers (1992) demonstrating that CK5/6 
were present in the basal cells of the pseudo-stratified respiratory epithelium. 
Cells isolated from a fully-differentiated epithelium and cultured in vitro showed a 
tendency to cease expression of their differentiation-specific cytokeratins. 
However, these cells continued to express at least the baseline level of the CK 
5/14 pair along with a significant increase in the hyper-proliferation keratin pair of 
CK 6/16, 17 (Goldman and Steinert, 1990).
Development of a monolayered NHBE culture to a pseudo-stratified epithelium 
resulted in the gradual decrease of total CK 5/6 staining, with a noticeable 
depletion and even eradication of staining within cells on the apical surface by 
Day 18. Day 18 demonstrated the typical staining pattern observed within this 
mature culture from this day until Day 36. CK 5/6 staining was now intense and
1 2 9
D e v e l o p m e n t a l  H i s t o l o g y  o f  t h e  N H B E  M o d e l
present mainly in the basal and occasionally, within the supra-basal cell layers. 
Staining was presumed to be due to the presence of the CK 5/14 pair rather than 
the CK 6/16, 17 pair. This would be consistent with many observations that CK 
5/14 is found in basal cells as a marker of stratified or pseudo-stratified epithelium 
(Goldman and Steinert, 1990; Moll et al., 1982; Presland and Dale, 2000; 
Presland and Jurevic, 2002; Voynow et al., 2005). As previously stated, total CK 
5/6 staining from Day 18 until 24 remained relatively constant (~44%). However, 
the total percentage of CK 5/6 staining within the cultures did decrease from Days 
24 -  36. This was not thought to be due to a decrease in the quantity of CK 5/6 
staining, but more due to the pseudo-stratification of the apical layer of cells, 
resulting in an increase in the total and non-staining area of the cultures.
Culture deterioration from Days 36 to 39, revealed that CK 5/6 staining was less 
intense within the supra-basal layer, but did however, remain within the basal 
layer. Day 39, exhibited cells on the basal surface (resting on the insert 
membrane) that had no CK 5/6 staining. This could simply be due to loss of basal 
cells resulting in the apical layer ‘falling down’ in its place. Day 42 revealed a 
highly significant increase (p<0.001) in the CK 5/6 staining compared to Days 27 
-  39; this may have been due to the culture’s attempt to ‘rescue’ itself and that as 
CK 5/6 were known to be involved in the mitotic process, the increased 
expression could be due to this (Franke et al., 1983). However, it may be due to 
squamation of the culture resulting in a decrease in total and therefore, non­
stained area of the culture.
4.5.2 C C 10: C lar a  C ells
An antibody to the 10kDa Clara cell specific protein, CC10, was used to identify 
the presence and prevalence of Clara cells during the development of the NHBE 
cell culture model (Singh and Katyal, 1998).
No positive response was obtained from the CC10 antibody until Day 9, where 
staining appeared in the cytoplasm of some apically exposed cells. The number 
and percentage of CC10+ cells on Day 9 was approximately 1.5% and 7%, 
respectively. This increased slightly by Day 12 (2% and - 8 %, respectively),
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although the values remained relatively constant until Day 21. Many of the CC10+ 
cells demonstrated staining throughout the cell, highlighting the fact that these 
cells reached the insert membrane and proving the culture was pseudo-stratified.
The number and percentage of CC10+ cells increased after Day 21 and plateaued 
between Days 24 -  36 (-3.5 and 17%, respectively). This again further confirmed 
this period to be the stable phase for the NHBE model. Additionally, Boers and 
colleagues (1999) established that roughly 11% of the cells in the terminal 
bronchioles and 22% in the respiratory bronchioles were Clara cells, indicating 
that the patient donor samples used were derived from the lower respiratory tract, 
even in the vicinity of the terminal bronchioles. Although the percentage of CC10+ 
cells increased on Day 39 from the plateau phase, the average number of CC10+ 
cells remained the same. This was due to the fact that the cultures began to 
deteriorate and undergo squamation, meaning that there were less non-CC10+ 
cells within the region measured. However, by Day 42 a highly significant 
(p<0.001) change occurred in the Clara cell profile, with the cell number and 
percentage being severely decreased when compared to the plateau period. This 
again further re-enforced the conclusion that the NHBE culture was undergoing 
demise and dedifferentiation. Additionally, the decrease in Clara cells (as 
apposed to an increase) would suggest that although Clara cells were thought to 
contribute to renewal in the bronchial epithelium (Boers et al., 1999; Brody et al., 
1987), they were not attempting to contribute to the repair in the NHBE 
epithelium, at this time.
Although the exact physiological role that Clara cells play has not entirely been 
identified, they contain the P450-dependent, mixed-function oxidase enzyme; 
known to oxidatively metabolise xenobiotics within the lungs (Boyd, 1977; 
Devereux, 1984; Peao et al., 1993). This is an important function to have within 
the NHBE system, as some xenobiotics are specifically metabolised to harmful 
metabolites (e.g. 4-ipomeanol) within the lung (Boyd, 1977).
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4.5.3  P e r io d ic -A c id  S c h if f : G o b le t  C ells
The appearance of goblet cells within the NHBE culture was studied over the 42 
day culture period by using PAS to stain the mucopolysaccharides and glycogen 
components located within them (Zugibe, 1970).
No positive PAS staining was observed within the NHBE culture until Day 12. The 
relatively late appearance of mucopolysaccharides was anticipated because the 
culture needed to first undergo proliferation and squamous metaplasia prior to re­
differentiation into ciliated and goblet cells. Puchelle and co-workers (2006) 
seeded disassociated adult human airway epithelial cells into a denuded rat 
trachea. These cells initially proliferated into a confluent squamous epithelium 
prior to pseudo-stratification and then re-differentiation into an epithelium of 
muco-ciliary phenotype (Puchelle, 2006).
Positive staining within cells observed at Day 12, may have suggested the 
presence of goblet cells beginning to synthesise mucopolysaccharides; as 
staining only accounted for a small region within the cell. Clearly identifiable 
goblet cells were detected at Day 15, by positive PAS staining, with goblet cells 
remaining within the cultures until Day 42. A thin layer of staining was observed 
on the apical surface of the cultures, indicating that the goblet cells themselves 
were releasing mucins into the ‘lumen’ (apical region).
Deterioration of cultures, from Day 36 onwards, demonstrated cultures were 
reverting back to squamous monolayers, with a low level of PAS staining. 
Controversially, some cultures displayed goblet cell hyperplasia. This could be a 
defence mechanism, to produce more mucin as a protective mechanism during 
culture demise (Ward etal., 2002; West, 2003).
4.5 .4  p63: Ba sa l /P r o g en ito r  C ells
Basal cells were identified, through p63 positive staining, as the progenitor cells 
of the NHBE model and therefore, in the bronchial epithelium (Yang et a l, 1998; 
Yang etal., 1999; Wang etal., 2002).
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Almost all cells seeded onto inserts were p63+ 24 hours post-seeding (Day 1), 
inferring that the vast majority (98% average) of cells were basal cells. 
Proliferation and subsequent development of the NHBE model resulted in a 
gradual decrease in the percentage of p63+ cells as the progeny began the 
process of differentiation and therefore, rapid degradation of p63 (Yang et al., 
1998). By Day 6 , positive staining was restricted to the basal and supra-basal 
layers, with nucleic staining retreating to the basal layer by Day 9, with 50% of 
nuclei stained. This gradual decrease in p63 staining continued until Day 15, 
where the percentage of p63 positive cells remained constant (25 -  38%).
This stability in percentage p63+ cells (25 -  38%), along with staining locality 
(mainly the basal layer and occasionally the supra-basal layer) occurred from 
Days 15 to 39. This was consistent with the findings of Boers and colleagues 
(1998) who reported that, in airways of diameters >4mm, the mean basal cell 
population was 31% in the steady-state lung and that these were the progenitor 
cells (i.e. capable of renewal and repair in the bronchial epithelium). Deterioration 
of the NHBE culture by Day 42 coincided with an increase in the intensity of p63 
expression and also the migration of positively stained cells to the apical layer. 
This may be either a ‘rescue’ attempt of the cells to reform an intact epithelial 
barrier, through proliferation and/or differentiation, or that p63 may be involved in 
the initiation of cell cycle arrest and/or apoptosis. Accumulation of p63 isoforms 
within cells have been shown to cause the induction of differentiation, cell cycle 
arrest and apoptosis (Petitjean et al., 2008).
4.5.5  T ig h t  J u n c tio n  Pr oteins
The presence of three of the major tight junction proteins, ZO-1 (Stevenson et al., 
1986), occludin (Furuse et al., 1993) and claudin-1 (Furuse et al., 1998), were 
monitored in order to ascertain the temporal and spatial development and 
formation of epithelial tight junctions within the NHBE model.
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4.5.5.1 ZO-1
ZO-1 was the first tight junction specific protein to be discovered (Stevenson et 
al., 1986). Anderson and colleagues (1988) confirmed that ZO-1 was a peripheral 
membrane, tight junction-associated protein. Madara (1987) suggested that there 
may also be an association between actin microfilaments and intestinal tight 
junctions, possibly via tight junction-associated proteins such as ZO-1.
ZO-1 was observed throughout the cytoplasm of cells on Day 1, which was in 
agreement with the fact that, during early development of E-cadherin-based 
adherens junctions (Miyoshi and Takai, 2008), the ZO-1-catenin complex 
(associated with E-cadherin), mobilised ZO-1 to the plasma membrane 
(Rajaseklaran et al., 1996). Moreover, ZO-1 contains an actin binding region, 
which is not only important in the regulation of established tight junctions, but also 
in the translocation of ZO-1 to the free edges of cells, prior to junction formation 
(Paris et al., 2008). As the NHBE model matures, ZO-1 staining began to 
accumulate at the cell-cell contacts (Days 6 - 1 5 ) .
After Day 15, ZO-1 staining continued to delineate cells throughout the cultures 
until Day 42, indicating that tight junctions were fully formed. The N-terminal 
region of ZO-1 is known to associate with domain E of occludin (Fanning et al., 
1998; Furuse et al., 1994; McCarthy et al., 1996). Therefore, since an individual 
culture from each time point was stained for both ZO-1 and occludin, it was 
possible to observe the co-localisation of these tight junction proteins during 
NHBE culture tight junction formation. However, ZO-1 also appeared in regions 
not associated with occludin, especially before Day 15. This was probably due to 
the fact that, as well as binding occludin, the PDZ1 domain of ZO-1 binds directly 
to the COOH-terminal of claudins (Itoh et al., 1999), as well as the C-terminal end 
of some of the transmembrane JAM proteins; through the PDZ2 domain of ZO-1 
(Chiba et al., 2008). Cultures on Day 42 revealed significant staining at the cell­
cell contacts, however, some areas were devoid of this specific staining pattern, 
implying that there were problems with, or deterioration of, cell junctions.
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4.5.5 .2  O c c lu d in
Occludin, a four transmembrane protein was the next of the three tight junction 
proteins detected to be discovered (Furuse et al., 1993). Some faint, mainly 
cytoplasmic, staining was observed in the NHBE cultures on Day 1, with the 
staining quantity and intensity much less than either ZO-1 or claudin-1, at the 
same time point. This may be indicative of occludin being incorporated into the 
tight junctions at a slightly later time point than the other two.
Occludin staining on Day 6  exhibited intense staining at the borders of some cell­
cell contacts, suggesting that, at this point, occludin was being incorporated into 
the tight junctions. Furthermore, these more intense regions of staining 
corresponded to the same areas of intense staining of ZO-1; inferring that 
occludin may be associated with ZO-1, at this time (Furuse et al., 1994). From 
Days 6  to Day 15, occludin continued to accumulate at the cell-cell contacts as it 
was integrated into the tight junctional complexes.
NHBE cultures from Days 24 to 39 appeared relatively stable in their expression 
of occludin, with a strong network of staining delineating cells. On Day 42, this 
delineation was still observed, however, there were areas where this pattern no 
longer existed and an increase in cytoplasmic staining was more prominent. The 
effect this may have on the TEER of the cultures may be minimal. Baida and 
colleagues (1996) deduced that even though a COOH-terminally truncated 
occludin resulted in a discontinuous occludin staining pattern, the tight junction 
formation on freeze-fracture electron microscopy appeared normal. However, 
McCarthy and co-workers (1996) demonstrated that the incorporation of chick 
occludin into canine cells resulted in a 30 -  40% increase in TEER. Both of these 
researchers may be right, with occludin being important, but not necessary for the 
formation of tight junctions, but as a contributing factor to the ‘tightness’ (i.e. 
higher TEER) of the tight junction itself.
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4.5.5 .3  C la u d in -1
Claudin-1 is a member of the claudin family of transmembrane proteins, of which 
there are currently 24 identified in humans; with different members displaying 
varying tissue distribution (Furuse et al., 1998; Morita et al., 1999; Turksen and 
Troy, 2004). On Day 1, claudin-1 expression was dispersed throughout the 
cytoplasm of most cells, with occasional focal ‘hot-spots’ of intense staining. This 
would suggest that claudin-1  was being trafficked towards the cell membrane. 
ZO-1, which is known to target occludin to the correct region for tight junction 
formation via actin microfilaments (Fanning et al., 1998; Furuse et al., 1994; 
McCarthy et al., 1996), has also been shown to bind claudin-1 at its COOH- 
terminal via its (ZO-1) PDZ1 domain (Itoh et al., 1999). Due to the fact that 
detection of both claudin-1 and ZO-1 used the same 2° antibody it was not 
possible to detect any co-localisation between the two. However, some co­
localisation between occludin and claudin-1 and ZO-1 and occludin was 
observed, suggesting that some degree of co-localisation between ZO-1 and 
claudin-1  was probable.
After Day 1, claudin-1 staining appeared to migrate towards the cell borders, once 
there (Days 6  -  33), claudin-1 staining did not produce the characteristic 
‘unbroken’ delineation of the cells, as ZO-1 and occludin did, but instead 
produced a ‘dotted’ line appearance. Furuse and colleagues (1998) demonstrated 
in lung tissue with well developed tight junctions, the level of claudin-1  and - 2  
expression was relatively low compared to occludin, indicating that claudin-1  was 
not abundantly expressed in the lung. Claudin-1, -3, -4, -5, -7 and - 8  were all 
known to be expressed in the airway epithelium in vivo, with claudin-4, -7 and - 8  
expressed at especially high levels (Coyne et al., 2003; Morita et al., 1999). 
Therefore, the fact that the NHBE cells exhibited a non-characteristic (i.e. dotted 
delineation) expression of claudin at the cell borders (ZO-1 and occludin gave 
unbroken delineation), could be due to the fact that only claudin-1  and no other 
isoform was tested. Coyne and co-workers (2003), noted that 1° cell cultures 
derived from human airways only expressed claudin-1 and -4 and consequently, it 
would be interesting to delve further and discover if this was the case with the 
NHBE cell model.
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NHBE cultures from Days 36 -  42 displayed a change in claudin-1 staining. 
Staining had receded from the cell-cell contacts, appearing more prevalent in the 
cytoplasm. There was also excess autofluorescence, associated with dead/dying 
cells. This may imply that changes in claudin expression were associated with 
initiation of tight junction deterioration. It would also be interesting to determine if 
the expression of claudin-3, -5, -7 and - 8  were present in the NHBE model and if 
not, would they prevent this.
4 .6  C o n c lu s io n s
Histological analysis of the NHBE model development allowed an insight into 
individual cellular differentiation and culture formation. Positive CK 5/6 staining 
provided confirmation of the pseudo-stratified epithelial origins of the tissue, with 
its change in expression over the 42 days confirming model development and 
maturity. Earlier morphological analysis (Chapter 3) suggested the presence of 
Clara cells, immunohistochemistry work verified this. The fact that the NHBE 
model contained Clara cells signified that this was a representative model of the 
bronchial epithelium and potentially, contained important metabolic enzymes, 
such as the P450-depentent mixed-function oxidase (not detected in this project).
Although the apical secretions of the cultures were assumed to contain mucins 
(visually [visco-elastic fluid] and the positive Bradford assay -  Chapter 2), positive 
PAS staining reinforced this assumption by identification of mucin secreting 
goblet cells. Positive p63 staining identified the progenitor cells of the NHBE 
model, which were the basal cells. The ability to form tight junctions is essential in 
any model of the human respiratory epithelium. Without tight junctions, the 
specific barrier properties this epithelium has in vivo, would be lost, as would the 
models application for toxicity testing. Three of the major tight junction proteins 
were identified in the ‘in-house’ NHBE model.
Base-line expression and cell numbers of CK 5/6+ cells, Clara cells, goblet cells, 
p63+(basal/progenitor) cells and tight junction proteins of the mature NHBE model 
could be utilised to monitor the specific effects of any mechanical or toxicological 
induced injury and subsequent repair within the airway.
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5.1 In t r o d u c t io n
The natural history of the epithelium/cell morphogenesis within the NHBE model 
was characterised in Chapters 2, 3 and 4. This full characterisation enabled the 
identification of the toxicological experimental window (Days 27 -  33). In this 
Chapter, the model’s response to a panel of classical pulmonary toxicants (CPT) 
was evaluated.
The purpose of challenging this in vitro system was to monitor the biochemical 
responses (culture viability and TEER) and morphological changes (LM and 
SEM) of the NHBE epithelium to well-defined pulmonary toxicants. The panel of 
CPT chosen were Lipopolysaccharide (LPS; immunotoxic; Eisenbarth et al., 
2002), cadmium chloride (CdCI; cytotoxic; Croute et al., 2000), paraquat (Pq; 
redox reagent; Cappettetti et al., 1998), Amiodarone (Am; phospholipidotic; 
Camus et al., 2004) and cigarette smoke (CS; most common inhaled human 
toxicant; IARC, 2004). The final experimental work involved evaluation of the 
cytokine response of the model to LPS.
The hypothesis for this chapter of work was:
• That when challenged with classical pulmonary toxins the NHBE model 
would respond with general and toxicant specific responses.
5 .2  M a t e r ia l s  a n d  S t o c k  S o l u t io n s
5.2.1 M a t e r ia l s
M a t e r ia l s S u p p l ie r
Kentucky Research Cigarettes, 3R4F
Tobacco-Health Research, University 
of Kentucky, USA
Matrix 96-Well Polystyrene Plates, 
White, Flat Bottom
Fisher Scientific, Manchester, UK
Table 5.1 Table of materials used and their suppliers.
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S t o c k  S o l u tio n s
S o l u tio n s S u p p l ie r
Lipopolysaccharide (from E. coli 0127: 
B8 )
Cadmium Chloride
Dulbecco’s Phosphate Buffered Saline 
(PBS), with MgCfe and CaCh, sterile- 
filtered
Methyl Viologen Dichloride Hydrate 
98% (Paraquat)
Amiodarone Hydrochloride
Sigma, Dorset, UK
Hanks' Balanced Salt Solution (HBSS) Invitrogen Ltd, Paisley, UK
ViaLight® Plus Cell Proliferation and 
Cytotoxicity BioAssay Kit (ATP Assay)
Lonza Group Ltd., Switzerland
RayBio® Human Cytokine Array 3.1 Tebu-Bio, Peterborough, UK
Table 5.2 Table of stock solutions used and their suppliers.
5.2.3 Equipm ent
Eq u ip m e n t S u p p l ie r
Smoking Robot RM20S (Smoking 
Machine)
Borgwaldt-kc Teknik, Hamburg, 
Germany
FLUOstar OPTIMA 
OMPTIMA Control Program
BMG LABTECH, Aylesbury, UK
BioSpectrum®AC Imaging System UVP Ltd, Cambridge, UK
GeneTools SYNGENE, Cambridge, UK
RayBio® Antibody Array Analysis Tool Tebu-Bio, Peterborough, UK
Table 5.3 Table of equipment used and their suppliers.
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5 .3  M e th o d s
5.3.1 D o s in g
Third Passage NHBE cells grown at an ALI (Section 2.3.1) were dosed when 
cells were between Day 27 and Day 33. TEERs were checked prior to dosing to 
ensure that they were above 1,5000 (~4,5500.cm2) for Lipopolysaccharide 
(LPS), cadmium chloride (CdCI), paraquat (Pq) and Amiodarone (Am) dosing 
(Section 5.3.1.1 -  5.3.1.4) and above 1,0000 (~3,0300.cm2) for cigarette smoke 
exposure (Section 5.3.3.5).
Each CPT dose (50pl) was applied apically to NHBE cultures (n = 3). After 
incubation with CPT or carrier solution (24 hours), the TEER was recorded on 
each NHBE culture insert (Section 5.3.2), that same insert was then used to 
assess culture viability (Section 5.3.3). Both the TEER and cellular viability (ATP 
Assay) were expressed as a percentage of the controls. The doses that were 
determined to cause a 5% or 20% decrease in culture viability compared to 
controls (i.e. TD5 [toxic dose 5%] and TD2o), were then assessed for 
morphological changes (Section 5.3.4 -  5.3.5).
5.3.1.1 L ip o p o l y s a c c h a r id e
LPS (1mg) was dissolved in HBSS, to produce a 1 mg/ml stock solution (w/v). 
This stock was further diluted in HBSS to produce the dose range: 0.1, 0.2, 0.3, 
0.4, 0.5, 0.6, 0.7, 0.8, 0.9 and 1.0mg/ml. HBSS was used as the control solution. 
In addition, TD5 and TD20 doses were used to monitor the cytokine response of 
the NHBE model to LPS (Section 5.3.6).
5 .3 .1 .2  C a d m iu m
CdCI (100mM) was dissolved in PBS, to produce a 1mM stock solution (v/v). This 
stock was further diluted in PBS to produce the dose range: 0.05, 0.1, 0.15, 0.2, 
0.25, 0.3, 0.35, 0.4, 0.45 and 0.5mM. PBS was used as the control solution.
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5 .3 .1 .3  Pa r a q u a t
Pq was dissolved in PBS (100|jl) overnight, to produce a 100mM stock solution 
(w/v). This stock was further diluted in PBS to produce the dose range: 150, 300, 
450, 600, 750, 900, 1050, 1200, 1350 and 1500pM. PBS was used as the control 
solution.
5 .3 .1 .4  A m io d a r o n e
Am was dissolved in dH20  (500pl) overnight, to produce a 5mg/ml stock solution 
(w/v). This stock was further diluted in dH20  to produce the dose range: 100, 200, 
300, 400, 500, 600, 700, 800, 900 and 1000pg/ml. The control solution was 
dH20.
5.3.1.5 C ig a r e t t e  S m o k e  Ex p o s u r e
The smoke exposure of the NHBE cells was undertaken at AstraZeneca R&D 
(Loughborough, UK), using their smoking machine (Smoking Robot RM20S; 
Figure 5.1). Experiments were performed with the expert help of Senior Scientist 
Ms. Wendy Merrison.
The smoking machine was set up to smoke the NHBE cultures (n = 3) at one of 
the three different constant smoke dilutions; 1:20, 1:30 or 1:50. Smoke was drawn 
from Kentucky Research Cigarettes 3R4F using the International Organisation for 
Standardisation standard conditions (35ml puff drawn over 2 seconds, exhaled 
over 20 seconds, every minute). The cells were smoked continually for 30 
minutes (~4 -  5 cigarettes to each smoking chamber). NHBE cell cultures were 
placed in the smoking chambers (Figure 5.2) containing 38ml ALI media 
(therefore, cells had media on the basal side and exposed to the air/smoke on the 
apical side). NHBE cells in the smoking chambers were kept in a cell culture
laminar flow hood for the smoke exposure (RT). Control cells were left in a cell
culture laminar flow hood with ALI media for the duration of the experiment so 
that equivalent temperatures were maintained. Following treatment the NHBE 
cultures were placed back into 24-well plates, containing fresh ALI media (300pl;
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37°C) in each well, and re-placed back into the cell culture incubator for a defined 
‘recovery-time’. NHBE cultures (n = 3) exposed to 1:20 and 1:50 smoke dilutions 
were allowed to recover for 4 hours (1:20-4h and 1:50-4h). With additional NHBE 
cultures (n = 3) exposed to 1:20, 1:30 and 1:50 smoke dilutions, that were 
allowed to recover for 24 hours (1:20-24h, 1:30-24h and 1:50-24h).
Smoke
Machine
Smoke
Dilution
Cham ber
Figure 5.1 Image of the Smoking Robot RM20S and a closer view of the smoke dilution chambers 
used to dilute the cigarette smoke to the required concentrations.
I Smoke Chamber
T
X
- ‘- V"rnm X .
+ —
1 Culture Insert ! 
Holder
ALI Media 
Reservoir
Figure 5.2 Image of the base of the smoking chamber used to hold and ‘smoke’ the NHBE cell 
cultures. The ALI media resides in the large well at the base, the NHBE culture inserts are placed 
into the appropriate holder. The lid is placed on top and the pipes to the smoke machine are 
attached (Image not shown).
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After recovery (4 or 24 hours) the TEER was recorded on each NHBE culture 
insert (Section 5.3.2), that same insert was then used to assess culture viability 
(Section 5.3.3). Both the TEER and cellular viability (ATP Assay) were expressed 
as a percentage of the controls. Each smoke dilution, for each recovery period, 
were assessed for morphological changes (Section 5.3.4 -  5.3.5).
5.3.2 T r a n s -E p ith e l ia l  E le c t r ic a l  R es is tan ce
The TEER of NHBE cultures, immediately prior to- and 24 hours post-dosing, was 
established using the method previously described (Section 2.3.3).
5.3.3 ATP Assay
The ViaLight® Plus Cell Proliferation and Cytotoxicity BioAssay Kit (Lonza, 
Switzerland) was used to assess cellular ATP activity. ATP Monitoring Reagent 
Plus (AMR Plus) was prepared by reconstituting the lypophilised AMR Plus (1 
vial) with the supplied Assay Buffer (50ml). The AMR Plus was allowed to 
equilibrate for 15 minutes at RT. Cell lysate solution was brought up to RT before 
use and stored in workable aliquots after (-20°C).
NHBE inserts that had been dosed and had their TEER read were then placed in 
an empty well in preparation for the ATP assay. Cell lysis reagent (100pl) was 
applied apically to each insert and incubated for at least 1 0  but no more than 2 0  
minutes. The cell lysate (100pl) was then placed into a well of a white, flat- 
bottomed 96-well plate. AMR Plus reagent (100pl) was added to the cell lysate in 
each well and incubated for 2 minutes (dark). The luminescence was read using 
the FLUOstar OPTIMA and analyzed using the OPTIMA Control System software 
(BMG LABTECH, Aylesbury, UK).
5.3.4 L ig h t M ic ro s c o p y : T o lu id in e  B lu e
Inserts dosed with controls, TD5, TD20 and all CS doses for 4 and/or 24 hours, 
were then prepared for semi-thin sectioning and staining with toluidine blue and 
images taken (Section 3.3.1).
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5.3.5 S cann ing  E le c t r o n  M ic ro s c o p y
Inserts dosed with controls, TD5, TD2o and all CS doses for 4 and/or 24 hours, 
were then prepared for scanning electron microscopy and images taken (Section
3.3.3).
5.3.6 C y to k in e  A r r a y
The RayBio® Human Cytokine Array 3.1 (Tebu-Bio, Peterborough, UK) which 
detects 42 cytokines, chemokines and growth factors, was used to monitor the 
changes in the cytokine profile of the NHBE cultures in response to LPS.
5.3.6.1 P r e p a r a t io n  o f  S a m p le s
The 2x Cell Lysis Buffer diluted with dH20  to produce a 1x Cell Lysis Buffer. The 
1x Cell Lysis Buffer (1ml) was added apically to each NHBE culture insert and 
cells lysed for 10 minutes. Cell lysate was spun-down and stored in -80°C for 
future use. The lysates were thawed thoroughly before continuation of cytokine 
analysis.
5.3.6.2 Blocking  a n d  Incubation
Each array membrane was placed in a separate well in the plate provided, taking 
care only to touch the corner of the membrane with the tweezers. Membranes 
were incubated with 2ml of 1x Blocking Buffer (dilute 2x Blocking Buffer with 
dH20 ) for 30 minutes. The 1x Blocking Buffer was removed and the membranes 
were incubated with 1ml of sample (cell lysate) for 1 hour. The sample was 
removed and membranes were washed in 2ml of 1x Wash Buffer I (dilute 20x 
Wash Buffer I with dH20 ) for 5 minutes on a shaker table and then removed (x3). 
Membranes were washed in 2ml of 1x Wash Buffer II (dilute 20x Wash Buffer II 
with dH20 ) for 5 minutes on a shaker table and removed (x2).
The 1x Blocking Buffer (100pl) was added to each Biotin-Conjugated Anti- 
Cytokines tubes, mixed by gentle inversion, then transferred to a tube containing
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2ml of 1x Blocking Buffer. Membranes were incubated in 1ml of the diluted Biotin- 
Conjugated Anti-Cytokines for 1 hour (RT). This was removed and membranes 
were washed in 2ml of 1x Wash Buffer I for 5 minutes (x3), then in 2ml of 1x 
Wash Buffer II for 5 minutes (x2). Membranes were incubated for 2 hours in 2ml 
of 1,000 fold diluted HRP-conjugated streptavadin. This was removed and 
membranes were washed in 2ml of 1x Wash Buffer I for 5 minutes (x3), followed 
by washing in 2ml of 1x Wash Buffer II for 5 minutes (x2).
5.3.6.3 Detectio n
Detection Buffer A (500pl) and Detection Buffer B (500pl) were mixed for every 
array membrane. Excess wash buffer was drained from the membranes by 
holding membranes vertically with the tweezers. Membranes were incubated in 
Detection Buffer AB for 1 minute. Detection buffer was removed and membranes 
placed protein side up on a plastic sheet. Another piece of plastic sheet was 
placed over the membranes, and air bubbles removed carefully. Signals were 
detected using the BioSpectrum®AC Imaging System (UVP, Cambridge).
5.3.6.4 A nalysis  of Results
Images of the array signal were converted to JPEGs and opened using the 
GeneTools software (SYNGENE, Cambridge, UK). Spot blot analysis was 
undertaken and raw values exported to Excel (Microsoft Office 2003). Values 
were imported into the RayBio® Antibody Array Analysis Tool (Tebu-Bio, 
Peterborough, UK) which normalized the data and subtracted background signal. 
This data was used to calculate the signal of each cytokine as a percentage of 
the control signals. Signals changed by £1.5 fold were considered significant.
5 .4  R e s u l t s
NHBE cultures grown in cell culture inserts at an ALI (Days 27 -  33) were used in 
evaluating CPTs. Many different dose ranges of the pulmonary toxins were used 
on cultures, with TEER and cellular viability acquired, in order to obtain a dose 
range that included the TD5 and TD20 doses. Once established, NHBE cultures (n
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= 3) were dosed with each CPT over that dose range (for 24 hours), then 
assessed for TEER (Section 5.3.2) and ATP content (Section 5.3.3). NHBE 
cultures were then dosed with TD5 and TD20 doses (24 hours) and underwent 
morphological analysis (Section 5.3.4 -  5.3.5). This provided an insight into the 
biochemical and corresponding structural reactions of the NHBE model to each 
CPT.
5.4.1 N H B E  R e s p o n s e  to  L ip o p o l y s a c c h a r id e
5.4.1.1 C u lt u r e  V ia b ility  a n d  T r a n s -E pith elia l  E le c tr ic a l  R esis ta n c e
A dose range (Omg/ml -  1 mg/ml) of LPS contained the desired T D 5 and T D 2o 
responses. The ATP assay for viability over this dose range displayed a biphasic 
response, where an initial drop in culture viability was followed by an increase 
and subsequent drop in culture viability (compared to control cultures) (Figure
5.3). The lower doses of LPS (0.1 -  0.2mg/ml) exhibited a reduction in culture 
viability, compared to controls; the T D 5 dose was obtained from this initial drop in 
culture viability (0.1 mg/ml). Subsequently, as the concentrations increased there 
was an increase in culture viability, to approximately 120% (0.3mg/ml), followed 
by a slight drop to 115% (0.4mg/ml). However, when the concentration of LPS 
was increased to 0.5mg/ml, a significant drop in culture viability was observed 
(80%); yielding the T D 2o dose. Increasing the LPS dose up to 0 .8 mg/ml had a 
limited effect on culture viability (remaining -80% ). A slight decrease in viability at 
0.9mg/ml and 1.0mg/ml (-50% ) was observed.
TEER values over the dose range (0 -  1.Omg/ml) did not give the biphasic 
response observed with the ATP assay. TEER values decreased gradually 
between 0.1 -  0.5mg/ml of LPS, to approximately 4% of the control. Higher doses 
of LPS had no further effect on TEER values, which remained extremely low (0.5 
- 5 % )  (Figure 5.3).
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Figure 5.3 Graph displaying NHBE culture TEER and ATP assay after 24 hours treatment with 
Lipopolysaccharide. ATP (♦ ) and TEER (■) values displayed as percentage of control values. 
Standard Deviation was shown for both ATP ( ) and TEER (I), n = 3.
5.4 .1 .2  L ig h t  M ic r o s c o p y : T o lu id in e  Blue
Control cultures (treated with HBSS) appeared pseudo-stratified and well- 
differentiated. However, prominent gaps around the cell-cell contacts between the 
basal and supra-basal cells were apparent (Figure 5.4[A]). The TD5 dosed 
cultures revealed morphological changes, with evidence of hypotrophy, focal loss 
of cells and an increase in mucin producing cells, with possible increased mucin 
secretion (Figure 5.4[B]). Basal cells appeared to be the most structurally 
effected, with cell shrinkage and apparent loss of cell-cell attachments (Figure 
5.4[B]).
The T D 2o dosed cultures exhibited significant morphological changes, with multi­
focal cell loss and degeneration apparent (Figure 5.4[C]). Numerous inter-cellular 
gaps and intra-cellular vacuoles were present and clear disruption of cellular 
junctions were apparent. Cell shrinkage was evident throughout and especially 
noticeable in the columnar cells, which appeared to have detached from the 
membrane (Figure 5.4[C]).
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Figure 5.4 LM images of NHBE cultures treated with LPS, stained with toluidine blue. [A] Control 
cultures treated with HBSS (carrier solution). [B] NHBE cultures treated with TD5 (0.1 mg/ml) LPS; 
basal cell shrinkage and damage was evident, arrows indicate increased mucin production. [C] 
NHBE cultures treated with the TD20 (0.5mg/ml) LPS; clear disruption of cell contacts, columnar 
cell shrinkage; dotted area displays degenerative material, such as reticular fibre or ECM debris.
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5 .4 .1 .3  S c a n n in g  E l e c t r o n  M ic r o s c o p y
Topographically, both control and T D 5 cultures exhibited a structurally intact 
apical surface, denoted by the presence of numerous populations of cilia and 
microvilli (Figure 5.5[A] and [B]). Cultures treated with the T D 2o dose of LPS 
displayed focal regions of damage to the apical surface, characterised by 
detached, shrunken, rounded cells, with many protruding cilia (Figure 5.5[C]). 
Other areas of the cultures consisted entirely of multiple layers of spherical cells 
with protruding cilia (Figure 5.5[D]).
Figure 5.5 SEM images of NHBE cultures treated with LPS. [A] Control cultures treated with 
HBSS (carrier solution). [B] NHBE cultures treated with TD5 (0.1 mg/ml) LPS. [C] NHBE cultures 
treated with TD2o (0.5mg/ml) dose of LPS; arrows indicate detached (balled-up) cells. [D] NHBE 
cultures treated with TD2o dose of LPS; higher magnification of an area of increase focal damage, 
displaying multiple layers of detached cells, with many protruding cilia.
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5.4.2 NHBE R esponse t o  Cadmium
5.4.2.1 C u l t u r e  V ia b i l i t y  a n d  T r a n s - E p ith e l ia l  E le c t r i c a l  R e s is ta n c e
A dose range of 0 -  0.5mM of CdCI was determined to encompass both target 
TD5 and TD20 doses. The ATP assay for viability over the dose range displayed a 
biphasic response (Figure 5.6). At 0.05mM CdCI, there was a reduction in culture 
viability when compared to the control values, this was deemed to be the TD5 
dose. At 0.1mM CdCI, there was a rise in culture viability (~110%), this was a 
transient increase in viability, but the ATP activity remained above control levels 
until 0.3mM (102%). When the concentration of CdCI was increased to 0.35mM, 
there was a significant decrease in culture viability (75%). The TD2o dose was 
then calculated from this graph as 0.34mM. In response to higher doses, a 
steady-rate of decreased culture viability (35% at 0.5mM) was observed.
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Figure 5.6 Graph displaying NHBE culture TEER and ATP assay after 24 hours treatment with 
cadmium chloride. ATP (♦ ) and TEER (■) values displayed as percentage of control values. 
Standard Deviation was shown for both ATP ( ) and TEER (I), n -  3.
TEER values over the dose range (0 -  0.5mM) did not elicit the biphasic 
response observed with the ATP assay. TEER values gradually decreased 
between 0.05 -  0.35mM CdCI to approximately 2% of the control. Higher doses of
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CdCI did not affect the TEER, which remained extremely low (0 -  2%) and 
deemed negligible (Figure 5.6).
5.4 .2 .2  L ig h t M ic ro s c o p y : T o lu id in e  B lu e
Control cultures (treated with PBS) exhibited the characteristic pseudo-stratified 
and muco-ciliary culture (Figure 5.7[A]). Morphologically, the TD5 dosed cultures 
were degenerated; undergoing basal squamation and hypertrophy, columnar 
cuboidalisation and dedifferentiation of goblet and Clara cells (Figure 5.7[B]). 
Basal cells appeared hypertrophic, remained attached to the membrane, with an 
increase in cytoplasmic vacuoles. Vacuoles were also observed in the apical 
layer of cells. Some ciliated cells appeared to ‘bulge’ into the apical region, as if 
detaching from the epithelium (Figure 5.7[B). The NHBE epithelium was severely 
compromised in the area observed after treatment with the TD2o concentration; 
cultures had deteriorated to a squamous monolayer, with a few cells detached 
from the membrane altogether and many displaying signs of cell death (Figure 
5.7[C]).
5 .4 .2 .3  S c a n n in g  E lec tr o n  M ic r o s c o p y
Control NHBE cultures (treated with PBS), exhibited normal surface topography 
(Figure 5.8[A]). TD5 treated cultures, displayed only minor damage, with the 
epithelium appearing relatively intact. The surface was mainly covered in 
microvilli, with the occasional ciliated cell present. Numerous ciliated cells 
appeared to have detached and ‘balled-up’, surrounded by protruding cilia or cilia­
like structures (Figure 5.8[B). The surface topography of NHBE cultures treated 
with the TD2o dose was significantly changed. In areas where the epithelium was 
relatively intact, it appeared dedifferentiated; in addition, there were numerous 
regions of spherical, detached cells and/or highly protruding undifferentiated cells 
(Figure 5.8[C]). Other areas of the NHBE cultures appeared more severely 
damaged, with numerous layers of undifferentiated, balled-up cells, devoid of cilia 
possibly undergoing cell death, with an unusual stringy covering observed, 
possibly cell debris or ECM material (Figure 5.8[D]).
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Figure 5.7 LM images of NHBE cultures treated with CdCI stained with toluidine blue. [A] Control 
cultures treated with PBS (carrier solution). [B] NHBE cultures treated with TD5 (0.05mM) CdCI; 
aqua arrow demonstrates basal cell hypertrophy and squamation, pink arrow indicates a ciliated 
cell detaching from the epithelium. [C] NHBE cultures treated with TD2o (0.34mM) CdCI; 
squamous epithelium, displaying increased cellular damage.
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Figure 5.8 SEM images of NHBE cultures treated with CdCI. [A] Control cultures treated with PBS 
(carrier solution). [B] NHBE cultures treated with TD5 (0.05mM) dose of CdCI; a few detached 
‘balled-up’ ciliated cells observed (arrows). [C] NHBE cultures treated with TD20 dose of CdCI; 
arrows indicate bulging cells. [D] NHBE cultures treated with TD2o (0.34mM) dose of CdCI; higher 
magnification of area of severe damage, detached cells covered in stringy covering.
5.4.3 NHBE R esponse t o  P a ra q u a t
5.4.3.1 C u l t u r e  V ia b i l i t y  a n d  T r a n s - E p ith e l ia l  E le c t r i c a l  R e s is ta n c e
A dose range of 0 -  1500pM of Pq was determined to encompass both target TD5 
and TD2o doses. The ATP assay displayed a slow, steady decline in culture 
viability with increasing doses of Pq (Figure 5.9). The TD5 dose was determined 
as 75pM Pq, with the culture viability gradually decreasing, 750pM Pq was 
deemed to be the TD2o dose. In response to higher doses the culture viability 
continued to decline at a slow-rate, to -65% at 1500pM Pq.
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TEER values elicited a biphasic response, with an initial increase of NHBE 
cultures exposed to 150pM (-135%) and 300pM (-145%) Pq. TEER values 
decreased dramatically in response to 450pM Pq (-13%). TEER values showed 
little change above 600pM Pq, with TEER values between 1.5 and 9% of the 
control (Figure 5.9).
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Figure 5.9 Graph displaying NHBE culture TEER and ATP assay after 24 hours treatment with 
paraquat. ATP (♦) and TEER ( I)  values displayed as percentage of control values. Standard 
Deviation was shown for both ATP ( ) and TEER (1), n = 3.
5.4.3.2  L ig h t  M ic r o s c o p y : T o lu id in e  B lu e
Control cultures (treated with PBS) exhibited the characteristic multi-layered, 
pseudo-stratified and fully-differentiated culture (Figure 5.10[A]). The NHBE 
epithelium underwent major changes in response to the TD5 dose of Pq (Figure 
5.10[B]). The epithelium became a cuboidal stratified epithelium (Figure 5.10[B]), 
with basal cell hypertrophy and squamation. There was a loss of ciliated cells, 
along with an increase in secreting cells. Apart from these phenotypic changes, 
there was little evidence of damage to the epithelial integrity; however, a large 
vacuole was observed (Figure 5.10[B]). After treatment with the TD2o dose, 
cultures appeared as an undifferentiated squamous/cuboidal monolayer (Figure 
5.10[C]).
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Figure 5.10 LM images of NHBE cultures treated with Pq stained with toluidine blue. [A] Control 
cultures treated with PBS (carrier solution). [B] NHBE cultures treated with TD5 (75pM) dose of 
Pq; cuboidal stratified epithelium, one cuboidal cell highlighted, increased cellular secretion 
observed at the apical surface. [C] NHBE cultures treated with TD2o (750pM) dose of Pq; 
undifferentiated, squamous/cuboidal epithelium, dotted area highlighting cuboidal cell.
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5.4.3.3 S c an n in g  E lectro n  M ic r o sco py
Control NHBE cultures (treated with PBS), exhibited normal surface topography 
(Figure 5.11 [A]). NHBE cultures treated with TD5 Pq displaying minor damage to 
the epithelial integrity. However, there was evidence of dedifferentiation, with 
microvilli covering the vast majority of the surface (Figure 5.11 [B]). The surface 
topography of NHBE cultures treated with the TD20 dose of Pq was dramatically 
transformed. There was loss of epithelial integrity and microvilli, occasional 
detached cells and cellular blebbing as a probable result of apoptosis (Figure 
5.11[C]). Higher magnification revealed a few remaining ciliated cells, loss of 
epithelial integrity and numerous cells undergoing cell death (Figure 5.11 [D]).
Figure 5.11 SEM images of NHBE cultures treated with Pq. [A] Control cultures treated with PBS 
(carrier solution). [B] NHBE cultures treated with TD5 (75|jM) dose of Pq; dedifferentiation of 
cultures, few ciliated cells remain, microvilli cover the surface. [C] NHBE cultures treated with TD2o 
(750pM) dose of Pq; loss of epithelial integrity and microvilli, dotted region highlighting blebbing 
cell. [D] NHBE cultures treated with TD2o dose of Pq; higher magnification of damaged area, loss 
of epithelial integrity and microvilli, dotted region highlighting blebbing cell.
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5.4.4 NHBE R e s p o n s e  t o  A m io d a ro n e
5 .4 .4 .1  C u ltu r e  V ia b il ity  a n d  T r an s -E pith elial  E le c tr ic a l  R esistan c e
A  dose range of 0 -  1000pg/ml of Am was determined to encompass both target 
T D 5 and T D 2o doses. The ATP assay for viability over the dose range displayed a 
very gradual decrease in culture viability (Figure 5.12). At 300pg/ml Am, there 
w as a 5% reduction in culture viability (TD 5 dose), the culture viability continued to 
gradually decrease, with the T D 2o dose calculated as 850pg/ml Am. In response 
to  higher doses a slight decrease in culture viability was observed (-75% at 
1000pg/ml).
TEER values over the dose range (0 -  1000pg/ml) elicited a biphasic response, 
however, average TEER values did not increase above control values. TEER 
values gradually decreased between 100 -  200pg/ml Am, to approximately 75% 
o f the control, this was followed with a return to normal TEER values by 
300pg/ml. Higher doses of Am resulted in a gradual decrease in TEER readings, 
down to 87% by 700pg/ml, followed by a steeper decrease in TEER; 67% at 
800pg/m l and 53% at 1000pg/ml (Figure 5.12).
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F ig u re  5.12 Graph displaying NHBE culture TEER and ATP assay after 24 hours treatment with 
Am iodarone. ATP (♦ ) and TEER (■) values displayed as percentage of control values. Standard 
Deviation was shown for both ATP (!) and TEER (1), n = 3.
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5.4.4.2 L ig h t  M ic r o s c o p y : T o lu id in e  Blue
Control cultures (treated with dhfeO) exhibited the characteristic pseudo-stratified, 
muco-ciliary culture (Figure 5.13[A]). The TD5 dosed cultures underwent a certain 
amount of dedifferentiation, appeared squamous and lost cilia. There was also 
evidence of cellular loss and deterioration of cellular junctions (Figure 5.13[B]). 
The major changes observed after treatment with the TD2o dose was further 
squamation of cultures. The epithelial integrity on the surface appeared relatively 
intact, with little to no disruption of cell contacts in this area, with occasional cilia 
present on the apical surfaces (Figure 5.13[C]).
5 .4 .4 .3  S c a n n in g  E le c tr o n  M ic r o s c o p y
Control NHBE cultures (treated with dH20), exhibited normal surface topography 
(Figure 5.14[A]). NHBE cultures treated with a TD5dose of Am displayed minimal 
damage to the surface topography, with cultures appearing as controls (Figure 
5.14[B]). Even in response to the higher, TD2o dose of Am, there was little visible 
damage to the surface topography of NHBE cultures. There were some gaps 
probably due to the loss of cells (Figure 5.14[C]) and evidence of cilia loss and 
possible regeneration (presence of cilia/microvilli pediments) (Figure 5.14[D]).
5.4.5 N HB E RESPONSE TO CIGARETTE SMOKE
5.4.5.1 C u lt u r e  V ia b il ity  a n d  T r a n s -E pith e lia l  E lec tr ic a l  R e sista n c e
NHBE culture viability had decreased to 82%, 4 hours after exposure to a 1:50 
dilution (1:50-4h) of CS and to 54%, 4 hours after exposure to a 1:20 dilution 
(1:20-4h), compared to controls (Figure 5.15). The TEER response however, was 
biphasic, with an increase in TEER reading to approximately 125% of controls at 
the 1:50-4h and a decrease in TEER to -65%  to the higher 1:20-4h dilution 
(Figure 5.15).
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Figure 5.13 LM images of NHBE cultures treated with Am and stained with toluidine blue. [A] 
Control cultures treated with dH20 (carrier solution). [B] NHBE cultures treated with TD5 
(300|jg/ml) dose of Am; squamating epithelium, dedifferentaition and loss of cilia. [C] NHBE 
cultures treated with TD20 (850pg/ml) dose of Am; deterioration of epithelium.
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Figure 5.14 SEM images of NHBE cultures treated with Am. [A] Control cultures treated with dH20 
(carrier solution). [B] NHBE cultures treated with TD5 (300pg/ml) dose of Am; no real damage 
observed. [C] NHBE cultures treated with TD2o (850|jg/ml) dose of Am; highlighted region 
displaying some minor surface damage. [D] NHBE cultures treated with TD20 dose of Am; higher 
magnification, highlighted areas displaying cilia/microvilli pediments.
Both NHBE culture viability and TEER displayed a steady decrease in response 
to increasing concentrations of CS, 24 hours after treatment (Figure 5.16). After 
exposure to a 1:50-24h dilution of CS, the culture viability had decreased to 60% 
and the TEER to -25%. A 1:30-24h dilution of CS caused a reduction in culture 
viability to 32% and TEER to -5%. The higher concentration of CS, 1:20-24h, 
resulted in a further drop in both culture viability and TEER, 10% and -4.5%, 
respectively (Figure 5.15).
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Figure 5.15 Graph displaying NHBE culture TEER and ATP assay after 30 minutes exposure to 
CS and 4 hours recovery. ATP (■) and TEER (■) values displayed as percentage of control 
values. Standard Deviation was shown for both ATP ( ) and TEER (I), n = 3.
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Figure 5.16 Graph displaying NHBE culture TEER and ATP assay after 30 minutes exposure to 
CS and 24 hours recovery. ATP (■) and TEER (■) values displayed as percentage of control 
values. Standard Deviation was shown for both ATP ( ) and TEER (I), n = 3.
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5.4.5.2 L ig h t  M ic r o s c o p y :  T o lu id in e  B lu e
The 4 hour control cultures (left in the hood during exposure, RT) exhibited a 
characteristic pseudo-stratified, fully-differentiated culture; however, there was 
some detachment of cell-cell contacts around the basal cells and some basal cell 
shrinkage (Figure 5.17[A]). Cultures exposed to 1:50-4h CS appeared to separate 
into two distinct layers, with the apical layer relatively intact, with cilia loss, but 
presence of microvilli. The most damage was observed at the basal region of 
apically located cells and in the cells of the basal layer, with disruptions to 
junctions and presence of vacuoles. There was also evidence of dedifferentiation, 
cell loss and basal cell hypertrophy (Figure 5.17[B]). Cultures exposed to 1:20-4h 
CS appeared as a monolayer, where numerous cells displayed signs of damage 
denoted by both intra-cellular vacuoles and inter-cellular gaps (Figure 5.17[C]).
The 24 hour control cultures (left in the hood during exposure, RT) exhibited the 
characteristic pseudo-stratified and muco-ciliary culture. However, there was 
some detachment of cell-cell contacts around the basal cells and some basal cell 
shrinkage, but less than 4 hour recovery cultures (image not shown). Cultures 
exposed to 1:50-24h displayed clear signs of cellular toxicity. The cultures had 
practically reverted to a monolayer, with numerous cells riddled with vacuoles. 
Many of the cells present appeared to be large, hypertrophic basal cells (Figure 
5.18[A]). Exposure to 1:30-24h, CS resulted in a very high level of damage, with 
individual cells almost unattached from the membrane and/or neighbouring cells. 
These cells contained numerous vacuoles, no distinct nucleus and very pale 
staining with toluidine blue (basophilia) and were possibly all hypertrophic basal 
cells (p63 staining could confirm this) (Figure 5.18[B]). Extreme damage was 
observed with cultures exposed to 1:20-24h CS, as denoted by the absence of 
cells on all areas sectioned and stained for toluidine blue (Figure 5.18[C]).
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Figure 5.17 LM images of NHBE cultures 4 hours after 30 minutes exposure to CS and stained 
with toluidine blue. [A] Control cultures; air exposed. [B] NHBE cultures treated with a 1:50 dilution 
of CS; cultures split into two cell layers, evidence of dedifferentiation, cilia loss and cell death. [C] 
NHBE cultures treated with 1:20 dilution of CS; loss of normal epithelial structure, dedifferentiation 
and numerous dead cells.
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Figure 5.18 LM images of NHBE cultures 24 hours after 30 minutes exposure to CS and stained 
with toluidine blue. [A] NHBE cultures treated with a 1:50 CS; dedifferentiation and cell death, 
highlighting a hypertrophic basal cell. [B] NHBE cultures treated with 1:30 CS; total destruction 
rendering a monolayer of very damaged basal cells. [C] NHBE cultures treated with 1:20 CS; all 
areas sectioned and stained revealed no cells remaining on the membrane (highlighted).
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5.4.5 .3  S c an ning  E lectro n  M ic r o sco py
Control NHBE cultures (4h), exhibited normal surface topography (Figure 
5.19[A]). The 1:50-4h CS treated cultures revealed no real disruption to the 
surface integrity. Dedifferentiation was observed, most cells were only covered in 
microvilli, with the loss of numerous ciliated cells (Figure 5.19[B]). Focal damage 
was observed in response to the 1:20-4h treatment. Some areas were similar to 
1:50-4h treated cultures, with less microvilli and cellular delineation (Figure 
5.19[C]). Other areas displayed more damage to the cells and epithelial integrity 
(Figure 5.19[D]). These areas of increased damage had a compromised epithelial 
barrier, with detaching, dedifferentiated cells with a ruffled cell membrane, the 
insert membrane was also visible (Figure 5.19[D]).
'
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Figure 5.19 SEM images of NHBE cultures 4 hours after 30 minutes exposure to CS. [A] Control 
cultures; air exposed. [B] NHBE cultures treated with 1:50 CS; dedifferentiation and cilia loss. [C] 
NHBE cultures treated with 1:20 CS; less damaged area, dedifferentiation, cilia loss, highlighted 
area demonstrating microvillus loss. [D] NHBE cultures treated with 1:20 CS; more damaged area, 
loss of barrier, dedifferentiated cells, insert membrane visible (highlighted).
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The 24 hour control NHBE cultures (left in the hood during exposure, RT), 
exhibited normal surface topography (Figure 5.20[A]). The surface of cells after 
1:50-24h treatment had a pitted/retracted appearance. The cilia present were also 
very sunken into the surface and appeared to stick to or merge with neighbouring 
cilia (Figure 5.20[B]). The epithelial integrity of 1:30-24h cultures was severely 
compromised with the vast majority of cells, detaching, fragmenting and blebbing 
(Figure 5.20[C]). Extreme damage and almost complete epithelial shedding was 
observed after 1:20-24h treatment. In the areas where cells were located, they 
were either present as individual cells sparsely scattered on the membrane or as 
a small cluster of cells forming part of an epithelial sheet. The majority of these 
cells appeared to be dedifferentiated and undergoing cell death (Figure 5.20[D]).
Figure 5.20 SEM images of NHBE cultures 24 hours after 30 minutes exposure to CS. [A] Control 
cultures; air exposed. [B] NHBE cultures treated with 1:50 CS; pitted surface, dotted area displays 
clumped and sunken cilia. [C] NHBE cultures treated with 1:30 CS; major destruction, numerous 
detached, undifferentiated and dying cells. [D] NHBE cultures treated with 1:20 CS; cells were 
lacking from the majority of the insert, with a few clusters of highly-damaged cells remaining.
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5.4.6 NHBE C y to k in e  R e sp o n se  t o  L ip o p o ly s a c c h a r id e
Thirty seven (out of 42) cytokines tested displayed a 1.5-fold change or more in 
response to at least one of the LPS treatments (Figure 5.21 and 5.22). NHBE 
cultures treated with the TD5 (24 hours) dose exhibited increased expression of 6  
and decreased expression of 17 cytokines. In the TD2o dosed cultures, the 4  
hours LPS challenge induced 11 and reduced 1 cytokine expression. In the 
culture treated with TD20 dose for 24 hours, 9 cytokines had increased and 14 
decreased their expression.
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Figure 5.21 Graph displaying major cytokine changes in NHBE cultures after 24 hours incubation 
with the TD5 (0.1 mg/ml) dose of LPS. Cytokine expression above 150% of control (■) or below 
150% of control (■) were displayed, n = 1.
A number of correlations were observed between different LPS treatments (Table 
5.4). ENA-78 and G-CSF were up-regulated and SCF down-regulated in both 
doses after 24 hours (Group 1). IL-1a and IFN-y decreased expression with the 
TD5 dose, but increased after both TD2o doses (Group 2). IL-1 a, IL-1(3 and IFN-y 
all increased in response to the TD20 dose after 4 hours and slightly more after 24 
hours (Group 2 and 3). IL-5, IL-6 , RANTES and TPO were all upregulated above 
the 1.5-fold threshold level after the TD20-4 hour dose only (Group 4).
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Figure 5.22 Graph of major cytokine changes in NHBE cultures after 4 and 24 hours incubation 
with T D 2o (0.5mg/ml) dose of LPS. Cytokine expression above 150% of control or below 150% 
of control after 4 hours incubation. Cytokine expression above 150% of control (■) or below 
150% of control (■) after 24 hours incubation, n -  1.
T D 5-24h T D 20-4h T D 20-24h
1
ENA-78 — ENA-78
G-CSF — G-CSF
SCF — SCF
2
IL-1 a IL-1 a IL-1 a
IFN-y IFN-y IFN-y
3 — IL-1 p IL-1 p
4
— IL-5 —
— IL-6 —
— RANTES —
— TPO —
Table 5.4 Crrelations between cytokine changes after treatment with LPS. Red boxes indicated 
increased expression £1.5-fold, blue boxes indicated decrease in expression £1.5-fold.
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Figure 5.22 Graph of major cytokine changes in NHBE cultures after 4 and 24 hours incubation 
with TD20 (0.5mg/ml) dose of LPS. Cytokine expression above 150% of control (^) or below 150% 
of control £*) after 4 hours incubation. Cytokine expression above 150% of control (■) or below 
150% of control (■) after 24 hours incubation, n = 1.
TD5-24h TD20-4h TD20-24h
1
ENA-78 — ENA-78
G-CSF — G-CSF
SCF — SCF
2
IL-1 a IL-1 a IL-1 a
IFN-y IFN-y IFN-y
3 — IL-1 P IL-1 p
4
— IL-5 —
— IL-6 —
— RANTES —
— TPO —
Table 5.4 Crrelations between cytokine changes after treatment with LPS. Red boxes indicated 
increased expression £1.5-fold, blue boxes indicated decrease in expression H.5-fold.
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5.5  D is c u s s io n
5.5.1 NHBE R esponse t o  L ip o p o ly s a c c h a rid e
5.5.1.1 C ultu re  V iability  an d  T r an s-E pith elial Elec tr ic al  R esistance
The ATP assay produced a biphasic response over the dose range tested, with 
the T D 5 dose (0.1 mg/ml) obtained from the initial decrease in culture viability. The 
subsequent increase in culture viability (up to 1 2 0 %) was thought to be part of an 
early-protective response of the culture. This protective increase in culture 
viability could be due to numerous reasons, including goblet cell hyperplasia 
(Harris et a l., 2007), an increase in glycolysis (Spolarics and Spitzer, 1993) and 
cellular hypertrophy (Kumar et al., 2010). Higher concentrations of LPS over-rode 
these early-protective responses, resulting in a decrease in culture viability, with 
the T D 2o dose being achieved at 0.5mg/ml LPS, to a T D 5 0  at 1 mg/ml. The LPS 
dose range used appeared high when compared to monolayer data (A549; 12 
fold; Tang et al., 2006); which may be due to a variety of reasons. Firstly, in order 
to achieve an adequate response to LPS in 24 hours. Secondly, the toxic effect of 
endotoxins is not mediated by direct killing of host cells or inhibition of cellular 
functions (Rietschel et al., 1994). Thirdly, the human airway epithelium has been 
shown to be hyporesponsive to LPS, due to a low MD-2 expression in primary 
cultures (Jia et al., 2004).
Culture integrity was evaluated by monitoring the TEER, which decreased in 
response to increasing LPS concentrations. The TEER readings did not increase 
above control readings (as did the ATP activity), but appeared to mimic the ATP 
response during the period of increased culture viability. This may indicate either 
that disruption of epithelial junctions in response to LPS plateaued at certain 
concentrations or that cellular hypertrophy and/or hyperplasia counteracted the 
decline in TEER readings from junctional disruption. In response to the TD5 dose 
there was a significant decline in TEER (55% of controls), with the TD20 dose 
yielding a TEER of only 4% of the control; at this level of resistance epithelial 
integrity was deemed to be negligible. This decrease in culture integrity in 
response to increasing concentrations of LPS would suggest that the cellular
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junctions were being corrupted, with tight junctions known to open in response to 
LPS (Eutamene et al., 2005). However, this disruption or detachment of epithelial 
cell contacts could be part of a protective and regeneration response, with cells 
detaching in order to migrate to areas of increased damage and restore the 
epithelial barrier (Park et al., 2006).
5 .5 .1 .2  M o r p h o l o g ic a l  C h a n g e s
Morphological assessment of NHBE cell cultures treated with a TD5 dose of LPS 
revealed that the basal cells were the most severely affected cell type. Many were 
shrunken in appearance and displayed detachment of cell-cell contacts, features 
suggestive of apoptosis (Elmore, 2007). However, some basal cells appeared to 
be migrating to the columnar layer, i.e. becoming intermediate cells. TEER values 
were low at this dose, indicating that cell junctions were compromised, enhancing 
the basal cells exposure to LPS (and inflammatory mediators; Han et al., 2004). It 
is therefore presumed that, basal cell demise/death contributed to the 
corresponding drop in culture viability. In addition to basal cell damage, there was 
a shift in the epithelial phenotype, denoted by increased mucus producing cells 
leading to excess apical mucin. Mucin hypersecretion is a well known protective 
response to lung injury (Burgel and Nadel, 2004), but the exact nature of this 
response is not always known. The replacement of many non-mucus with mucus 
cells was probably a combination of goblet cell hyperplasia (Toward and 
Broadley, 2002), basal cells differentiating into goblet cells and transdifferentiation 
of Clara and ciliated cells (Jeffery and Li, 1997; Evans et al., 2009; Park et al., 
2006). The transdifferentiation of Clara and ciliated cells was likely to account for 
the majority of ‘new’ mucin-secreting epithelial cells observed and are therefore,, 
not ‘true’ goblet cells. In response to injury, Clara and ciliated cells are known to 
become Clara-mucus and ciliated-secretory cells, with each retaining some 
characteristics of their original cell type, whilst incorporating mucus producing 
characteristics (Jeffery and Li, 1997). Histochemical and immunohistochemical 
techniques to detect specific cell types may shed light on the origin or dual nature 
of these transdifferentiated cells. Additionally, it is unknown whether the mucin 
secreted by these pseudo-goblet cells alters the physiochemical properties of the 
mucous layer, and if they do, is this change advantageous?
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Topographically, NHBE cultures treated with the TD5 dose appeared similar to 
control cultures, with an intact apical surface speckled with microvilli and cilia. 
There was evidence of dedifferentiation, with less ciliated cells than expected 
(control and TD5 cultures). These findings reinforced previous observations that a 
high dose of LPS could disrupt epithelial junctions without causing significant cell 
death, thereby allowing preferential damage to the basal cells.
In response to the T D 2o dose of LPS, there was loss of cell-cell contacts, with 
large inter-cellular gaps observed. Numerous cells, at all levels within the 
epithelium appeared shrunken with large nucleus-to-cytoplasmic ratios or indeed 
no discernable nucleus; all features indicative of cell death (Elmore, 2007). Large 
areas of degenerative material could be observed, which was thought to be 
reticular fibre or other ECM components (Fueki et al., 2009), further histological 
staining would be necessary to confirm this.
The NHBE cultures surface, following the T D 2o dose, demonstrated focal 
damage, with some areas exhibiting normal surface topography. Zones of 
intermediate regions displayed cells detached from their neighbours, which were 
spherical in appearance and had numerous protruding cilia, with other cells 
bulging apically, as if beginning to detach. Areas of severe damage revealed 
multiple cell layers of unattached, cilia protruding, cells. These regions of 
disrupted apical surface would cause the negligible TEER values exhibited at this 
dose. The reason for the detaching cells could be 2-fold, firstly, these cells were 
undergoing cell death and were detaching for this reason. Secondly, that these 
ciliated cells were detaching in order to migrate to areas of severe damage, 
where the epithelium had been completely denuded and were attempting to 
regenerate the epithelium in this region. It has been documented that ciliated cells 
that detach from explant cultures dedifferentiate, become squamous and 
contribute to the formation of a mature epithelium (Wallace et al., 1994).
5 .5 .1 .3  C y to k in e  C h a n g es
Only one CPT (LPS) was taken forward in an experimental trial to characterise 
the cytokine responses of the NHBE model. The NHBE cultures response to
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differing LPS doses provided an insight only into the cytokine and possible 
subsequent immune response and was therefore, not conclusive. This is mainly 
due to the fact that the NHBE culture consists of cells of the bronchial epithelium 
only and does not involve any immune cells that could be attracted in response to 
cytokines produced by the epithelium and in turn secrete their own mediators that 
could change the cytokine profile observed. Another limitation is that the array 
used only detects 42 and not all possible cytokines; therefore any conclusions 
may only be made on the changes observed. Additionally, this experiment was 
only performed on one insert, from one donor and without sufficient ‘n’ numbers is 
inconclusive.
In light of the above limitations and the large number of cytokines that have been 
altered, only certain cytokines and groups thereof, were investigated in more 
detail. The first of these groups involved the cytokines capable of initiating a TH1 
or a Th2 immune response (Table 1.3). IL-12 is the major cytokine involved in the 
activation of a TH1 response, whilst IL-4 in the activation of a TH2 response (Liu, 
2002). From our results, the response to the TD5dose was a reduced expression 
of IL-12, with an increased expression of IL-4. Four hours after the TD20 dose, IL- 
4 was increased. In response to both TD20 doses (4 and 24 hour exposures), IFN- 
y (an important TH 1 cytokine) was increased. IFN-y was also reduced after the 
TD5 dose. This data suggested that the ‘low’ LPS dose produced a Th2 response 
and the ‘high’ LPS dose resulted in the TH1 response; a documented response in 
hyposensitised individuals (Singh and Schwartz, 2005; Kim et al., 2007). 
Morphologically, a TH2 response leads to chronic inflammation, goblet cell 
hyperplasia and hypersecretion and fibrotic repair, which can eventually result in 
COPD (Liu, 2002; Tulic et al., 2000). Semi-thin sections of the TD5 dose, thought 
to be initiating a TH2 response also displayed evidence of increased mucin 
producing cells.
It was believed that only high doses of LPS cause the activation of an adaptive 
immune response in normal individuals, this response would be presented as a 
Th1 response. Whilst, in asthmatic/allergic (i.e. hypersensitised) individuals a TH2 
response is induced and thought to be the common response to inhaled antigens, 
even to low doses of LPS (Lui, 2002). Non-asthmatic individuals can also suffer
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from a Th2 type response, in tobacco smokers (Singh and Schwartz, 2005) and 
occupational exposure to high levels of LPS (“Monday asthma”; Liu, 2002). 
However, there is growing evidence that in asthmatic and allergic individuals, the 
immune response launched is based on the dose of LPS, with a low dose 
initiating a Th2 response and a high dose a Th1 response (Singh and Schwartz, 
2005; Kim e ta i,  2007).
Four groups of cytokines displayed interesting changes in response to LPS 
(Table 5.5). Group 1; ENA-78, G-CSF (up-regulated) and SCF (down-regulated) 
changed in both TD5 and TD2o exposures after 24 hours. These could serve as 
general indicators/mediators of injury (at this time only in response to LPS), which 
persisted 24 hours after initial infection. Group 2; IL-1 a and IFN-y displayed a 
decrease in expression with the TD5 dose, but an increase after both TD2o doses, 
with a slight increase from 4 to 24 hours. These cytokines could be helpful 
markers in differentiating low level injury compared to severe injury. Group 3; IL- 
1 p displayed an increase in expression in both TD20 doses, which in conjunction 
with Group 2, could serve as possible indicators of more severe injury. Group 4; 
IL-5, IL-6 , RANTES and TPO, were all up-regulated in the 4 hours TD20 dose, but 
no others, therefore, these cytokines have the potential as early-indicators of 
injury within the bronchial epithelium.
One advantage that the NHBE model possessed was the fact that the culture 
consisted only of the cells of the bronchial epithelium. This was advantageous 
since initial products from the epithelium itself, in response to pulmonary toxins, 
could be detected before they become masked by cytokines secreted by attracted 
immune cells. This may help to identify ‘early-markers of injury’, as well as, 
‘cellular targets’ for new therapeutic drugs for diseases associated with an over- 
active immune response. The obvious disadvantage to this system is that it only 
accounts for the cells of the bronchial epithelium, thereby eliminating the larger, 
downstream response produced by inflammatory cells.
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5.5.2 NHBE R e s p o n s e  t o  C a d m iu m
5.5.2.1 C u ltu r e  V ia b ility  a n d  T r a n s -E pith elia l  E lec tr ic a l  R e sis ta n c e
The ATP assay displayed a biphasic response over the dose range, with the TD5 
dose (0.05mM) obtained from the initial decrease in culture viability. The 
subsequent increase in culture viability (up to 1 1 0 %) was thought to be part of an 
early-protective response of the culture. This protective increase could be due to 
hypertrophy and/or an increase in glycolysis, both of which are known responses 
to cadmium (Shin et al., 2003; Waalkes, 2003). Higher concentrations over-rode 
these early-protective responses, resulting in decreased culture viability, with the 
TD20 dose obtained at 0.34mM, down to 35% of controls at 0.5mM.
The TEER of cultures to CdCI gave a dose response, with increasing 
concentrations resulting in decreasing TEER. There was a significant drop in 
TEER to 40% in response to the T D 5  dose, with the decrease in TEER after this 
point being more gradual, until the T D 2o dose. At the T D 2o dose, the TEER was 
only 2% of the control values and deemed to be negligible. Higher doses of CdCI 
did not have any effect on the TEER values, which remained extremely low (0 -  
2%). This loss in culture integrity would suggest that CdCI was eliciting its effects 
on the cellular junctions. Cadmium has been shown to selectively damage cell­
cell junctions in many epithelial cells, including the lung, through initial disruption 
of E-cadherin adherens junctions. This initial damage to epithelial adherens 
junctions could in time result in subsequent intracellular accumulation of cadmium 
which would cause the separation of tight junctions and result in further cell 
damage and eventually cell death (Prozialeck, 2000; Pearson and Prozialeck, 
2001; Pearson etal., 2003).
5.5.2.2 M o r p h o lo g ic a l  C h a n g e s
Distinct morphological changes were observed between NHBE cultures treated 
with both the TD5 and TD20 doses of CdCI. In response to the TD5 dose, the 
cultures had undergone mild degeneration, with basal cell squamation and 
hypertrophy, columnar cuboidalisation and dedifferentiation of goblet and Clara
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cells. Numerous cells, of all types appeared to suffer from the cytotoxic effects of 
CdCI, with cell shrinkage and vacuolisation apparent throughout. As mentioned 
earlier, cadmium is known to affect cell-cell junctions causing the cells to detach 
and become rounded (Prozialeck, 2000). This effect was observed more 
significantly on ciliated cells at the T D 5  dose, with numerous ciliated cells balled- 
up and detached from the epithelium. The reason that the ciliated cells were 
affected first could be due to the fact that their junctions have been preferentially 
disrupted (which should be the same for all cell types) but may be more due to 
the fact that CdCI is known to cause ciliostasis (Gabridge and Meccoli, 1982) and 
this is probably due to inhibition of mitochondrial ATP production (Kisling et al., 
1987). This inhibition of mitochondrial ATP production may also be the reason 
that Clara and goblet cells appeared to have dedifferentiated. However, a 
relatively small dose of cadmium is known to be highly toxic to Clara cells and 
may be the reason for their early disappearance (L&g et al., 2005).
Semi-thin sections of NHBE cultures revealed areas of severe damage, much 
more than would be expected at a TD2o dose. The epithelium presented as an 
almost confluent monolayer of cells, many of which displayed signs of cell death. 
SEM observations at this dose revealed that the semi-thin section was 
representative of an area of severe focal damage and not representative of the 
whole culture; hence the utility of using multiple microscope techniques. Surface 
analysis revealed that most of the culture had a dedifferentiated surface, with 
distinct lack of ciliated cells and numerous cells protruding and detaching from the 
surface; many of which were undergoing cell death. There were also numerous 
areas of severe focal damage, containing detached cells undergoing cell death 
and covered in a strange stringy coating, which was thought to be cell or ECM 
debris.
5.5.3 NHBE R e s p o n s e  t o  P a r a q u a t
5.5.3.1 C u ltu r e  V ia b ility  a n d  T r a n s -E pith elia l  E lec tr ic a l  R e s is ta n c e
The ATP assay displayed a gradual decrease in culture viability with increasing 
Pq concentrations. The TD5 dose was deemed to be 75pM and the TD20 dose to
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be 750pM. The culture viability decreased down to around 65% of controls by 
1500|jM. Pq concentrations required to have the same effect on NHBE cultures 
was roughly 15 fold higher than monolayer (A549) and 1.5 fold higher than BEAS- 
2B cell line (Song e ta i,  2006).
TEER of cultures to different concentrations of Pq yielded a biphasic response. 
Initial low doses (100 and 300pM) resulted in TEER higher than controls and 
subsequent higher doses of Pq resulted in total obliteration of TEER 
measurements. At the TD5 dose the projected TEER would be around 115%, 
whilst the TD20 dose resulted in a TEER of only around 9%. Pq concentrations 
£450pM resulted in negligible TEER readings. The initial increase in TEER 
readings was possibly part of an early-protective response with the increase likely 
to be caused by tightening of cellular junctions, stratification of the epithelium, 
mucus hypersecretion, cellular hypertrophy or hyperplasia. However, these TEER 
increasing factors need to balance with a slight loss in culture ATP levels. Wang 
and co-workers (1992) pointed to the mitochondria as the initial toxic site of Pq 
and Clara cells are known to be particularly sensitive to Pq toxicity (Masek and 
Richards, 1990; Smith et al., 1990). Therefore, as long as these losses in ATP 
content were larger than any subsequent increase caused by the above TEER 
raising mechanisms, this result could be achieved.
5.5.3.2 M o r p h o l o g ic a l  C h a n g e s
In response to the T D 5  dose, the cultures had changed from a pseudo-stratified 
epithelium to a cuboidal, stratified epithelium, with basal cells hypertrophic and 
squamated; all known responses to Pq (Clark et al., 1966; Kelly et al., 1978). 
There was evidence for ciliated cell loss and appearance of cytoplasmic 
vacuoles, which may be due to the observations of Wang and colleagues (1992), 
that the mitochondria were the initial site for Pq toxicity. There was an increase in 
secreting cells, however, due to cellular cuboidalisation, it was hard to determine 
if these were of goblet or Clara phenotype; CC10 and PAS staining (Chapter 4) 
could confirm this. Large inter-cellular gaps along with cytoplasmic vacuoles 
indicated that there was a degree of cell death. All of the morphological
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observations could account for an increase in TEER and slight decrease in 
culture viability at this dose.
There were significant morphological changes in response to the TD2o dose, with 
the cuboidal, stratified epithelium becoming a cuboidal monolayer, as observed in 
mice by Popenoe (1979). The surface revealed some dedifferentiation, loss of 
microvilli and some remaining ciliated cells. There were also regions of disrupted 
epithelium, cellular detachment and blebbing of apoptotic/necrotic cells (Mullinger 
and Johnson, 1976; Wyllie et al., 1980). This could account for the drop in TEER 
values to barely negligible levels.
5.5.4 NHBE RESPONSE TO AMIODARONE
5.5.4.1 C u ltu r e  V ia b ility  a n d  T r a n s -E pithelia l  E lec tr ic a l  R e sis ta n c e
The ATP assay produced a biphasic response over the dose range, with the TD5 
dose (300pg/ml) obtained from the initial decrease in culture viability. The 
subsequent increase only returned to control values and not above (at 500pg/ml), 
and was thought to be a slight early-protective response. As this protective 
increase did not increase culture viability above control values, was unlikely to be 
causes by extensive hypertrophy or hyperplasia. Although, they could be present 
in a subtle way, with an increase in glycolysis likely. Higher concentrations over­
rode these responses, resulting in decreased culture viability, with the TD20 dose 
obtained at 850pg/ml and further culture demise to 75% (1,000pg/ml).
Culture integrity (TEER), like the ATP profile displayed a slight biphasic response, 
with TEER readings not rising above controls. At 200pg/ml, the TEER values had 
decreased to 75%, yet by the T D 5  dose (300pg/ml) the TEER readings had 
returned to control values, that may be due to the tightening of cellular junctions. 
Subsequent TEER readings gradually declined as the concentration of Am 
increased to 700pg/ml, but, above this, there was a much sharper decrease in 
TEER measurements to 50% at 1,00pg/ml. The TEER and therefore, junctional 
and epithelial integrity was not as severely affected in response to Am as it was to 
the other CPTs. This may indicate that Am does not specifically affect the cellular
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junctions and probably affected the basal cells of the bronchial epithelium more 
severely without causing too much disruption to the surface barrier.
5 .5 .4 .2  M o r p h o lo g ic a l  C h a n g e s
There were more significant morphological changes observed in semi-thin 
sections than from the surface topography. The TD5 dosed sections revealed a 
degree of dedifferentiation, loss of cilia and basal cell squamation and 
hypertrophy. Surface analysis revealed no significant change from control 
cultures, indicating that the epithelial surface and apical junctions were intact 
(correlating with TEER data).
The TD20 dose revealed further degeneration and dedifferentiation of the 
epithelium. Basal cells appeared to be the most severely affected, with evidence 
of basophilia (Wyllie et al., 1980). There was also evidence of numerous darkly 
stained intra-cytoplasmic inclusions, which are known to accumulate in bronchial 
epithelial cells in response to Am (Colgan and Simon, 1984). Surface topography 
revealed some disruption of the epithelial barrier, with a few holes present, but on 
the whole the surface remained relatively normal. Higher magnification revealed 
surface dedifferentiation and cells were possibly regenerating, with the presence 
of what may be immature cilia and/or microvilli.
5.5.5 NHBE RESPONSE TO CIGARETTE SMOKE
5.5.5.1 C u ltu r e  V ia b ility  a n d  T r a n s -E pith e lia l  E lec tr ic a l  R e sis ta n c e
Culture viability was decreased in response to both concentrations 4 hours after 
recovery, with 82% for 1:50-4h and 54% for 1:20-4h. In addition to these two 
dilutions of CS, a 1:30 dilution was also utilised and all three monitored 24 hours 
after exposure. The viability of NHBE cultures 24 hours after exposure were 
severely damaged, with 60% for 1:50-24h, 32% for 1:30-24h and only 10% for 
1;20-24h. This response appeared severe, however, cultures did undergo 
continuous exposure to CS for 30 minutes, which was undertaken in order to 
produce a long-term effect of CS exposure. CS and its constituents are known to
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cause apoptosis and necrosis of bronchial epithelial cells (Domagala-Kulwik, 
2008; Izard and Libermann, 1978; Parsanejad e ta i,  2008).
Early, low-dose response (1:50-4h), resulted in increased TEER (-'125%), even 
though the culture viability was reduced almost to a TD20. This again 
demonstrated the NHBE models early-protective response to toxicants and would 
be indicative of a tightening epithelial tight junctions and/or an increase in 
glycolysis along with specific damage to basal cells. This protective mechanism 
was over-rode in response to the higher dose (54% at 1:20-4h), as well as 24 
hours later (25% at 1:50-24h). Both the 1:30-24h and 1:20-24h dilutions resulted 
in negligible TEER readings (both around 5% of controls), suggesting that 
epithelial integrity had been compromised. The decrease in TEER of the 
bronchial epithelium is a known response to CS, with loss of desmosomes and a 
decrease in ZO-1 and Claudin-1 genes known to occur (Frasca et al., 1968; 
Glader etal., 2006; Maunders e ta i,  2007).
5.5.5.2 M o r p h o l o g ic a l  C h a n g e s
Significant morphological changes were observed in response to CS. In response 
to the 1:50-4h dose the most striking change was exhibited in the total separation 
of the basal cells from the columnar cells and their detachment from the insert 
membrane. With loss of desmosomes known to occur in response to CS (Frasca 
et al., 1968), this had been exaggerated due to damage caused during tissue 
processing. There was evidence of dedifferentiation, cilia loss, mucin 
hypersecretion, basal cell hypertrophy, as well as cell death; all known in 
response to CS (Domagala-Kulwick, 2008; Parsanejad et al., 2008; van der Toorn 
et al., 2007). Surface topography revealed loss of ciliated cells and 
dedifferentiation, with most cells covered in microvilli only. There was an increase 
in damage by the 1:20-4h concentration, with the epithelium regressing to a 
monolayer phenotype, with numerous inter- and intra-cellular gaps/vacuoles, 
indicative of cell death (Wyllie et al., 1980). SEM images displayed evidence of 
focal damage in response to the 1:20-4h dose. Areas of minor damage appeared 
similar to the lower dose, with surface dedifferentiation apparent, fewer ciliated 
cells and there appeared to be loss of the microvillus covering. The areas of more
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severe damage displayed detached, undifferentiated cells, with the insert 
membrane visible in places.
Cultures exposed to 1:50-24h CS displayed degeneration, dedifferentiation, cell 
death and basal cell hypertrophy. The culture surface was pitted with cells 
appeared to have sunken, probably due to a significant amount of cell loss (40% 
loss). Cilia seemed to be retracting into the cell itself, which may infer the initiation 
of transdifferentiation of ciliated cells (Park et a i, 2006). Additionally, some cilia 
appeared to have clumped together, which may be part of the re-absorption of 
cilia or may be due to the combination of ciliostasis (Izard and Libermann, 1978; 
Romet-Haddad et a i, 1992) and acidic mucus (Rogers and Jeffery, 1986; Izard 
and Libermann, 1978). Toluidne blue sections of the 1:30-24h dose revealed 
extensive destruction of the epithelium, with a monolayer of undifferentiatied, 
basophilic, dying cells remaining. SEM analysis confirmed these observations 
with the presence of undifferentiated cells and numerous cells undergoing cell 
death and an abundance of cellular debris (Mullinger and Johnson, 1976). The 
ATP reading of cultures was 10% of control values, revealed very few remaining 
cells at the 1:20-24h exposure. This was highlighted in semi-thin sections where 
no cells were discovered in any sections. This was confirmed by SEM with most 
of the insert membrane devoid of cells. There were only a few areas where 
solitary or small sheets of cells remained.
5.6  C o n c l u s io n s
The NHBE model was exposed to a number of CPT in order to elucidate 
mechanisms of injury within the NHBE construct. In this manner, the model could 
not only be validated in terms of response to each toxicant as comparable to the 
in vivo situation, but, further analysis may elucidate cell/bronchial specific 
responses to each toxicant. This, in turn, may provide new targets for pulmonary 
drugs. A select panel of 5 toxins were chosen for their different toxic properties, in 
order to demonstrate a more complete view of defence, injury and repair 
mechanisms within the NHBE model.
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Naturally, the NHBE model displayed similarities in its response to CPTs, as there 
were a finite number of changes possible in such a closed or ‘static’ system of 
defined phenotype. However, in spite of this, the model appeared to reproduce 
toxicant-specific responses, often characteristic of the changes previously 
observed in vivo and in vitro.
Many of the compounds elicited an early-protective response with either a 
biphasic response of the ATP assay, TEER measurements or both. This indicated 
that in response to lower doses of some toxicants, the NHBE model can mount a 
protective response, which could in the future, be utilised to produce a ‘disease’ 
phenotype for testing ‘new’ pulmonary drugs.
The morphologic changes associated with CPT challenge involved numerous 
general responses (mucin hypersecretion, dedifferentiation, basal cell squamation 
and hypertrophy), as well as some toxicant specific alterations (e.g. cuboidal, 
stratification of the epithelium in response to Pq). Indicating that the NHBE model 
was relatively sensitive to different challenges, highlighting its potential as an in 
vitro model reflective of in vivo toxicity.
The cytokine expression profiles for LPS enabled a brief glimpse into the initial 
cytokine responses of the bronchial epithelium without the influence of other 
immune ceils. This information may, in turn, permit the identification of markers of 
injury and/or target sites for pulmonary drugs.
The exposure of the NHBE model to a selection of CPTs done in this chapter 
revealed its potential as an investigative system in respiratory toxicology and 
pharmacology.
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6.1 In t r o d u c t io n
Exposure of the NHBE model to CPTs (Chapter 5) was preformed to ensure that 
the model responded in the appropriate manner to these established toxicants. 
Further validation of the NHBE model as a viable in vitro alternative to animal 
testing, could be achieved by conducting blind-exposure to a number of AZ 
candidate respiratory compounds. The irritancy response was then compared to 
that obtained from AZ in vivo (rat), in-house testing and physicochemical data 
(supplied by AZ).
Biochemical (ATP and Bradford assays and TEER) and morphological (LM) 
analysis of irritancy was performed after blind-exposure of the NHBE model to AZ 
candidate respiratory compounds. Comparison of the in vitro irritancy data with 
corresponding in vivo data would be utilised to validate the NHBE model as a 
robust predictor of in vivo irritancy in respiratory toxicology and pharmacology, 
enabling Reduction, Refinement and Replacement of animals in this sense (3Rs 
principles: NC3R, 2010).
Certain trends in the ability of compounds to cause irritancy may be elucidated 
from their physicochemical properties. In 1997, Lipinski and co-workers analysed 
numerous orally administered drugs approved into Phase II trials in order to 
determine certain physicochemical properties that would suggest poor absorption 
and permeability. They devised the ‘rule of 5’, which stated that, poor absorption 
or permeability was more likely when: molecular weight >500Da; hydrogen bond 
donors >5; hydrogen bond acceptors >10; an octanol-water partition coefficient 
(clogP)>5. The ‘Lipinski Score’ denotes how many of these rules have been 
breached.
COPD currently affects an estimated 210 million people worldwide (WHO, 2009) 
and current, available treatments have only a limited effect on inflammation and 
do not treat chronic symptoms or disease progression. Therefore, the AZ 
candidate respiratory drugs developed and tested in this chapter are inhibitors of 
three key pathways involved in driving COPD; p38, kappa-B kinase-2 (IKK2) and 
phosphodiesterase-4 (PDE4) (Barnes, 2006; Seemungal et ai,. 2008).
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The p38 pathway can be activated in the COPD lung by several stimuli, including 
tobacco smoke, infection and oxidative stress (Newton and Holden, 2006; Renda 
et a i, 2008). Activation of the p38 pathway within the lung can cause 
inflammatory cell migration and activation, as well as, pro-inflammatory mediator 
release. All of which have been implicated in the development and exacerbation 
of COPD (Chung, 2001).
The inhibition of the IKK2 pathway is expected to reduce mucus secretion, cell 
death, acidic conditions and influx and activation of neutrophils and mononuclear 
cells. All of which are major pathological consequences of COPD, contributing to 
disease severity and progression (Barnes, 2006).
PDE4, a cAMP specific PDE, located predominantly within inflammatory cells 
(neutrophils, macrophages and lymphocytes), fibroblasts and airway smooth 
muscle, which are present in COPD airways (Boswell-Smith and Spina, 2007). All 
current oral PDE4 inhibitors are associated with target-related side-effects. The 
development of inhaled PDE4 inhibitors are hoped to reduce systemic exposure 
and hence, side-effects of oral PDE4 inhibitors (Boswell-Smith and Spina, 2007).
6.2  M a t e r ia l s  a n d  S t o c k  S o l u t io n s
6.2.1 M a te r ia ls
M a te r ia ls S u p p l ie r
AZ1 -  15 Compounds; powder 
AZ25 -  37 Compounds; powder
AstraZeneca R&D, Loughborough, UK
Table 6.1 Table of materials used and their suppliers.
6.2.2 S to c k  S o lu t io n s
S o l u tio n s S u p p l ie r
Dimethyl Sulfoxide (DMSO) Sigma, Dorset, UK
Table 6.2 Table of stock solutions used and their suppliers.
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6.3  M e t h o d s
6.3.1 Do sin g
NHBE cells grown at an ALI (Section 2.3.1) were dosed when cultures were 
between Days 27 -  33. TEERs were checked prior to dosing to ensure that they 
were above 1,5000 (-4 ,55 00 .cm2). All AZ compounds (dry powder) were 
dissolved in dimethyl sulfoxide (DMSO) overnight (dark, RT) on a shaker, to give 
a 100mM stock solution before further dilution (in ALI media) and dosing.
AZ1 -  10 were the initial compounds tested and stock solutions (100pM in 
DMSO) were diluted in ALI media to produce the dose range: 1, 3, 10, 30 and 
100pM in 0.1% DMSO. DMSO (0.1%) was used as the control solution. Each 
dose (50pl) was applied apically to NHBE cultures (n = 3). After incubation with 
the AZ compound or 0.1% DMSO (24 hours), the TEER was recorded on each 
NHBE culture insert (Section 6.3.2) and the PBS used in the TEER reading kept 
for future analysis of protein content (Bradford assay; Section 6.3.4). That same 
insert was then used to assess culture viability (ATP assay; Section 6.3.3). All 
doses (/? = 2) were assessed for morphological changes (Section 6.3.5). 
Following this, it was deemed that this dose range was too small and AZ1 -  10 
were all re-dosed at 400pM in 0.4% DMSO and ALI media (0.4% DMSO used as 
control) and assessed for culture viability and TEER.
Stock solutions (100mM in DMSO) of AZ11 -  15 were diluted in ALI media to 
produce the dose range: 10, 30, 100pM in 0.1% DMSO (0.1% DMSO used as 
control); 400pM in 0.4% DMSO (0.4% DMSO used as control); 800pM in 0.8% 
DMSO (0.8% DMSO used as control); 1000pM in 1% DMSO (1% DMSO used as 
control). Each dose (50pl) was applied apically to NHBE cultures (/? = 3). After 
incubation with AZ compound or relevant DMSO control (24 hours), the TEER 
was recorded on each NHBE culture insert (Section 6.3.2) and the PBS used in 
the TEER reading kept for future analysis on protein content (Section 6.3.4). That 
same insert was then used to assess culture viability (Section 6.3.3). Cultures 
treated with 10, 100 and 400pM doses of each AZ compound (n = 2) were 
assessed for morphological changes (Section 6.3.5).
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Stock solutions (100mM in DMSO) of AZ25 -  37 were diluted in ALI media to 
produce the dose range: 100|jM in 0.1% DMSO (0.1% DMSO used as control); 
400pM in 0.4% DMSO (0.4% DMSO used as control); 800pM in 0.8% DMSO 
(0.8% DMSO used as control). Each dose (50pl) was applied apically to NHBE 
cultures (n = 3). After incubation with AZ compound or relevant DMSO control (24 
hours), the TEER was recorded (Section 6.3.2) and the PBS used in the TEER 
reading kept for future analysis on protein content (Section 6.3.4). That same 
insert was then used to assess culture viability (Section 6.3.3). There was not 
enough culture inserts from that donor to do the corresponding morphological 
assessment, therefore, this was not done with AZ25 -  37.
All culture viability (ATP assay), TEER and apical protein content (Bradford 
assay) was presented as a percentage of the relevant controls. Irritancy was 
generally revealed at 100pM or 400pM (if less irritant), based on this these were 
the two concentrations focused on in this chapter.
6.3.2 T r a n s -E pith e lia l  E lectrical  R esistance
The TEER of NHBE cultures, immediately prior to- and 24 hours post-dosing was
established using the method previously described (Section 2.3.3).
6.3.3 ATP A ss a y
NHBE inserts that had been dosed and had their TEER measured were then 
placed in an empty well (24 well-plate) prior to performing the ATP assay, method 
previously described (Section 5.3.3).
6.3.4 B r a d fo r d  A ssay
The PBS (150pl) added apically to the dosed cultures for measuring the TEER 
was removed and assessed for protein content via the Bradford assay, method 
previously described (Section 2.3.4).
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6.3.5 L ig h t M ic ro s c o p y : T o lu id in e  B lu e
Inserts dosed with AZ1, 3 - 6  compounds and carrier solution (DMSO controls) 
for 24 hours were prepared for semi-thin sectioning and staining with toluidine 
blue and images taken (Section 3.3.1). NHBE inserts dosed with AZ2, 7 - 1 5  
compounds and carrier solutions (DMSO controls) for 24 hours were prepared for 
semi-thin sectioning as before (Section 3.3.1.1 -  3.3.1.5), with sectioning, 
toluidine blue staining and images taken by Dr. Sarah Bolton (AstraZeneca R&D, 
Loughborough, UK). Images were captured using the Zeiss Axioskop 2 
microscope (Carl Zeiss Ltd., Hertfordshire, UK), with a Leica DFC320 camera, 
using Leica DFC Twain Acquire software (Leica Ltd., Milton Keynes, UK) and 
Adobe Photoshop CS3 (Adobe Systems Incorporated, 2010).
6.3.6 C o r r e la t io n  o f  in v i t r o  D a ta  w ith  in vivo  S tudies
Compound information and correlative in vivo data (where possible) was provided 
by Dr. Victor Oreffo (AstraZeneca R&D, Loughborough, UK). Due to the 
confidential nature of the work in vivo dosing methods, morphology analysis and 
concentrations of compounds used were not released.
6 .4  R es u lts
6.4.1 P h y s ico ch e m ica l P ro p e r t ie s  o f  th e  AZ Compounds
Physicochemical properties of the AZ candidate respiratory compounds were 
provided by the industrial sponsor AZ (Table 6.3) after completion and analysis of 
testing in the NHBE model. These properties were believed to influence the 
irritancy potential and as such, were indicative of drug absorption/permeability in 
vivo (Hughes et a i, 2008; Lipinski et a i, 1997; Tronde et a i, 2003; Waring, 
2009).
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G r o u p3
.QN< Ion
C l a s s 0 MWTd PSA8 CLOGPf L o gD9
L ipinski
SCOREh
1 B 527.67 79 6.87 5.34 2
2 B 577.72 85 7.46 4.92 2
p38 3 N 340.33 43 3.08 3.60 0
4 B 572.70 94 3.10 3.00 1
5 B 592.14 111 4.10 1.21 1
6 B 431.54 64 3.16 -0.01 0
7 ND ND ND ND ND ND
IKK2 8 B 346.41 130 1.26 -0.56 1
9 B 346.41 130 1.26 -0.56 1
10 B 360.44 130 1.28 -0.31 1
11 B 681.83 107 6.36 1.15 2
12 B 703.82 106 6.03 1.38 3
13 B 690.75 107 6.55 0.68 3
14 ND ND ND ND ND ND
15 B 690.75 107 6.55 0.68 3
25 B 681.85 115 5.59 3.41 2
26 B 707.89 112 6.56 3.09 2
27 B 755.96 121 5.99 3.15 3
PDE4 28 Z 764.94 134 7.16 4.14 329 B 693.86 101 4.95 3.49 1
30 B 656.82 111 5.87 3.01 2
31 B 681.85 115 5.59 3.41 2
32 B 704.85 125 5.60 3.09 3
33 B 700.88 134 5.20 3.14 2
34 N 518.59 136 3.80 2.64 1
35 A 499.49 108 5.27 5.10 1
36 B 667.83 115 5.07 2.97 2
37 B 477.51 76 5.87 2.68 1
Table 6.3 Physicochemical properties of the AZ compounds tested. a Pathway targeted by the 
compound. b AZ candidate drug number. c Ion class of the molecule; A = acid, B = base, N = 
neutral, Z = zw itterion.d Molecular weight (Da), red text = >500Da. e Polar Surface Area (PSA; A2). 
f cLogP, red text = >5. 9 ACD LogD at pH 7.4. h Number of violations of Lipinski’s rule of 5. ND = 
not determined.
6.4.2 B io c h e m ic a l I r r i t a n c y  o f  AZ C o m p o u n d s
NHBE cultures were exposed to a variety of AZ compounds at many different 
concentrations. The whole panel of AZ compounds were exposed to both the 
100pM and 400pM doses, with biochemical irritancy (in vitro) revealed at these 
concentrations, the results were therefore focused on these concentrations.
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The culture viability (ATP assay), TEER and apical protein content (Bradford 
assay) were all displayed as a percentage of the relevant controls. Generally, the 
AZ compounds displayed 3 main responses at this biochemical level: 1) no 
irritancy; 2) possible irritancy; and 3) irritancy. These three main responses have 
been demonstrated graphically with AZ14, AZ9 and AZ28, respectively (Figure 
6 . 1).
250 I ATP BTEER □  Bradford
No Irritancy Possible Irritancy Irritancy
6  100
-50
100 400
AZ14pM
100 400
AZ9(jM
100 400
AZ28mM
Figure 6.1 Graph displaying the three main biochemical responses of the NHBE culture to AZ 
compounds 24 hours after treatment. AZ14; no irritancy. AZ9; possible irritancy. AZ28; irritancy. 
ATP (D), TEER (H) and Bradford (□) values displayed as percentage of relevant control values. 
Standard Deviation was shown for ATP (I), TEER (I) and Bradford (I), n = 3.
The biochemical response (ATP assay, TEER and apical protein) of NHBE 
cultures to AZ compounds was graded and biochemical irritancy decided. This 
was then compared to in vivo morphological irritancy (Table 6.4). Morphological 
irritancy (in vivo) was given post-/>7 vitro dosing and analysis. Changes to ATP 
and TEER values, as a percentage of controls were graded as follows: +/- =
change of 20 — 49%; ++/—  = change of 50 — 79%; +++/-----= change >80%.
Apical protein content often increased above 100% of control values and were 
therefore graded: + /- = change of 40 — 69%; ++/—  = change of 70 — 79%; 
+++/-----= change >100%.
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G r o u p AZ A TPC TEERC B r a d f o r d 5 Ir r it a n t?a b 100pM 400pM 100pM 400pM 100pM 400(jM IN VITRO e in  v iv o f
1 ---- No/Poss M ild
2 - + + No/Poss Y es
p38 3
- - + No/Poss Y es
4 - - + No/Poss Y es
5 - - - ---- + Poss No
6 + + + No/Poss No
7 - - + + - + Poss ND
IKK2 8
- No/Poss No
9 ---- + + Poss Y es
10 + + + + + Poss Y es
11 + ------- - ------- + + + + + Y es Y es
12 + - ---- + + Y e s * Y es
13 + ------- ---- ------- + + + + + + Y es Y es
14 + - No/Poss ND
15 - + + Y es Y es
25 - ------- ------- + + + + + Y es Poss*
26 - ------- + + ------- + + + + + Y es ND
27 - ------- ------- + + + Y es Y es
PDE4 28 + + + + Y es No29 - -------- -------- + + + + + Y es ND
30 - -------- -------- + + + + Y es Y es
31 -------- + -------- + + + Y es ND
32 -------- -------- + + + Y es ND
33 - -------- - -------- + + + Y es ND
34 - - No/Poss No
35 - No/Poss No
36 - -------- -------- + + + + + + Y es ND
37 - ---- ---- Y e s * Y es
Table 6.4 Biochemical response of the NHBE culture to AZ compounds 24 hours after treatment. 
a Pathway targeted by the compound. b AZ candidate drug number. c Change in ATP assay or
TEER compared to controls : + /- = change of 20 -  49% ; ++/—  = change of 50 -  79%; +++/------=
change >80%. d Change in apical protein content compared to controls: + /- = change of 40 -
69%; ++/—  = change of 70 -  99% ; +++/-----= change >100%.8 Irritancy based on biochemistry in
vitro (NHBE)f Irritancy based on morphology in vivo. Poss = possibly, ND = not determined. * AZ 
compound was highly toxic at 800pM. 1 Inflammatory response only.
Biochemical irritancy analysis revealed that 10 of the AZ compounds (all targeting 
the PDE4 pathway), deemed irritant in vitro had corresponding in vivo data. Out 
of these 10, 7 were irritant, 1 was possibly irritant and 2 displayed no irritancy in 
vivo (morphological assessment) (Table 6.4).
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6.4.3 M o r p h o lo g ic a l  A n a ly s is  o f  AZ C o m p o u n d s
Due to blind-testing and large numbers of AZ compounds, morphological analysis 
was only performed on doses up to, 100pM for AZ1 -  10, 400pM for AZ10 -  15 
and none on AZ25 -  37.
Morphologic analysis of NHBE cultures treated with various AZ compounds would 
enable distinction between compounds that weren’t deemed irritant at the 
biochemical level. The four main morphological responses to AZ compounds 
were: 1) no irritancy; 2) no/possible irritancy at the biochemical level, which 
revealed irritancy at the morphological level; 3) irritant in vitro but not irritant in 
vivo\ 4) irritant at both biochemical and morphological levels (Figure 6.2).
[B]
4 I
I— I
_________________________ 10pm
[D]
I— I
10pm
Figure 6.2 LM images of NHBE main responses to AZ compounds, stained with toluidine blue. 
[A] AZ compound deemed not irritant (biochemically), confirmed morphologically; NHBE culture 
treated with AZ8 (100|jM). [B] Not/possible irritant AZ compound (biochemically), mild irritant 
morphologically; NHBE culture treated with AZ10 (100pM). [C] AZ compound deemed not irritant 
in vivo, but irritant morphologically in vitro; NHBE culture treated with AZ1 (100pM). [D] Irritant AZ 
compound (biochemically), confirmed morphologically; NHBE culture treated with AZ13 (100pM).
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AZ compounds that were deemed not irritant at the biochemical level (Table 6.4). 
underwent morphological analysis in order to confirm/dispel irritancy potential in 
vitro. This was compared to in vivo irritancy data (morphology) and correlations 
determined (Table 6.5).
G roup3 A Z b
B io c h e m ic a l
Ir r ita n t
IN VITROc
M orphc
IRRIT/ 
IN VITRO
DLOGY -  
kNT?
IN VI
I r r i t a n t  
In  v i t r o
In  vivo -  In  
v i t r o  
C o r re la t io n
p38
1 No/Poss
Y e s /
M ild M ild
Y es /
M ild Y es
2 No/Poss No* Y es Poss Poss
3 No/Poss No* Y es Poss Poss
4 No/Poss
Y e s /
M ild Y es
Y es /
M ild Y es
5 Poss Y es No Y es No
6 NO/Poss
Y e s /
M ild No
Y es /
M ild No
IKK2
7 Poss No* ND Poss ND
8 NO No* No Poss Poss
9 Poss No* Y e s 1" Poss Poss
10 Poss Y e s /M il d * Y es Y es Y es
PDE4
14 No Y e s /M ild * ND
Y e s /
M ild ND
34 No ND No Poss/No# Poss
35 No ND No Poss/No# Poss
Table 6.5 Table correlating in vitro and in vivo responses to AZ compounds deemed not/possible 
irritant at the biochemical leve la Pathway targeted by the compound. b AZ candidate drug number. 
c Biochemical irritancy, in vitro, determined from Table 6.5. d Compound irritancy based on 
morphology. Poss = possibly, ND = not determined.* = Morphology only done at 100pM, where 
compound was not biochemically toxic. f  = Irritant via an inflammatory response. # Not deemed 
toxic at 800pM.
Irritancy analysis of AZ compounds that were deemed not/possibly irritant 
biochemically in vitro were checked for morphological signs of irritancy. From
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these 11 had corresponding in vitro and in vivo data; 3  correlated, 2  did not and 6  
possibly did. Out of the 6  possible irritants, 3 were irritant and 3 displayed no 
irritancy in vivo.
6.5  D iscussion
The main purpose of exposing the NHBE model to unknown AZ compounds was 
to validate the model’s efficiency at predicting irritancy outcomes in vitro which 
maybe predictive of the in vivo situation. Additionally, comparison of 
physicochemical properties of the AZ compounds with their irritancy potential in 
vitro and in vivo may reveal those characteristics which should be avoided or 
targeted when designing new respiratory drugs. The above was not as easily 
determined due to the nature of the work, that is, with the dose ranges and 
selection of compounds/doses to be used for morphological work often controlled 
by the industrial sponsor (AZ).
The initial concentration range utilised failed to highlight possible compound 
irritancy, until a 400pM spot-test (n = 3) with biochemical characterisation 
undertaken. This higher dose proved to be a more accurate predictor of 
biochemical irritancy. Following this, the dose range for subsequent compounds 
(AZ11 -  15, 25 -  37) was scaled-up along with corresponding morphology. This 
resulted in gaps in the data set, which may have been useful and should 
therefore, be incorporated into any future experiments. Additional gaps in the data 
set were due to not all of the AZ compounds tested in vitro being tested in vivo or 
their physicochemical properties determined.
Biochemical irritancy testing revealed that 15 AZ compounds (all targeting the 
PDE4 pathway of which there were 17) were deemed irritant in the NHBE system. 
The physicochemical properties of the PDE4 inhibitor group were mainly basic, of 
high molecular weight, lipophilic and had Lipinski scores of 2 or 3. Based on 
these parameters it was unsurprising that many of them were irritant. From the 15 
irritant PDE4 compounds, 10 had been tested in vivo, of which, 7 were 
considered irritant in vivo. One of which displayed no irritancy with a nasal spot- 
test, but showed evidence of an inflammatory response in the rat. The other
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compound (AZ28) was determined as not irritant in vivo (rat), however, from the 
biochemical data (in vitro) collected, AZ28 was the most irritant compound tested. 
Unfortunately, no morphological evaluation was performed on this compound in 
the NHBE system. The NHBE response to AZ28 may either reflect the true 
response (i.e. human in vivo) or it may represent a false-positive. Based on 
physicochemical properties alone the likely-hood of AZ28 being a poor candidate, 
promiscuous drug, was high (Leeson and Springthorpe, 2007; Lipinski et a i, 
1997; Ritchie et a i, 2009). AZ28 is a zwitterion of high molecular weight 
(764.94Da), high clogP (7.16), logD (4.14) and having a Lipinski score of 3. 
Further continuation of this drug into dog and human trials may reveal the correct 
response and possible validation of the NHBE system to detect irritant 
compounds prior to in vivo work being implemented. Numerous drugs are known 
to fail at Phase II and III clinical trials due to preliminary testing being undertaken 
in inappropriate systems (Kola and Landis, 2004), the possibility that AZ28 fails at 
these stages is likely based on irritancy in the NHBE system and its 
physicochemical properties. Equally, the deduction of AZ28 as an irritant may be 
a false-positive due to limitations in the in vitro system. These limitations include: 
1 ) bronchial epithelium only; 2 ) ballistic properties of the aerosol and particle size 
distribution lost; 3) no inflammatory cells and therefore, phagocytosis; and 4) 
possible dissolution in the lung lining fluid in vivo.
All compounds that were classed as being irritant, at the biochemical level 
(NHBE), displayed evidence of irritancy in corresponding morphological analysis 
(where undertaken). Therefore, it was decided to look closer at the morphology of 
those AZ compounds that were deemed not/possible irritants at the biochemical 
level. This was done not only to gain a more detailed view of what changes may 
have occurred but to ensure that the biochemical response did not produce false- 
negatives. This could occur if the compound caused a multicellular event (i.e. 
hypertrophy or hyperplasia) within the NHBE model.
From the 13 AZ compounds that suggested no/possible irritancy at the 
biochemical level, 11 had corresponding in vitro and in vivo data; 3 correlated, 2 
did not and 6  possibly did. AZ5 and AZ6  (p38 inhibitors) displayed irritancy in the 
NHBE system but not in vivo (rat only); further investigation would confirm the
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true response. AZ5 was not phospholipidotic, but basic, with a high molecular 
weight (592.14Da) and a Lipinski score of 1. It was therefore probable that this 
was a false-positive result by the NHBE system. AZ6  had a Lipinski score of 0, 
indicating that it was unlikely to be an irritant. However, according to Hughes and 
colleagues (2008) any compound which had a clogP >3 and a polar surface area 
(PSA) <75A2 (as AZ6  is) was 2.5 times more likely to be toxic than clean.
Of the 6  compounds that were possible irritants, 3 were deemed irritant and 3 not 
in vivo. It would be expected that the 3 AZ compounds that were deemed irritant 
in vivo (AZ2, 3 and 9) would demonstrate irritancy in vitro, with morphology 
undertaken at the 400pM doses of these compounds. The only reason they were 
deemed ‘possible’ irritants, as opposed to irritants, was due to the fact that 
morphological analysis, at 100pM displayed no irritancy. However, all of these 
compounds did not display biochemical evidence of irritancy until 400pM and 
morphological analysis at this dose may clarify whether these compounds were 
irritant in vitro.
The 3 compounds that were not irritant in vivo were AZ8  (IKK2 parent 
compound), 35 (PDE4) and 35 (PDE4). AZ8  did not display biochemical irritancy 
until 400pM, where no corresponding morphology was undertaken, further 
investigation would be required to determine its true irritancy. AZ34 and AZ35 did 
not have any in vitro morphology information (due to lack of inserts at the time), 
but did not display biochemical signs of irritancy even at 800pM. This suggested 
that they were not irritants in vitro, but this was not confirmed. Both of these 
compounds are currently in Phase II clinical trials and as yet, have not displayed 
evidence of irritancy. Both of these compounds were from the PDE4 inhibitor 
group, but displayed some physicochemical differences to the other compounds 
in this group, which were mainly basic, of high molecular weight and 
phospholipidotic. AZ34 was a neutral molecule, with a slightly high molecular 
weight (518.59Da), but was not phospholipidotic, whilst AZ35 was an acidic 
molecule, that was slightly phospholipidotic (clogP: 5.27 and logD(7.4): 5.10). 
This indicated that when searching for a candidate drug that inhibits PDE4 a 
neutral or acidic molecule with a low Lipinski score (both = 1) may provide the 
best candidate.
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In the development of IKK2 candidate compounds, AZ8  was optimised for further 
evaluation. In the process of optimising the compound for dry powder inhalation 
studies, a salt form was required to achieve compound delivery as a dry powder. 
When AZ8  delivered as a succinate salt, was subsequently shown to be irritant in 
vivo. In vitro analysis of AZ7 (succinic acid) indicated the salt itself was an irritant 
to the epithelium. AZ8 , the parent compound, was found not to be irritant to 
NHBE cells in vitro in agreement with findings observed in vivo. An alternative 
compound, AZ10, was also evaluated, however, the parent compound proved to 
be both irritant in vivo and in vitro. The limited IKK2 compound set evalauted, 
demonstrated that the order of cytotoxic injury to the ALI culture agreed with the 
severity of irritancy seen in vivo. The irritancy severity could be ranked as follows: 
IKK2 drugl succinate succinic acid (AZ79)»IKK2 drug 2 (AZ10)»IKK2 drugl 
parent (AZ8 ) > control (AZ1).
With respect to the p38 group (AZ1 -  6 ) and IKK2 group (AZ7 -  10) of 
compounds, an insufficient compound set was available to ascertain clear 
physiochemical properties that were associated with irritancy. A larger screen of 
compounds with an increase in the variety of the physicochemical parameters 
assessed may reveal more promising candidate respiratory drugs with an 
indication of which parameters confer irritancy with these targets.
6 . 6  C o n c lu s io n s
Correlation between the NHBE in vitro model and in vivo rat model, based on this 
work, where a correlation was a clear yes or no was 76.9%. If all the possible 
correlations did correspond this would increase to 85%. However, this is only 
based on a limited study utilising a small set of compounds and more analysis 
would be required to confirm the accuracy of the NHBE model at predicting the in 
vivo rat response and if this has any correlation with the human in vivo response.
There is a high attrition rate of new compounds at Phase II and III of clinical trials 
(Kola and Landis, 2004). It is many researchers belief that this is mainly due to 
inadequate or inappropriate screening prior to these phases (Matsuda et a i,
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2009; May et at., 2009). One issue is that the animal system tested is not an 
accurate enough reflection of the human in vivo situation; another is due to 
toxicity to organs/systems not directly associated with the compound (off-target 
toxicity). In light of this, the NHBE culture system may be utilised as part of 
candidate respiratory drug screening protocols. However, as the candidate 
respiratory drugs utilised in this chapter (with the exception of AZ34 and 35) have 
not been tested in humans, the accuracy of the NHBE in vitro model to determine 
human in vivo irritancy has not been established. Continuation of the comparison 
of candidate respiratory drugs throughout their pre-clinical and clinical screening 
processes with the NHBE model may shed light on the accuracy of the in vitro 
model at predicting human in vivo outcomes. For instance, the monitoring of 
compounds such as AZ28 (highly irritant in vitro [NHBE], but not in vivo [rat]), 
during future clinical trials, may provide us with the answer to whether the NHBE 
model could determine human respiratory irritancy in vivo.
Therefore, in the future, the use of the NHBE culture system in the screening of 
candidate respiratory drugs could possibly be beneficial by 1 ) potentially reducing 
attrition rates in Phase II and III of clinical trials; and 2) reducing the number of 
compounds tested in animals. However, more work is needed in order to 
determine these potential benefits and is only speculative at this phase.
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C h a pter  7: 
G en er a l  D is c u s s io n
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7.1 O v e rv ie w
The overall objective of this research project was to utilise NHBE cells in creating 
an in vitro model of the human bronchial epithelium as a toxicological testing tool. 
In order to validate the NHBE model as a suitable alternative, extensive 
biochemical, morphological and toxicological analysis was essential. In this way, 
it was ensured that the NHBE model not only resembled the in vivo bronchial 
epithelium, but that it responded to toxic challenges in a similar manner.
The bronchial epithelium provides one of the initial lines of defence to inhaled 
substances, including inert, non-pathologic and xenobitotic particles, pathogenic 
organisms and toxic/inert gases (Berne et a/., 2004; Gerritsen, 2000; Korpas and 
Honda, 1996; Nicod, 1999), making it an ideal region to study the toxicological 
consequences of inhaled substances. In addition to this, numerous pulmonary 
diseases, such as COPD and asthma, cause severe damage/alterations to the 
bronchial epithelium (Puchelle et ai., 2006; Trautman et ai., 2005; White and 
Dorscheid, 2002). In order to better understand the impact of inhaled substances, 
disease mechanisms and to accurately test potential new drugs, within the 
context of the respiratory epithelium, an adequate human-like model system was 
required.
The first hypothesis proposed that “primary normal human bronchial epithelial 
(NHBE) cells can be cultured at an air-liquid interface in order to create a 
fully-differentiated bronchial epithelium of muco-ciliary phenotype 
containing basal, intermediate, Clara, serous, goblet and ciliated c e l l s This 
was confirmed through extensive biochemical and morphological analysis, as well 
as histochemical and immunohistochemical identification of specific cell/epithelial 
markers. The mature NHBE model (Days 27 -  33) displayed a pseudo-stratified, 
fully-differentiated, muco-ciliary epithelium characteristic of the human in vivo 
bronchial epithelium (Breeze and Wheeldon, 1977; Rhodin, 1959). In addition to 
the basic morphology of the model, major bronchial-specific cell types were 
identified on more than one level. Basal cells were identified via their location (LM 
and TEM; Baldwin, 1994) and selective positive staining of CK 5/6 and p63 in the 
mature epithelium (Stosiek et a i, 1992; Yang et a i, 1998). Goblet cells were
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confirmed from their characteristic ‘goblet’ shape (LM and TEM; Rogers 2003), 
secretion of mucin (SEM, visually [visco-elastic fluid] and positive Bradford 
assay), as well as histochemical staining by PAS (Zugibe, 1970). Ciliated cells 
were distinguishable by the numerous cilia protruding form their surface (LM, 
TEM and SEM; Breeze and Wheldon, 1977), with cilia verified at the TEM level by 
the electron-dense striations caused by the microtubules, the classical “9 +2 ” 
axoneme on transverse sections and the anchoring basal bodies, surrounded by 
mitochondria (Hasleton and Curry, 1996). Clara cells were identified 
morphologically (LM [semi-thin sections] and TEM; Boers et a i, 1999) and via 
expression of the Clara cell specific marker, CC10 (Singh and Katyal, 1997). The 
additional presence of Clara cells identified the NHBE model as a bronchial, not a 
tracheobronchial model, with this potentially indicating that the NHBE model 
contained important P450 metabolising enzymes (not investigated in this 
research project; Boyd, 1977). The presence of cellular junctions were 
established biochemically (TEER; Gardener et a i, 1997) and the tripartite 
junctional conformation (tight junction, adherens junction and desmosome), 
determined visually (TEM; Farquar and Palade, 1963). The detection of three 
major tight junction proteins, ZO-1, occludin and claudin-1 were ascertained 
within the model. All of the above parameters stabilised during the maturation of 
the model to generate a static, in vitro model of the human bronchial epithelium 
between Days 2 7 -3 3 .
The hypothesis for Chapter 5 postulated that "when challenged with classical 
pulmonary toxins the NHBE model would respond with general and toxicant 
specific responses”  and the second main hypothesis inferred that "the NHBE 
cell model will predict drug irritancy outcomes for rat in vivo airway 
exposures”. Exposure of the NHBE model to classical pulmonary toxins (CPT) 
revealed that the model was sensitive to these known CPTs. The NHBE model 
produced some general characteristic morphological changes, such as, mucin 
hypersecretion, dedifferentiation, squamation, hypertrophy and cell death. In 
addition, the NHBE model also produced some toxicant-specific responses: 1) 
LPS -  goblet cell hyperplasia, hypersecretion and disruption of cellular junctions 
(Euramene et a i, 2005; Lui, 2002; Tulic et a i, 2000); 2) CdCI -  disruption to 
cellular junctions (probably E-cadherin based), highly cytotoxic to Clara cells and
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loss of ciliated cells (most likely due to mitochondrial toxicity; Gabridge and 
Meccoli, 1982; Kisling et a i, 1987; Lag et a i, 2005); 3) Pq -  alteration to cuboidal 
stratified epithelium with squamated basal cells in response to lower doses and 
deterioration to cuboidal monolayer at higher doses (Clark et a i, 1966; Kelly et 
a i, 1978; Popenoe, 1979); 4) Am -  presence of electron-dense, intra-cytoplasmic 
inclusions (Colgan et a i, 1984); 5) CS -  dedifferentiation, cell death, cilia loss, 
mucin hypersecretion and basal cell hypertrophy (Domagala-Kulwick, 2008; 
Parsanejad et a i, 2008; van der Toorn et a i, 2007). The NHBE model 
demonstrated the ability to alter its cytokine profile in response to LPS; a useful 
tool when studying toxicological consequences. The NHBE model also underwent 
blind-exposure to AZ candidate respiratory drugs, subsequent toxicological 
analysis and corresponding in vivo exposures performed. Overall, the NHBE 
model had a ~76.9 -  85% correlation with rat in vivo toxicity.
7.2  C o n c lu s io n s
In conclusion, the use of NHBE cells to create a fully-differentiated model of the 
human respiratory epithelium and determine its validity as a possible in vitro 
model predictive of in vivo toxicity, resulted in numerous observations and these 
have been discussed below.
Key deductions from initial NHBE model development:
• Correct culturing of NHBE cells in non-collagen coated flasks and seeding 
at Passage 3 into Millipore® cell culture inserts, produced around 300 
inserts from one donor cryovial (~500,000 cells), improving cost 
effectiveness greatly over the Richter method (i.e. 60 inserts form one 
cryovial)
• The formation of tight junctions, measured by TEER, resulted in similar 
profiles from 3  different donors, demonstrating lack of donor variability in 
this aspect
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• The development of the NHBE epithelium mimicked the re-epithelialisation 
of a COPD patients bronchial airway
Key deductions from fully-developed NHBE model:
• LM and TEM observations over the models morphogenesis revealed the 
production of a well-differentiated, pseudo-stratified epithelium of muco­
ciliary phenotype similar to the human in vivo situation
• Morphological, histochemical and immunohistochemical analysis
confirmed the presence of basal, intermediate, Clara, goblet and ciliated 
cells within the NHBE model as is in the human bronchial epithelium
• TEM accurately determined the presence of cilia from their length, 
electron-dense striations, characteristic “9+2” axoneme structure and 
anchoring basal bodies
• SEM enabled surface topography analysis of the muco-ciliary phenotype 
as well as whole culture overviews (useful in determining focal or severe 
damage)
• Extensive characterisation, biochemically, morphologically as well as the 
relative cell numbers of each specific cell type within the NHBE model may 
prove a useful tool when monitoring toxicological response
• The NHBE model was stable in all monitored parameters from Days 27 -
3 3  and this, should therefore, be the toxicological dosing window
Key deductions from exposure to classical pulmonary toxicants:
• The NHBE model displayed numerous general defence/irritancy responses 
to CPTs (such as goblet cell hyperplasia), which may be useful in creating 
‘disease’ models of the bronchial epithelium
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• Toxicant-specific responses were also noted in response to the CPTs, 
indicating that the model was sensitive to at least some of the specific 
mechanisms of action of each individual pulmonary toxicant
• Cytokines are produced by the NHBE model and their expression profile 
was altered in response to LPS and would therefore, probably alter in 
response to other irritants/drugs
• A closed system of defined phenotype, such as this enabled the initial 
response of the bronchial epithelium to be elucidated, prior to masking by 
incoming inflammatory cells, thereby, identifying initial changes and 
possible new therapeutic targets
Key deductions from AZ candidate respiratory drug testing:
• Biochemical analysis (TEER and ATP assay) alone was, occasionally, 
insufficient in attempting to determine irritancy
• Complimentary morphological analysis revealed false-negatives from 
biochemical irritancy assessment, which occurred when the response was 
a multicellular event
• The NHBE model predicted the in vivo (rat) toxicological response 
relatively accurately, with a 76.9 -  85% correlation, indicating it was a 
suitable alternative to in vivo (rat) testing
2 0 4
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7.3 F u tu r e  W o r k
7.3.1 G e n e r a l  NHBE Pa r a m e te r s
With respect to the establishment of the NHBE model for use in toxicological 
testing, the method is well-characterised, with the dosing window between Days 
27 -  33. However, the use of biochemical, morphological, histochemical and 
immunohistochemical characterisations, employed to determine this dosing 
window, may be implemented on Days 25, 26, 34 and 35, in order to potentially 
broaden this window.
The Bradford assay was a useful tool in assessing the protein content of apical 
secretions; it does not however, specifically identify mucin. One particular 
alternative could be the lectin-based mucin assay, which used a modified 
standard ‘sandwich’ immunoassay to more accurately determine and quantify 
mucin production (Jackson et a i, 2002).
The identification of the tight junction proteins, ZO-1, occludin and claudin-1 was 
deemed successful. One highlighted problem was that human lung cells (in vivo) 
express claudin-1, -3, -5, -7 and -8 (Coyne et a i, 2003; Morita et a i, 1999) and 
that human primary cultures (in vitro) only contain claudin-1 and -4 (Coyne et a i, 
2003). Further examination of the different claudin family members, possibly via 
immunohistochemistry, could determine if this is indeed the case within the NHBE 
model.
The fact that the NHBE model contained Clara cells suggested that it possessed 
potential P450 activity. As P450 expression is relatively low in the lung, the most 
reliable method to assess this would be quantitative real-time RT-PCR of specific 
CYP family members, known to be expressed in the human bronchial epithelium 
in vivo (Castell et a i, 2005).
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7.3.2  T o x ic o lo g ic a l  Ex p o s u r e
In continuation of the work on CPTs, further analysis could be undertaken on the 
specific response of the NHBE model to each CPT. Specific cell types and their 
profile alteration, could be monitored through use of the histochemical and 
immunohistochemical procedures utilised in Chapter 4. This would identify an 
increase in and specific toxicity of, any particular cell type. Additionally, 
transdifferentiating cells, such as, ciliated-secretory or Clara-mucous cells may be 
detected (Jeffery and Li, 1997). The monitoring of cell junction proteins may 
enlighten the specific junctional interactions/interference that individual toxins 
may have, such as E-cadherin in CdCI treated cultures (Prozialeck, 2000) or 
desomosomes in response to CS (Frasca e ta i,  1968).
Cytokine changes in response to LPS were interesting, but were only achieved 
for n = 1 insert for each treatment and therefore, could only be interpreted with 
caution. The completion of this experiment, with sufficient ‘r i  numbers would give 
more weight to the conclusions drawn. The monitoring of cytokine production 
after exposure to other pulmonary toxins may also give a great insight into the 
bronchial epithelium cytokine response and due to the confined nature of the 
system may reveal new therapeutic targets.
Blind-exposure of the NHBE model to AZ candidate respiratory drugs 
demonstrated a relatively high level of accuracy in predicting the in vivo animal 
(rat) response. Further feedback on those AZ compounds continued to the next 
stage in the screening procedure (especially those which were deemed non­
irritant in vivo but irritant in vitro), may provide essential information on the 
validation of the NHBE model as an accurate predictor of human in vivo 
respiratory toxicity.
7.3.3 Fu tu r e  D ir e c tio n s
The development of this model as a toxicological and pharmacological tool could 
be pushed well beyond the scope of this research project. The model could be 
adapted further, with the co-culture of fibroblasts, dendritic cells, T-cells, or even
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a combination of these cell types. This would enable researchers to create ever­
more complicated models, which would more accurately reflect the human in vivo 
situation.
The co-culture of the NHBE cells with fibroblasts to create a ‘full-thickness’ model 
could be utilised in a scratch-wound assay. This could enable the normal and 
fibrotic (disease) repair mechanisms to be elucidated, with the potential to create 
new therapeutic agents to minimise or prevent fibrosis within the bronchial 
epithelium.
In addition to this, the model may be manipulated, for instance to a goblet cell 
hyperplasia mode, thereby, creating potential ‘disease’ models. These ‘disease’ 
models could allow further understanding of disease mechanisms within the 
bronchial epithelium and allow the effective testing of new therapeutic agents in 
retarding/reversing the disease phenotype.
7.4  U lt im a te  C o n c lu s io n
The ultimate conclusion from this research project was that the NHBE cells could 
be cultured at an air-liquid interface to provide a suitable in vitro model of the 
human respiratory epithelium, which may be predictive of human in vivo 
toxicology. This model (under current characterisation parameters) may be 
utilised for toxicological testing during Days 27 -  33.
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